Join us for a vital webinar on Graves’ disease! Discover evolving treatment patterns and strategies to address unmet needs. Register for free: www.workcast.com/register?cpak=2673713453367707&hss_chann… #gravesdisease #webinar #healthcare #autoimmune #thyroid #research #immunovant
Mary Ann Liebert
Mary Ann Liebert, Inc. is a publishing company founded by its president, Mary Ann Liebert, in 1980 and a subsidiary of Sage Publishing. The company publishes peer-reviewed academic journals, books, and trade magazines in the areas of biotechnology, biomedical sciences, medical research, and life sciences; clinical medicine, surgery, and nursing; technology and engineering; environmental science; public health and policy; law, regulation, and education. More on Wikipedia
-
Mary Ann Liebert Inc
@LiebertPub
-
Mary Ann Liebert Inc
@LiebertPub
Join our upcoming webinar on Graves’ Disease! Discover evolving treatment patterns and future management strategies with experts. Register for free: www.workcast.com/register?cpak=2673713453367707&hss_chann… #gravesdisease #webinar #healthcare #autoimmune #thyroid #medicalresearch #patientcare
-
Mary Ann Liebert Inc
@LiebertPub
The State of AI in Precision Oncology virtual summit is tomorrow.
📅 Tue, Dec 16 | 11 AM–3 PM ET
💻 Free and virtual
Hear from leaders advancing AI in cancer care.
Register: summits.sagepub.com/e/the-state-of-ai-in-precision-oncolo…
@AI_PrecisionOnc -
Mary Ann Liebert Inc
@LiebertPub
Virtual summit on AI in precision oncology.
Dec 16, 11 AM–3 PM ET.
Free registration: summits.sagepub.com/e/the-state-of-ai-in-precision-oncolo…
Speakers: @DrAbernethyFDA @zakkohane @LucioGordanMD plus leaders from @DanaFarber and @MassGenBrigham. #aiinoncology #medicalinnovation
__________________________ -
Mary Ann Liebert Inc reposted
Sage Journals
@SageJournals
UN Sustainable Development Goal 1 aims to end poverty in all its forms everywhere.
Explore our research collection aligning with our commitment to SDG1 No Poverty: journals.sagepub.com/sdg1-no-poverty
#sdg1 #nopoverty -
Mary Ann Liebert Inc
@LiebertPub
Discover the future of kidney stone removal! Explore new aspiration tech for better outcomes, efficiency, and cost savings. Download the free eBook by @calyxoinc: multimedia.sagepub.com #urology #healthcare
-
Mary Ann Liebert Inc
@LiebertPub
Discover proactive strategies to prevent biospecimen loss with @gen_vault experts in our free webinar. Secure your spot: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #biobanking #webinar #biospecimens #research #lifesciences
-
Mary Ann Liebert Inc
@LiebertPub
Join our free webinar on proactive strategies to prevent biospecimen loss with @gen_vault experts. Register now: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #biobanking #webinar #biospecimens #research #lifesciences
-
Mary Ann Liebert Inc
@LiebertPub
Explore emerging aspiration technologies in ureteroscopy at our free webinar on October 14. Gain expert insights on safety and innovation. Register now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
@calyxoinc @calyxoinc @DornierMedTech #urology #endourology #innovation -
Mary Ann Liebert Inc
@LiebertPub
Join our free webinar on October 14: Discover the latest aspiration technologies in ureteroscopy, with expert insights on safety, innovation, and practice tips. Register now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
@calyxoinc @DornierMedTech
#ureteroscopy #ureteroscopy #endourology #urology -
Mary Ann Liebert Inc
@LiebertPub
Join our free webinar: Biobanking Security, Proactive Strategies for Preventing Biospecimen Loss. Learn from @gen_vault experts on safeguarding your samples and avoiding common pitfalls. Register now: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #biobanking #webinar #lifesciences
-
Mary Ann Liebert Inc
@LiebertPub
We’re excited to welcome Dr. Bettina M. Beech, DrPH, MPH, FAHA as Editor-in-Chief of Population Health Management. She succeeds founding editor Dr. David Nash, a leader in the field.
🔗 journals.sagepub.com/publications/population-health-manag…
#populationhealth #publichealth #maryannliebert -
Mary Ann Liebert Inc
@LiebertPub
Join our free webinar on emerging aspiration technologies in ureteroscopy! Learn from six experts about innovations, clinical evidence, and practical tips. Register now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
@calyxoinc @DornierMedTech
#ureteroscopy #endourology #medicalwebinar #innovation -
Mary Ann Liebert Inc
@LiebertPub
NEW PODCAST! In this episode, Dr Dhruv discusses TED patient identification and management based on the published American Thyroid Association (ATA)/European Thyroid Association (ETA) consensus statement. Listen to this FREE podcast: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCCE! TODAY, our industry experts will discuss the impactful role of circulating tumor DNA (ctDNA) testing for MRD assessment in GI cancer management. Register now to join us for this free webinar sponsored by @nateragenetics: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. REGISTER: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 9/10, our industry experts will discuss the impactful role of circulating tumor DNA (ctDNA) testing for MRD assessment in GI cancer management. Register now to join us for this free webinar sponsored by @nateragenetics: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
What’s next in precision medicine?
Join @GENbio’s State of Biotech 2025 on Sept 24. Insights for clinicians, researchers, and diagnostics leaders.
Free to attend → summits.sagepub.com/e/the-state-of-biotech-2025
#healthtech #drugdiscovery #clinicalresearch #biopharma #medtech -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 9/8, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. REGISTER: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
George Church, PhD.
Biotech icon. Visionary mind.
Join @GENbio on Sept 24 at 12PM ET for a can't-miss convo on gene editing, synthetic biology + more at #stateofbiotech.
🎟️ Save your spot:
summits.sagepub.com/e/the-state-of-biotech-2025
#gen #georgechurch #biotech #genomics @geochurch -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 9/10, our industry experts will discuss the impactful role of circulating tumor DNA (ctDNA) testing for MRD assessment in GI cancer management. Register now to join us for this free webinar sponsored by @nateragenetics: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
📘 New @AmThyroidAssn guidelines in @ThyroidJournal detail updated management for adult patients with differentiated thyroid cancer. Must-read for clinicians.
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#thyroidcancer #ata #endocrinology #clinicalguidelines #thyroidhealth #ata2025 -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 9/8, Vicky Smith, PhD, an expert in RNA biology, will provide a practical blueprint for enhancing mRNA quality using proven manufacturing strategies from TriLink’s 25+ years of expertise. REGISTER: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
🧬 New study: Cartilage grown from stem cell spheroids—no scaffold needed.
A major breakthrough in regenerative medicine, from Tissue Engineering, Part A.
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#tissueengineering #stemcellresearch #cartilagerepair
@scrippsresearch @scrippshealth -
Mary Ann Liebert Inc
@LiebertPub
🚀 The State of Biotech 2025 — hosted by @GENbio.
Wed, Sept 24 | 11 AM–3:30 PM ET.
Free virtual summit with leaders in AI, CRISPR & biotech innovation.
🔗 summits.sagepub.com/e/the-state-of-biotech-2025
#biotech #lifesciences #innovation #stateofbiotech -
Mary Ann Liebert Inc
@LiebertPub
New article collection spotlights women’s health across disciplines—from reproductive care to mental health and more.
Explore: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#womenshealth #healthequity #traumainformedcare #medicalresearch #maryannliebert -
Mary Ann Liebert Inc
@LiebertPub
Everest in days? Climbers using xenon gas for rapid high-altitude adaptation sparked global debate.
A new position statement from the UIAA is now free to read in High Altitude Medicine & Biology:
journals.sagepub.com/doi/10.1089/ham.2025.0018?cf-mal-red…
#mountaineering #xenoninhalation #altitudemedicine -
Mary Ann Liebert Inc
@LiebertPub
How do we keep AI truly human-centric? Our latest release outlines a six-pillar roadmap to align AI with human values & well-being.
Read more 👉 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#ai #ethics #wellbeing #humancenteredai #aiethics #researchintegrity #maryannliebert #liebert Publishing -
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE TO REGISTER!
Don't miss your opportunity to explore the evolving landscape of breast cancer management through the lens of MRD testing.
Secure your place in this crucial discussion—REGISTER NOW!
www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
📈 AI in Precision Oncology just surpassed 50K downloads!
Led by Dr. Douglas Flora & Dr. Nikhil Thaker, the journal is shaping the future of cancer care through AI.
🔗 journals.sagepub.com/aipo?cf-redirected
#aiprecisiononcology #cancerinnovation #50kdownloads #aiinhealthcare -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT!
Save the date: July 1, 2025!
1:00 pm PT, 4:00 pm ET, 10:00 CET
Join us for a FREE webinar where we journey into the evolving landscape of breast cancer management through the lens of MRD testing.
Sponsored by Natera. Register Here
www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
🌈 New for #pridemonth: Explore our 2025 LGBTQ+ Research Collection—open access all June!
🔬 Gender-affirming care, neurodiversity, mental health & more.
Read now ➡️ www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#lgbtqresearch #openaccess #equityinscience #maryannliebert #lgbthealth -
Mary Ann Liebert Inc
@LiebertPub
Register for GEN's State of CRISPR & Genome Editing summit, kicking off at 11am ET. Fyodor Urnov PhD reflects on the inspiring "Baby KJ" story and last week's extraordinary meeting between cell and gene therapy scientists and the new FDA/HHS leadership.
summits.sagepub.com/e/the-state-of-crispr-and-gene-editin… -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR ALERT!
Dive into the future of breast cancer management with MRD testing. Join us on July 1st to explore how it’s revolutionizing treatment decisions. Don’t miss out—REGISTER NOW! www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
🧠✨ The New Yorker spotlights groundbreaking research from Psychedelic Medicine on how psilocybin is transforming spiritual leadership.
“This Is Your Priest on Drugs” by Michael Pollan: www.newyorker.com/magazine/2025/05/26/this-is-your-priest…
#psychedelicmedicine #michaelpollan #mentalhealth #spirituality
Mary Ann Liebert Inc
@LiebertPub
📖 Read the study published in Psychedelic Medicine: www.liebertpub.com/doi/10.1089/psymed.2023.0044
-
Mary Ann Liebert Inc
@LiebertPub
Join global leaders in gene editing—including Dr. Feng Zhang—at The State of CRISPR and Gene Editing 2025 virtual summit.
🗓️ Date: June 11, 2025
🕒 Time: 11:00 AM - 3:30 PM (ET)
🔗 Register Now for FREE: summits.sagepub.com/e/the-state-of-crispr-and-gene-editin… -
Mary Ann Liebert Inc
@LiebertPub
💡 New in Medical Acupuncture: A new NIH-funded database, TARA, offers a powerful tool for acupoint research—open access and ready to drive innovation.
Learn more: journals.sagepub.com/doi/10.1089/acu.2024.0138?cf-mal-red…
#acupuncture #medicalacupuncture #integrativehealth #openaccessresearch #nih -
Mary Ann Liebert Inc
@LiebertPub
Join us for the State of CRISPR & Genome Editing virtual summit on June 11th! Don’t miss an exclusive interview with Beth Shapiro, PhD, discussing ancient DNA, dire wolves, and the de-extinction debate. Register now for this free event! summits.sagepub.com/e/the-state-of-crispr-and-gene-editin…
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, June 3, 2025!
Dive into the future with our FREE webinar featuring leading experts in genetic engineering and biotechnology. Sponsored by TriLink BioTechnologies. Secure your spot: Register Now www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#genbiotechnology -
Mary Ann Liebert Inc
@LiebertPub
🧠 The NIH’s NINDS just launched a groundbreaking system to define and classify traumatic brain injuries.
A major milestone for research + patient care—now in Journal of Neurotrauma.
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#tbi #neurotrauma #ninds #braininjury #medicalresearch -
Mary Ann Liebert Inc
@LiebertPub
Join GEN for The State of CRISPR and Genome Editing virtual summit on June 11! Hear from experts like Feng Zhang and Fyodor Urnov. Don't miss out—register for free today! summits.sagepub.com/e/the-state-of-crispr-and-gene-editin…
-
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! Save the date: June 3, 2025! Join us a FREE webinar where top industry experts will unravel the future of genetic engineering and biotechnology. Secure your spot now! Sponsored by TriLink BioTechnologies. Register Here www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#genbiotechnology -
Mary Ann Liebert Inc
@LiebertPub
Dream team. Dream topic. Dream call for papers.
Submit to Health Equity’s special issue on Reimagining Perinatal Care—open now!
Rolling deadline: Sept 1, 2025
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#healthequity #callforpapers #perinatalcare #academiccall #publichealth#OpenAccessPublishing -
Mary Ann Liebert Inc
@LiebertPub
Huge turnout at #asgct. Here, Mike McCune, head of the HIV Frontiers Program at the Gates Foundation in the Presidential Symposium discussed bringing effective and accessible curative interventions for HIV and sickle cell disease to all in need.
-
Mary Ann Liebert Inc
@LiebertPub
Are you in New Orleans for the 2025 ASGCT Annual Meeting? Stop by Booth #1350 to catch up with the Mary Ann Liebert, GEN, and Inside Precision Medicine teams! Pick up your copies of Human Gene Therapy, GEN, CRISPR Journal, and more at this year's meeting. #asgct2025
-
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! Mark your calendars for June 3, 2025, Dive into the latest advancements in genetic engineering and biotechnology with industry leaders.
Register now to join us for this FREE webinar sponsored by TriLink BioTechnologies.
www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#genbiotechnology -
Mary Ann Liebert Inc
@LiebertPub
🌟 Meet the Medicine and Surgery awardees recognized in the 2024 RFS Awards in Science! 🌟
Learn more: journals.sagepub.com/company/rfs-awards/210?cf-redirected
#stemdiversity #medicine #surgery
@waynestate
@DrMCabanillas
@MDAndersonNews
@DrIramHussain
@UTSWMedCenter -
Mary Ann Liebert Inc
@LiebertPub
We’re proud to spotlight the Biomedical Research awardees of the 2024 RFS Awards in Science! 🌟
Learn more: journals.sagepub.com/company/rfs-awards/210?cf-redirected
#stemdiversity #biomedicalresearch #scientificexcellence
@MassGenBrigham
@JNJInnovMed
@NovartisNews
@YelenaBodien
@VUMCDiscoveries
@UFMedicine -
Mary Ann Liebert Inc
@LiebertPub
Celebrating the 2024 RFS Awards in Science winners for Public Health! Honoring women & underrepresented minorities advancing public health research. 🌟
Learn more: journals.sagepub.com/company/rfs-awards/210?cf-redirected
#stemdiversity #publichealth #scientificinnovation #liebertpublishing #scientificexcellence -
Mary Ann Liebert Inc
@LiebertPub
Celebrating the 2024 RFS Awards in Science winners for Biotechnology & Regenerative Medicine! Honoring women & underrepresented minorities in STEM. 🌟
Learn more: journals.sagepub.com/company/rfs-awards/210?cf-redirected
#stemdiversity #scientificinnovation #regenerativemedicine #liebertpublishing
@ucl
@UMich -
Mary Ann Liebert Inc
@LiebertPub
The wait is almost over! Join us TODAY at 11am ET for "The State of Multiomics & NGS" virtual summit. Register now and be part of this groundbreaking event.
🔗To view the full agenda and register for FREE, visit: summits.sagepub.com/e/the-state-of-multiomics-2025
#multiomics #ngs #virtualsummit #genomics -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On April 24th, three expert speakers will outline the unique features of this multiplatform test and provide an overview of microRNA markers. REGISTER: www.workcast.com/register?cpak=9879171895691551&hss_chann… @InterpaceBio #thyroid
-
Mary Ann Liebert Inc
@LiebertPub
April is #nationalminorityhealthmonth.
Explore our curated research collection tackling disparities in care—across autism, LGBTQ+ health, oncology & more.
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#healthequity #healthdisparities #dei #minorityhealth #socialdeterminants #inclusivecare -
Mary Ann Liebert Inc
@LiebertPub
This #autismacceptancemonth, we celebrate Autism in Adulthood—a journal led with and by autistic adults, focused on research that sparks real change.
Explore: journals.sagepub.com/publications/autism-in-adulthood/646…
#neurodiversity #inclusionmatters #disabilityrights #neurodiversity #autisminadulthood -
Mary Ann Liebert Inc
@LiebertPub
🚨 Last chance! Don’t miss the @SWHR 35th Annual Awards Gala on April 30!
Secure your seat now: swhr.org/events/swhr-annual-awards-gala/swhr-2025-annual-…
#swhrgala #womenshealth #medicalresearch -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On April 24th, three expert speakers will outline the unique features of this multiplatform test and provide an overview of microRNA markers. REGISTER: www.workcast.com/register?cpak=9879171895691551&hss_chann… @InterpaceBio #thyroid
-
Mary Ann Liebert Inc
@LiebertPub
Women’s health research matters! Join us on April 30 at the @SWHR 35th Annual Awards Gala as we celebrate 35 years of progress.
Secure your seat: swhr.org/events/swhr-annual-awards-gala/swhr-2025-annual-…
#swhrgala #womenshealth #healthequity -
Mary Ann Liebert Inc
@LiebertPub
📅 April 1 | 11am ET
Learn how the new Control-IQ+ AID system helps people with T1D stay in range longer—with less effort.
🎙️ Dr. Gregory Forlenza
🔗 Register: www.workcast.com/register?cpak=1902119744287024&hss_chann…
#diabetestech #t1d #controliq #insulinpump #type1diabetes #diabetescare @TandemDiabetes -
Mary Ann Liebert Inc
@LiebertPub
The inaugural issue of AI in Neuroscience is here! 🧠
Explore research on Parkinsonism, spinal cord injury, and more.
📖 Read now: journals.sagepub.com/toc/ains/1/1?cf-mal-redirected=true&…
#aiinneuroscience #artificialintelligence #neuroscienceresearch #openaccess #academicpublishing -
Mary Ann Liebert Inc
@LiebertPub
📅 Save the date! The @SWHR 35th Annual Awards Gala is on April 30. Celebrate leaders in women’s health research!
Learn more: swhr.org/events/swhr-annual-awards-gala/swhr-2025-annual-… #swhrgala #womeninscience #womenshealth -
Mary Ann Liebert Inc
@LiebertPub
MARK YOUR CALENDAR! TOMORROW, Mark Perreault will share case studies showcasing TFF design innovations for handling mAb and AAV production workflows. Register now to join us for this free webinar sponsored by Repligen: www.genengnews.com/multimedia/webinars/advances-in-tangen…
-
Mary Ann Liebert Inc
@LiebertPub
Explore Journal of Palliative Medicine Virtual Collections—Top Ten, ED Palliative Care & more in one place: journals.sagepub.com/publications/journal-of-palliative-m…
#palliativecare #jpm @PalliativeMed_j -
Mary Ann Liebert Inc
@LiebertPub
🚨 Big news! Psychedelic Medicine is now indexed in PubMed! 🎉
Find the latest research shaping the future of clinical applications + policy: pubmed.ncbi.nlm.nih.gov?term="Psychedelic Med (New Rochel…
📢 Submit your work: journals.sagepub.com/publications/psychedelic-medicine/67…
#psychedelicresearch#PubMed#MedicalAdvancements#PsychedelicMedicine -
Mary Ann Liebert Inc
@LiebertPub
AI in diagnostics, surgery, mental health & more—see what top-cited research says about ChatGPT in healthcare. 🧠📊
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#aiinhealthcare #digitalhealth #chatgpt #medicalinnovation #maryannliebert -
Mary Ann Liebert Inc
@LiebertPub
Gaming Law Review was featured on Last Week Tonight with John Oliver!
John Oliver cited:
"The NFL’s Gambling Strategy Is a Risk to Public Health" (GLR, 3/9/22)
🎥 Watch: www.youtube.com/clip/Ugkxy9cLXujB4tOkc1D1_QSruWgyTccDtOki…
📖 Read: journals.sagepub.com/doi/10.1089/glr2.2021.0040?cf-mal-re…
#gaminglaw #nfl #sportsbetting @gaminglawrev -
Mary Ann Liebert Inc
@LiebertPub
Top-cited cancer research—free to access!
🔬 Explore leading oncology studies from the Open Impact Series & stay ahead in cancer science.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#cancerresearch #oncology #openaccess #medicalscience #liebertopenaccess -
Mary Ann Liebert Inc
@LiebertPub
🏥 Health of Women 2025 is May 2 in collaboration with the Journal of Women's Health! Join us in Richmond, VA, for expert-led discussions on women's health.
Register today! ⬇️
🔗 vcu.cloud-cme.com/course/courseoverview?EID=34386&P=2
#womenshealth #medicaleducation #healthcareprofessionals #cpe #cme #cne -
Mary Ann Liebert Inc
@LiebertPub
The Journal of Women’s Health is proud to be the official media sponsor the @SWHR 35th Annual Awards Gala! Join us April 30 to celebrate 35 years of impact in women’s health research.
Learn more: swhr.org/events/swhr-annual-awards-gala/swhr-2025-annual-… #swhrgala #womenshealth -
Mary Ann Liebert Inc
@LiebertPub
New research in Human Gene Therapy shows that over half of NPC1 patients tested lack neutralizing antibodies to AAV2/AAV9, supporting the feasibility of AAV9-based gene therapy.
Read more: journals.sagepub.com/doi/10.1089/hum.2024.233?cf-mal-redi…
#genetherapy #raredisease #npc1 -
Mary Ann Liebert Inc
@LiebertPub
💊 Breakthrough in drug delivery! Core-shell nanoparticles enable targeted release, improved stability, & fewer side effects—revolutionizing precision medicine. 🔬✨
📖 Read more: journals.sagepub.com/doi/10.1089/omi.2024.0182?cf-mal-red…
#nanotechnology #drugdelivery #precisionmedicine #medicalinnovation -
Mary Ann Liebert Inc
@LiebertPub
🔬 Scientists gathered in NYC to send a clear message: Science, not silence! 🗣️ Nobel laureate Harold Varmus, MD, led the charge at the #sciencerally.
Read more: 🔗www.genengnews.com/topics/translational-medicine/scientis…
#sciencerally #sciencematters #nyc #sciencenotsilence #standupforscience #defendscience -
Mary Ann Liebert Inc
@LiebertPub
🚀 Biotech Unbound—your gateway to cutting-edge biotech research.
🔹 80,000+ articles from @LiebertPub, @GENbio & @Inside_PM
🔹 Seamless access across teams
🔹 TDM & AI-powered discovery
Learn more: journals.sagepub.com/biotechunbound?cf-mal-redirected=tru…
#biotechunbound #biotech #lifesciences #research -
Mary Ann Liebert Inc
@LiebertPub
📢 The ATTD 2024 Yearbook launches March 18!
Stay ahead with the latest in diabetes research, tech, and treatment—just in time for #attd2025 (March 19-22, Amsterdam)!
📍 Grab a copy at the ATTD booth or access it online: attd.kenes.com/attd-yearbook?hss_channel=tw-250271525
#diabetesinnovation #diabetestech -
Mary Ann Liebert Inc
@LiebertPub
🧬 Antibody-based immunoassays enhance bioanalysis of oligonucleotide therapeutics.
🔗: journals.sagepub.com/toc/nat/35/1?cf-mal-redirected=true&…
📸 HeLa cell staining post-gymnotic uptake of an LNA gapmer ASO. Image: Inês Fial (NATA).
#oligonucleotidetherapeutics #immunoassays #drugdiscovery #molecularbiology -
Mary Ann Liebert Inc
@LiebertPub
📢 New research in @AutismAdulthood outlines guidelines for making consent materials more accessible for autistic adults & people with intellectual disability.
Read more: journals.sagepub.com/doi/10.1089/aut.2024.0263?cf-mal-red…
#autismresearch #inclusion #accessibility #researchethics -
Mary Ann Liebert Inc
@LiebertPub
🌍 Happy International Women’s Day! Celebrate the achievements, resilience, and impact of women worldwide. Explore our OPEN IMPACT ARTICLE SERIES on Women’s Health—expert insights for a healthier future.
READ NOW 👉 home.liebertpub.com/lpages/open-access-series-womens-heal…
#iwd2025 #womenshealth #genderequality -
Mary Ann Liebert Inc
@LiebertPub
🚀 T1D care has evolved—but what’s next?
CGM, insulin pumps & AID systems are transforming diabetes management, but challenges remain. Can AID tech push the future even further?
📖 Full research: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#diabetestech #t1d #aid #diabetescare #medtronic -
Mary Ann Liebert Inc
@LiebertPub
🧬 AI is turning into a world-class medical detective! A new study in AI in Precision Oncology reveals how LLMs can extract PD-L1 biomarker data from patient records with expert accuracy, transforming cancer care.
🔗 journals.sagepub.com/doi/10.1089/aipo.2024.0043?cf-mal-re…
#aiinoncology #precisionmedicine #ai -
Mary Ann Liebert Inc
@LiebertPub
📢 Carb Counting vs. Meal Announcements? Managing T1D can be complex, but alternative approaches may ease the burden. Learn more in the latest Diabetes Technology & Therapeutics supplement, supported by Medtronic.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#diabetestech #t1d #medtronic -
Mary Ann Liebert Inc
@LiebertPub
🔬 Functional Precision Medicine: A Game-Changer in Oncology! Learn how it’s transforming cancer treatment from top experts.
🔗 Register for FREE: summits.sagepub.com/e/The-State-of-Precision-Medicine-2025
Hosted by @Inside_PM | Sponsored by @illumina & @Proscia
#precisiononcology #cancerresearch#CancerTreatment -
Mary Ann Liebert Inc
@LiebertPub
💰 Where is precision medicine headed next?
Join investment leaders at The State of Precision Medicine virtual summit on March 5!
🔹@BradLoncar @BiotechTVHQ
🔹Peter Kelly @LifesciDynamics
🔹Nessan Bermingham @KhoslaVentures
FREE Event→ summits.sagepub.com/e/The-State-of-Precision-Medicine-2025
#biotech #medtech -
Mary Ann Liebert Inc
@LiebertPub
🌿 Call for Papers: Ecopsychology & Nature-Health Reciprocity 🌎💚
Submit your research on relational, community-based approaches to nature & well-being!
📅 Deadline: June 1, 2025
🔗 Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#callforpapers #ecopsychology #natureandhealth -
Mary Ann Liebert Inc
@LiebertPub
🚨How is AI revolutionizing patient care? 🧠
Join experts at The State of Precision Medicine on March 5!
🔹Tom Lawry (Second Century Tech)
🔹Matt Callstrom (@MayoClinic)
🔹Tam Nguyen (St. Vincent’s)
🔹Nigam Shah (@Stanford)
Register now → summits.sagepub.com/e/The-State-of-Precision-Medicine-2025
#ai #medtech -
Mary Ann Liebert Inc reposted
MIT Media Lab
@medialab
In the cover story for the current issue of 3D Printing and Additive Manufacturing (@liebertpub), Media Lab researchers and collaborators present Depthfusion, a novel text-to-3D model generation system that allows users to transform textual or 2D image inputs into detailed 3D models.
-
Mary Ann Liebert Inc
@LiebertPub
🚀Advancing Knowledge, Driving Innovation, Changing the World.
Celebrate #nationalscienceday with cutting-edge research in biotech & life sciences: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#biotech #stem #sciencematters #biotech #scientificdiscovery -
Mary Ann Liebert Inc
@LiebertPub
New eBook now available! In the past several years, blood-based brain biomarkers have garnered increasing attention as candidates for optimizing the evaluation of patients with suspected mTBI. Download this free eBook sponsored by @AbbottNews: multimedia.sagepub.com
-
Mary Ann Liebert Inc
@LiebertPub
📊 This #blackhistorymonth, we recognize the power of data in driving #healthequity. Expanding race & ethnicity standards is a crucial step toward a more inclusive public health system.
🔗 Read more: journals.sagepub.com/doi/10.1089/heq.2024.78946.tk?cf-mal…
#publishwithpurpose #dataforchange #publichealth @RWJF -
Mary Ann Liebert Inc
@LiebertPub
Join Inside Precision Medicine in two weeks for the third annual State of Precision Medicine virtual summit. Join the experts as they discuss the future of precision medicine and challenges facing the industry.
To register for free, visit:
summits.sagepub.com/e/The-State-of-Precision-Medicine-2025 -
Mary Ann Liebert Inc
@LiebertPub
🐾 It’s Love Your Pet Day, and we couldn’t miss a chance to celebrate our furry friends! 💙 Whether they inspire us or just brighten our days, we love them all. Drop a pic of your pet in the replies! 🐶🐱
#loveyourpetday #sciencelovespets #stempets #biotechpets #lablife -
Mary Ann Liebert Inc
@LiebertPub
New eBook! In the past several years, blood-based brain biomarkers have garnered increasing attention as candidates for optimizing the evaluation of patients with suspected mTBI. Download this free eBook sponsored by @AbbottNews: multimedia.sagepub.com
-
Mary Ann Liebert Inc
@LiebertPub
📢 @AutismAdulthood is now in SSCI! 🎉 With a 9.9 Impact Factor, it's #1 in Developmental Psychology & Rehabilitation.
📖 Recommend to your library: journals.sagepub.com/publications/autism-in-adulthood/646…
🔗 Submit your research: journals.sagepub.com/publications/autism-in-adulthood/646…
#autismresearch #ssci #academicpublishing -
Mary Ann Liebert Inc
@LiebertPub
Today is the International Day of Women and Girls in Science! 👩🔬
We celebrate the achievements of women in STEM and support research advancing women’s health.
Explore recent publications in this area: home.liebertpub.com/lpages/open-access-series-womens-heal…
#womeninscience #stem #womeninstem #sciencematters -
Mary Ann Liebert Inc
@LiebertPub
LGBTQIA+ Research Collection!
Explore new studies on workplace inclusion, health equity & affirming policies.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#lgbtqresearch #healthequity #inclusionmatters -
Mary Ann Liebert Inc
@LiebertPub
🔬 Breaking new ground in diabetes care!
The latest DTT supplement, supported by Medtronic, highlights breakthroughs in CGM, AI-driven management, and hybrid closed-loop systems.
📖 Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#diabetestech #medtronic #diabetesresearch #glucosemonitoring -
Mary Ann Liebert Inc
@LiebertPub
📢 Call for Papers: Special Issue on AAV Gene Therapy Safety! 🧬
@HGTJournal seeks original research & reviews on toxicity mechanisms, safety improvements & more.
📅 Submit by April 2025
🔗 www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#genetherapy #aav #clinicalresearch #callforpapers #biotech -
Mary Ann Liebert Inc
@LiebertPub
🔬 Advancing Diabetes Tech!
Check out the latest DTT supplement supported by @MDT_Diabetes, highlighting innovations in AI-driven diabetes management and glucose monitoring.
📖 Read here: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#diabetestech #medtronic #glucosemonitoring #medicalinnovation -
Mary Ann Liebert Inc
@LiebertPub
Patient values should be at the heart of care planning. We’re proud to publish research that advances patient-centered care and health equity.
#palliativecare #patientcenteredcare #healthequity #medicalresearch #healthcareinnovation
Billy Rosa, PhD, MBE, APRN
@BillyRosaPhD
🤩One of my academic joys is editing the Palliative Specialist Series for @PalliativeMed_j with @CAJonesMD. We've launched a new site to consolidate & more easily leverage the collection. Please share & see instructions if you want to write a piece. 🔗: home.liebertpub.com/top-ten-tips-in-palliative-care
-
Mary Ann Liebert Inc
@LiebertPub
📢 AI in Neuroscience (AINS) is now accepting submissions! 🧠🤖 If you're researching AI-driven neuroscience, submit your work to this new journal today.
🔗 journals.sagepub.com/publications/ai-in-neuroscience/681/…
#aineuroscience #ai #neuroscience #phdlife #postdoc #research -
Mary Ann Liebert Inc
@LiebertPub
🧠 Better Post-Acute Care for TBI 🏥
New research in Journal of Neurotrauma outlines key steps for non-hospitalized TBI recovery: education, activity guidance, mental health screening & referrals.
🔗 Read more: journals.sagepub.com/doi/10.1089/neu.2024.0414?cf-mal-red…
#tbi #neurotrauma #braininjury #healthcare -
Mary Ann Liebert Inc
@LiebertPub
AI is transforming tissue engineering! Explore our special issue, guest-edited by Stanford experts, featuring AI-driven osteoarthritis grading & pancreatic cancer research.
Read FREE through 2/12/2025: journals.sagepub.com/toc/tea/30/19-20?cf-mal-redirected=t…
#aiinhealthcare #tissueengineering #medicalresearch -
Mary Ann Liebert Inc
@LiebertPub
🚨 Allergen of the Year 2025: PTDS 🚨
The @ACDS_Dermatitis named Toluene-2,5-Diamine Sulfate (PTDS) to highlight its dual role—both an allergen & an alternative for some PPD-allergic individuals.
🔗 Read more: journals.sagepub.com/doi/10.1089/derm.2024.0384?cf-mal-re…
#dermatology #allergenoftheyear -
Mary Ann Liebert Inc
@LiebertPub
🚀 Our top @Altmetric article this week was featured by @medpagetoday!
🔬 "The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications" (DIA, 1/8/25) was cited in their latest piece.
🔗 journals.sagepub.com/doi/10.1089/dia.2024.0404?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
🌟 Explore groundbreaking open access research!
Check out the 10th Open Impact Series collection featuring cutting-edge endocrinology studies shaping the future.
🔗 Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#openaccess #researchimpact -
Mary Ann Liebert Inc
@LiebertPub
Hear from Michel Sadelain in his "CARs in 2025: the Cambrian Explosion Continues" keynote at the State of Cell and Gene Therapy summit happening January 29th
To register for FREE, visit: summits.sagepub.com/e/the-state-of-cell-and-gene-therapy-… -
Mary Ann Liebert Inc
@LiebertPub
📢 Mary Ann Liebert of @LiebertPub spoke with @scholarlykitchn about the @Sage_Publishing acquisition and what’s next for publishing.
📖 Full interview: scholarlykitchen.sspnet.org/2025/01/16/mary-ann-liebert-i…
#scholarlypublishing #independentpublishers -
Mary Ann Liebert Inc
@LiebertPub
The AI in Neuroscience Preview Issue has published! Explore how AI is transforming neurological research and patient care. 🧠Full issue coming in March.
Read now: journals.sagepub.com/toc/ains/00/0?cf-mal-redirected=true…
#ai #neuroscience #artificialintelligence #medicalinnovation -
Mary Ann Liebert Inc
@LiebertPub
🚨 Breaking Research!
No evidence links GLP1-RAs to thyroid cancer risk, per a new study in @ThyroidJournal, the journal of @AmThyroidAssn.
Data from 92,497 GLP1-RA users across 6 countries provides reassurance for patients & clinicians.
🔗 journals.sagepub.com/doi/10.1089/thy.2024.0387?cf-mal-red…
#diabetescare -
Mary Ann Liebert Inc
@LiebertPub
Congratulations to New Space Editorial Board Member, Bill Nye, BS, for receiving the Presidential Medal of Freedom! 🎉
Learn more about our journal: journals.sagepub.com/publications/new-space/610?cf-redire…
#billnye #scienceeducation #spaceexploration #environmentaladvocacy #newspacejournal
@NewSpace_JRNL -
Mary Ann Liebert Inc
@LiebertPub
Happy Holidays from Mary Ann Liebert, Inc.! 🎉
As the year comes to an end, we want to thank you for your continued support and partnership. Wishing you a season of joy, peace, and happiness. Here’s to a bright and successful New Year! ✨
#happyholidays #seasongreetings -
Mary Ann Liebert Inc
@LiebertPub
We’re excited to share that Mary Ann Liebert, Inc. has been acquired by Sage!
A lead independent academic publisher, @Sage_Publishing will carry on our brand, commitment to quality, & impact for the long-term.
www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
New eBook available! This eBook from OraSure Technologies provides an overview of the rising STI syndemic as well as solutions, workflows, case studies, and insights to improve syphilis, HIV and HCV testing. DOWNLOAD: multimedia.sagepub.com @orasure
-
Mary Ann Liebert Inc
@LiebertPub
New podcast available now! Mini-PCNL vs Standard PCNL: Why are we still talking about this? In this episode we discuss the contemporary use of mini PCNL. LISTEN: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @bostonsci
-
Mary Ann Liebert Inc
@LiebertPub
New eBook available! The articles included in this eBook provide thoughtful information to clinical care personnel and individuals administering TH and TTM for their respective patient populations. DOWNLOAD this free eBook: multimedia.sagepub.com @MedicalZoll #ther
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… @AstraZeneca #cancerscreening
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… @AstraZeneca #cancerscreening
-
Mary Ann Liebert Inc
@LiebertPub
This Thanksgiving, we celebrated with a festive luncheon and our first-ever Top Chef competition! 🏆 Grateful for great teammates, creativity, and fun. 🦃🍂
#thanksgiving2024 #topchefchallenge #gratefulteam -
Mary Ann Liebert Inc
@LiebertPub
NEW PODCAST! Mini-PCNL vs Standard PCNL: Why are we still talking about this? In this episode we discuss the contemporary use of mini PCNL. LISTEN: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @bostonsci
-
Mary Ann Liebert Inc
@LiebertPub
🚂 Agatha Christie's "Murder on the Orient Express" kept our book club on the edge of our seats this month with its unforgettable mystery and brilliant twists! 🕵️♂️
#murderontheorientexpress #companybookclub #liebertlife -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 12/3, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… @AstraZeneca #cancerscreening
-
Mary Ann Liebert Inc
@LiebertPub
Richard Wolf Podcast #70 now available! In this episode, two experts in endourology discuss the non-clinical aspects of single-use scopes such as environmental impact and purchasing decisions. LISTEN: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
Kevin Lo, PhD, is the new EIC of ASSAY and Drug Development Technologies!
Dr. Lo plans to enhance accessibility, add visuals and lay summaries, and increase social media engagement to reach broader audiences.
Learn more: www.liebertpub.com/ADT?hss_channel=tw-250271525
#drugdevelopment #biotechnology -
Mary Ann Liebert Inc
@LiebertPub
New eBook! This eBook from OraSure Technologies provides an overview of the rising STI syndemic as well as solutions, workflows, case studies, and insights to improve syphilis, HIV and HCV testing. DOWNLOAD: multimedia.sagepub.com @orasure
-
Mary Ann Liebert Inc
@LiebertPub
New eBook! The articles included in this eBook provide thoughtful information to clinical care personnel and individuals administering TH and TTM for their respective patient populations. DOWNLOAD this free eBook: multimedia.sagepub.com @MedicalZoll #ther
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, one of the developers of pooled knock-in screening, Dr. Theo Roth (Stanford University), will present an overview of this platform and the advantages of non-viral genome targeting. REGISTER: www.workcast.com/register?cpak=2377531034123866&referrer=… @MaxCyte_info
-
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 12/3, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… @AstraZeneca #cancerscreening
-
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 11/18, one of the developers of pooled knock-in screening, Dr. Theo Roth (Stanford University), will present an overview of this platform and the advantages of non-viral genome targeting. REGISTER: www.workcast.com/register?cpak=2377531034123866&referrer=… @MaxCyte_info
-
Mary Ann Liebert Inc
@LiebertPub
New Richard Wolf Podcast! In this episode, two experts in endourology discuss the non-clinical aspects of single-use scopes such as environmental impact and purchasing decisions. LISTEN: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
🧬 Join us Nov 18 for a webinar on Next-Gen Genetic Discovery in Immune Cells! Dr. Theo Roth explores breakthroughs in gene editing & pooled knock-in screening for improved cell therapies.
Register today! www.workcast.com/register?cpak=2377531034123866&referrer=…
#crisprjournal #celltherapy #biotech -
Mary Ann Liebert Inc
@LiebertPub
💬 Earlier this year, experts in positive psychology and autism came together to share how these fields can uplift the autism community. Dive into the discussion and learn how these insights can create real change: journals.sagepub.com/doi/10.1089/aut.2024.38246.pw?cf-mal…
#autismcommunity #positivepsychology -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 11/18, one of the developers of pooled knock-in screening, Dr. Theo Roth (Stanford University), will present an overview of this platform and the advantages of non-viral genome targeting. REGISTER: www.workcast.com/register?cpak=2377531034123866&referrer=… @MaxCyte_info
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, our researchers will describe the benefits of establishing AID as a standard of care by discussing recent publications that feature the MiniMed 780G system from Medtronic.. REGISTER: www.workcast.com/register?cpak=8629102289219931&referrer=… #medtrinic #aid #t1d
-
Mary Ann Liebert Inc
@LiebertPub
New eBook! The ability to manufacture AAV products at scale is critical for advancing products through late-phase clinical trials and commercial manufacturing. This guide will be a resource to advance your AAV manufacturing needs! DOWNLOAD: multimedia.sagepub.com @thermofisher
-
Mary Ann Liebert Inc
@LiebertPub
Today is the day! Join GEN for the State of AI in Drug Discovery. This free virtual summit features an outstanding group of thought-leaders including Ava Amini, PhD; Karen Akinsanya, PhD; Gevorg Grigoryan, PhD as well as many others. To register, visit👇
summits.sagepub.com/e/The-State-of-AI-in-Drug-Discovery-2024 -
Mary Ann Liebert Inc
@LiebertPub
The State of AI in Drug Discovery is happening this Wednesday, 10/30! Watch industry luminaries Jen Nwankwo, Philip Tagari, Alex Zhavoronkov, and Jacob Berlin in their session "Key Considerations for Small Molecule Drug Discovery".
Register now for free: summits.sagepub.com/e/The-State-of-AI-in-Drug-Discovery-2024 -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 11/1, our researchers will describe the benefits of establishing AID as a standard of care by discussing recent publications that feature the MiniMed 780G system from Medtronic.. REGISTER: www.workcast.com/register?cpak=8629102289219931&referrer=… #medtrinic #aid #t1d
-
Mary Ann Liebert Inc
@LiebertPub
Join us October 30th for GEN's inaugural AI in Drug Discovery summit! This free virtual event will feature industry leader Najat Khan, PhD (Recursion), giving a keynote on growing AI in the drug discovery industry.
To register for free, visit:
summits.sagepub.com/e/The-State-of-AI-in-Drug-Discovery-2024 -
Mary Ann Liebert Inc
@LiebertPub
🌍📚 It's International Open Access Week 2024! Explore our Open-Access Journals, available to read and share for free: journals.sagepub.com/publications/by-type/journals-open-a… 🆓✨
#oaweek #openaccess #researchforall -
Mary Ann Liebert Inc
@LiebertPub
🚨 "Give Cas a Chance": Fyodor Urnov calls for a CRISPR revolution in his latest editorial for @CRISPRjournal. He outlines urgent reforms needed for CRISPR gene therapies. Read more here: journals.sagepub.com/toc/crispr/7/5?cf-mal-redirected=tru…
#crispr #geneediting #casgevy #genomics #medicalinnovation #biotech -
Mary Ann Liebert Inc
@LiebertPub
New eBook! The ability to manufacture AAV products at scale is critical for advancing products through late-phase clinical trials and commercial manufacturing. This guide will be a resource to advance your AAV manufacturing needs! DOWNLOAD: multimedia.sagepub.com @thermofisher
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, Dr. Rachel Beekman will address rationale for the translational gap, discuss the need for a standardized high-quality temperature control, and propose future directions for addressing this unmet need. REGISTER: www.workcast.com/register?cpak=3894322944432461&referrer=… #zoll #ther
-
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 11/1, our researchers will describe the benefits of establishing AID as a standard of care by discussing recent publications that feature the MiniMed 780G system from Medtronic.. REGISTER: www.workcast.com/register?cpak=8629102289219931&referrer=… #medtrinic #aid #t1d
-
Mary Ann Liebert Inc
@LiebertPub
MARK YOUR CALENDAR! On 10/22, Dr. Rachel Beekman will address rationale for the translational gap, discuss the need for a standardized high-quality temperature control, and propose future directions for addressing this unmet need. REGISTER: www.workcast.com/register?cpak=3894322944432461&referrer=… #zoll #ther
-
Mary Ann Liebert Inc
@LiebertPub
Jennifer Doudna offers The @NewYorker her top 3 #crispr books to understand the gene-editing revolution:‘CRISPR People’ by @HankGreelyLSJU, ‘The Codebreaker’ by @WalterIsaacson, and our Exec Ed of @CRISPRJournal, ‘Editing Humanity’ by @KevinADavies.🔗www.newyorker.com/books/book-currents/jennifer-doudna-on-…
-
Mary Ann Liebert Inc
@LiebertPub
Watch On-Demand 📲
Our informative webinar Protein Therapeutics: An Automated Imaging Strategy for Elucidating Protein Stability is now available to watch on-demand. See the full webinar here: www.workcast.com/register?cpak=3663967626404083&hss_chann… -
Mary Ann Liebert Inc
@LiebertPub
Nobel Laureate David Baker headlines GEN's AI in Drug Discovery Summit on October 30th! This free virtual event, sponsored by @Microsoft & @RevvitySignals will feature an outstanding group of AI thought-leaders across the industry. To register, visit:
summits.sagepub.com/e/The-State-of-AI-in-Drug-Discovery-2024 -
Mary Ann Liebert Inc
@LiebertPub
New eBook now available! Read four original Biosafety articles on Mitigating Microbial Risks, designed to keep you and your lab informed and prepared. DOWNLOAD this free eBook sponsored by @Labconco: multimedia.sagepub.com
-
Mary Ann Liebert Inc
@LiebertPub
🍂 Fall Vibes with the @LiebertPub Team! 🍁
We’re celebrating the season with great company and fall spirit! Check out highlights from our celebration! 🎃
#fallfestivities #teamappreciation #maryannliebert #publishinglife #autumncelebration -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 10/22, Dr. Rachel Beekman will address rationale for the translational gap, discuss the need for a standardized high-quality temperature control, and propose future directions for addressing this unmet need. REGISTER: www.workcast.com/register?cpak=3894322944432461&referrer=… #zoll #ther
-
Mary Ann Liebert Inc
@LiebertPub
🆕 New Guidelines Alert!
The Surgical Infection Society presents new evidence-based guidelines for managing intra-abdominal infections (IAI) in the latest issue of Surgical Infections. 🌍
🔗 Open Access: journals.sagepub.com/doi/full/10.1089/sur.2024.137?cf-mal…
#surgery #medicalguidelines #healthcare -
Mary Ann Liebert Inc
@LiebertPub
📖 Our September book club pick was Less by Andrew Sean Greer! We loved its humor and heartfelt moments. Have you read it? #lessanovel #bookclub #pulitzerprizewinner #liebertlife
-
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 10/2, Dikran Khachadourian, with Halo Labs, will discuss how the Aura PTx leverages innovative modern imaging and fluorescence microscopy techniques to characterize protein therapy products in stability studies. REGISTER: www.workcast.com/register?cpak=3663967626404083&referrer=… @HaloLabs_BMI
-
Mary Ann Liebert Inc
@LiebertPub
Weren't able to catch The State of Biotech virtual summit earlier this month? GEN has you covered with free, on demand viewing! This event featured leaders from industry and academia to discuss the latest in biotech.
Register now and watch on demand: summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, Dr Shudong Li, will describe the identification of novel ALT regulators and genetic vulnerabilities of ALT cancers. REGISTER: www.workcast.com/register?cpak=8404296287695859&referrer=… @RevvityInc #crispr
-
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 10/2, Dikran Khachadourian, with Halo Labs, will discuss how the Aura PTx leverages innovative modern imaging and fluorescence microscopy techniques to characterize protein therapy products in stability studies. REGISTER: www.workcast.com/register?cpak=3663967626404083&referrer=… @HaloLabs_BMI
-
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… #aipo #sponsored
-
Mary Ann Liebert Inc
@LiebertPub
🎉Excited to share the eighth installment of our Open Impact Series, featuring groundbreaking open access research🔓
Dive into some of the most cited articles in biotechnology.
Read now: home.liebertpub.com/lpages/open-access-series-biotechnolo… -
Mary Ann Liebert Inc
@LiebertPub
The Journal of Women’s Health is proud to sponsor 'Women’s Unique Health Needs and the SDGs,' hosted by @SWHR & @ECHAlliance at the #unga79 Science Summit this fall. Join in-person in NYC or virtually on Sept 24 at 9:00 AM.
RSVP today: swhr.org/event/womens-unique-health-needs-and-the-sustain…
#womenshealth #sdgs -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 9/26, Dr Shudong Li, will describe the identification of novel ALT regulators and genetic vulnerabilities of ALT cancers. REGISTER: www.workcast.com/register?cpak=8404296287695859&referrer=… @RevvityInc #crispr
-
Mary Ann Liebert Inc
@LiebertPub
🔬 Don’t miss this!
🗓️ Sept 26 | 8:00 am PT | 11:00 am ET
Join Dr. Shudong Li as he uncovers genetic vulnerabilities in ALT+ cancers using CRISPR screening.
🔗 Register: www.workcast.com/register?cpak=8404296287695859&referrer=…
Sponsored by @RevvityInc
#cancerresearch #crispr #oncology #alt -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT! On 9/23, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… #aipo #sponsored
-
Mary Ann Liebert Inc
@LiebertPub
🚨 In case you missed it: Applied Biosafety released a special issue on biosafety & biosecurity concerns of synthetic genomics. Topics include nucleic acid synthesis & U.S. dsDNA screening framework.
Read now: journals.sagepub.com/toc/apb/29/2?cf-mal-redirected=true&…
#biosafety #biosecurity -
Mary Ann Liebert Inc
@LiebertPub
We’re excited to partner with @ResearchGate! 🚀 Five of our #openaccess journals in #health and #medical sciences are now more accessible to 26M+ researchers worldwide. 🌍📚
Learn more: home.liebertpub.com/news/researchgate-and-mary-ann-lieber…
#openaccess #researchgate #sciencepublishing
ResearchGate
@ResearchGate
@ResearchGate are pleased to announce their new partnership with @LiebertPub Inc!
Mary Ann Liebert is a global media company dedicated to creating, curating, and delivering impactful peer-reviewed research and authoritative content services. -
Mary Ann Liebert Inc
@LiebertPub
On Sept 24, 'Women’s Unique Health Needs and the SDGs' hosted by @SWHR & @ECHAlliance will cover key global advancements in women's health care & research. We're proud to be a media sponsor!
💻 Register: swhr.org/event/womens-unique-health-needs-and-the-sustain…
#womenshealth #globalhealth #healthcareinnovation -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 9/23, our expert panelists will discuss and evaluate current AI applications in cancer screening, including success stories and ongoing challenges. REGISTER: www.workcast.com/register?cpak=8841281850018460&referrer=… #aipo #sponsored
-
Mary Ann Liebert Inc
@LiebertPub
The @NYTimes (Sept. 5, 2024) features "School Firearm Violence Prevention Practices and Policies: Functional or Folly?" from @ViolenceGender.
📖 Read the full article: journals.sagepub.com/doi/10.1089/vio.2018.0044?cf-mal-red…
Read the @NYTimes story: www.nytimes.com/2024/09/05/us/georgia-shooting-apalachee-…
#schoolsafety #publichealth #nytimes -
Mary Ann Liebert Inc
@LiebertPub
🔬 Don’t miss this!
🗓️ Sept 26 | 8:00 am PT | 11:00 am ET
Join Dr. Shudong Li as he uncovers genetic vulnerabilities in ALT+ cancers using CRISPR screening.
🔗 Register: www.workcast.com/register?cpak=8404296287695859&referrer=…
Sponsored by @RevvityInc
#cancerresearch #crispr #oncology #alt -
Mary Ann Liebert Inc
@LiebertPub
LAST CHANCE! TODAY, Dr. Chunping Xu, Senior Director of Chemistry R&D at TriLink BioTechnologies, will provide an overview of mRNA applications in vaccine and therapeutic development. REGISTER: www.workcast.com/register?cpak=7633517198266606&referrer=… @TriLinkBioTech #mrna
-
Mary Ann Liebert Inc
@LiebertPub
Excited to sponsor 'Women’s Unique Health Needs and the SDGs,' hosted by @SWHR & @ECHAlliance during #unga79 Science Summit!
📅 Save the date: Sept 24
💻 RSVP: swhr.org/event/womens-unique-health-needs-and-the-sustain…
#womenshealth #sdgs #globalhealth #healthcareinnovation -
Mary Ann Liebert Inc
@LiebertPub
🎥 Watch: Campaign Finance Roundtable
🗳️ Moderated by Marc Meredith with experts Saurav Ghosh, @yesthatabbywood, and Richard Briffault.
Topics:
• Redboxing: Candidate-PAC coordination
• Voter Reactions
• Future campaign finance laws
🔗journals.sagepub.com/publications/election-law-journal/10…
#electionlaw -
Mary Ann Liebert Inc
@LiebertPub
GEN is hosting a virtual summit at 11am EST today! Join us for the State of Biotech. Registration is free, and there's still time to sign up! This event features an exciting lineup from industry and academia to discuss the latest in biotech. Register now: webinars.liebertpub.com/e/The-State-of-Biotech-2024?aff=9…
-
Mary Ann Liebert Inc
@LiebertPub
Be sure to tune in for the 2024 State of Biotech virtual summit on September 11th, 2024. This completely free event is hosted by GEN editors and brings together industry-leading experts across the field of biotech. Register now and join us at 11am EST.
summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc
@LiebertPub
Join us September 11 for The State of Biotech, a virtual summit featuring notable industry leaders, including a keynote from Sonia Vallabh, PhD, co-leader of the Broad Institute’s initiative to develop preventive drugs for prion disease.
Register now: summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc
@LiebertPub
🚀 Harnessing AI to transform cancer screening! Join our expert panel on Sept 23 to discuss AI’s impact on early detection & health equity. 🧠💡
📅 Mon, Sept 23
⏰ 8 am PT | 11 am ET | 17:00 CET
🔗 Register: www.workcast.com/register?cpak=8841281850018460&referrer=…
#aiinhealthcare #cancerscreening #webinar -
Mary Ann Liebert Inc
@LiebertPub
Join us on September 11th for the 2024 State of Biotech, hosted by GEN. This exciting virtual summit features David Altshuler and other industry leaders to discuss the latest in biotech!
Register now for this free and fully virtual event:
summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc
@LiebertPub
NEW WEBINAR! On 9/12, Dr. Chunping Xu, Senior Director of Chemistry R&D at TriLink BioTechnologies, will provide an overview of mRNA applications in vaccine and therapeutic development. REGISTER: www.workcast.com/register?cpak=7633517198266606&referrer=… @TriLinkBioTech #mrna
-
Mary Ann Liebert Inc
@LiebertPub
Only one week left to register for The State of Biotech! This virtual summit brings together industry leaders like Daphne Zohar, Founder & CEO at Seaport Therapeutics to discuss the latest innovations transforming biotech.
To register for free visit:
summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc reposted
SWHR
@SWHR
New article from the Journal of Women's Health @LiebertPub: "Number of Pregnancies and Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women: A Cross-Sectional Study of NHANES from 1999 to 2018". journals.sagepub.com/doi/abs/10.1089/jwh.2023.0859?cf-mal…
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Take a look at our August issue of @Cyberpsych_Jn @LiebertPub www.liebertpub.com/doi/10.1089/cyber.2024.0386 Parsing Platforms: Natural Language Processing and Public Mental Health Brenda K Wiederhold #nlp #mentalhealth
-
Mary Ann Liebert Inc
@LiebertPub
We are excited to present you with the seventh installment of our innovative Open Impact Series, showcasing influential open access research.
Read now: home.liebertpub.com/lpages/open-access-series-microbiolog…
The articles included are among our most cited in the field of microbiology. -
Mary Ann Liebert Inc
@LiebertPub
🚀 Biotech is booming with AI, gene therapy, and more! Join @GENbio on Sept 11 for The State of Biotech 2024, sponsored by @Cytiva. Keynotes, panels, and special sessions await. Register free now!
👉summits.sagepub.com/e/The-State-of-Biotech-2024 -
Mary Ann Liebert Inc
@LiebertPub
Curious about how recent mRNA findings are advancing therapeutic applications? Join the live webinar on Sept 12 to learn about novel chemical modifications boosting mRNA vaccine efficiency.
🗓️8 am PT | 11 am ET | 17:00 CET
🔗www.workcast.com/register?cpak=7633517198266606&referrer=…
#mrna #therapeutics #biotech -
Mary Ann Liebert Inc
@LiebertPub
Health Equity features a roundtable on the updated race & ethnicity data standards from OMB. These changes ensure historically marginalized communities are now visible in federal data—key for advancing health equity! 🏥✨ #healthequity #publichealth #datacollection
Mary Ann Liebert Inc
@LiebertPub
🔗Read the full transcript here: www.liebertpub.com/doi/10.1089/heq.2024.78946.tk
-
Mary Ann Liebert Inc reposted
GEN Biotechnology
@GENBiotechJrnl
Our SPECIAL ISSUE in #dei in Biotech is here!
▪️ Insights from the AfroBiotech Conferences - Karmella Haynes
▪️ Models for neglected tropical diseases @AnaMaPorras
▪️#ai demands biodiversity @Basecamp_Res
▪️and more!
Check out our full content! 🧵1/
www.liebertpub.com/toc/genbio/3/4 -
Mary Ann Liebert Inc
@LiebertPub
Our recent staff party was a blast! We pivoted our Amalfi Coast-themed picnic indoors and had a great turnout. Fun games, Karaoke, and group painting made for an evening of joy and laughter. 🎉
#staffparty #teambonding #funatwork -
Mary Ann Liebert Inc
@LiebertPub
Introducing the Trilogy Max Lithotripter. Experience the next generation of lithotripter technology, featuring enhancements physicians have asked for with the same efficient performance as its predecessor. Learn more: www.bostonscientific.com/us/en/healthcare-professionals/p…
-
Mary Ann Liebert Inc
@LiebertPub
🎉 Announcing RFS Awardees in Biomedical Research!
Celebrating outstanding contributions by women and minorities in STEM. Discover their groundbreaking research.
🔗 www.rosalindfranklinsociety.org/rfs-awards-in-science-202…
#womeninstem #minoritiesinstem #scientificexcellence #biomedicalresearch @RFS_Science -
Mary Ann Liebert Inc
@LiebertPub
🎉 Announcing RFS Awardees in Medicine and Surgery!
We're celebrating the outstanding contributions of women and minorities in these fields. Discover the groundbreaking research of our awardees.
🔗www.rosalindfranklinsociety.org/rfs-awards-in-science-202…
#womeninstem #minoritiesinstem #scientificexcellence -
Mary Ann Liebert Inc
@LiebertPub
🎉 Announcing RFS Awardees in Biotechnology and Regenerative Medicine! Celebrating outstanding contributions by women and minorities in STEM in honor of Rosalind Franklin's birthday.
🔗 www.rosalindfranklinsociety.org/rfs-awards-in-science-202…
#womeninstem #minoritiesinstem #scientificexcellence -
Mary Ann Liebert Inc
@LiebertPub
New eBook Now Available! Read four original Biosafety articles on Mitigating Microbial Risks, designed to keep you and your lab informed and prepared. DOWNLOAD this free eBook: multimedia.sagepub.com @Labconco
-
Mary Ann Liebert Inc
@LiebertPub
🎉 Happy National Ice Cream Day! 🍦 Whether you love classic or new flavors, grab a scoop and treat yourself!
☀️ Mary Ann Liebert, Inc. hosted an ice cream party with a 🍧 serving of appreciation 🍧
Check out these moments from our event! 📸
#liebertlife @IceCreamEmergen -
Mary Ann Liebert Inc
@LiebertPub
🚨 Health Security Alert! 🚨
Dr. Tom Inglesby, EIC of Health Security & director at Johns Hopkins, was quoted in @nytimes on the urgency of addressing bird flu. “This is the kind of thing that should be hammered out very quickly.”
🔗 Read more: www.nytimes.com/2024/07/17/health/bird-flu-tests.html?hss…
#birdflu -
Mary Ann Liebert Inc
@LiebertPub
🚪📖 Our company book club's July pick: The Book of Doors by Gareth Brown. It's a perfect fantasy adventure: magical books, epic battles, a compelling heroine, and more. Nothing like bonding over a good read! 📖✨ #thebookofdoors #companybookclub #bookrecommendations #fantasy
-
Mary Ann Liebert Inc
@LiebertPub
📣 Exciting News! We've launched our official Instagram account! 🎉Follow us @liebertpub for insights into our people, publications, and breakthroughs in biotech and life sciences. 📱👉 www.instagram.com/liebertpub #newoninstagram #followus #stayconnected
-
Mary Ann Liebert Inc
@LiebertPub
📢 The newest issue of AI in Precision Oncology is now live!
www.liebertpub.com/aipo
Our latest journal is your go-to source for staying at the forefront of oncology, featuring the latest innovations in AI-driven precision medicine.
#oncology #precisionmedicine #aiinhealthcare -
Mary Ann Liebert Inc
@LiebertPub
🌟 Big News! PHAGE: Therapy, Applications, and Research's impact factor is now 3.5*, up nearly 30%! 🎉 Join us and benefit from no submission fees, expert peer review, and global visibility.
#impactfactor #bacteriophageresearch #openaccess #medicaljournal -
Mary Ann Liebert Inc
@LiebertPub
🌟 Big News! Diabetes Technology & Therapeutics' new impact factor is 5.7! 🎉
Thanks to our editors, reviewers, authors, and readers for making this possible! Stay informed and publish with us to make a real impact.
#diabetesresearch #medicaljournal #openaccess -
Mary Ann Liebert Inc
@LiebertPub
🌟 Big News! Advances in Wound Care's new impact factor is 5.8*, up 18%! 🎉 A great achievement thanks to our authors, reviewers, and editorial board. Stay informed and publish with us to make a real impact.
#impactfactor #woundcare #research #medicaljournal -
Mary Ann Liebert Inc
@LiebertPub
The Brazilian Special Issue of New Space is now online!
Read for free today: www.liebertpub.com/toc/space/12/2 -
Mary Ann Liebert Inc
@LiebertPub
🎉 Autism in Adulthood's impact factor is now 9.5*, up nearly 40%! 🎉 We're the top journal in Developmental Psychology & #2 in Rehabilitation. 🌟
Subscribe for no fees, expert review, and global visibility! 📚
#impactfactor #research #academicpublishing @autismadulthood -
Mary Ann Liebert Inc
@LiebertPub
We are excited to present you with the fifth installment of our innovative Open Impact Series, showcasing influential open access research.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
The articles included are among our most cited in the area of neuroscience. -
Mary Ann Liebert Inc
@LiebertPub
🎬 On this day in 1993, "Jurassic Park" set a record with a $48M opening weekend!@GENbio 's publisher, @LiebertPub and herpetologist @myrnaphd, PhD, played crucial roles.
Read more about GEN's impact here: editions.mydigitalpublication.com/publication/?i=722688&a…
#jurassicpark @CRISPRjournal @GENBiotechJrnl -
Mary Ann Liebert Inc
@LiebertPub
🌟 Congrats to Maria Chan, our exceptional Production Team lead, on nearly 25 years of excellence across our 100 journals, including @Astrobiology_jn. Thank you for taking us and our readers to new heights! 🌌✨
#maryannliebert #publishingexcellence -
Mary Ann Liebert Inc reposted
Journal of Medical Extended Reality
@JMedXR
We are excited to announce that @JMedXR's leadership team is expanding!
Learn more about our exciting new developments here: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Last day of our strategic think tank with our partners at @Burgundy_Info, @Accucoms, Maruzen, @CWGAuthors, and @EBSCO South Korea! We're excited about the innovative ideas and progress we've achieved together.
#globalpartnership #maryannliebertinc #stmpublishing #authorservices -
Mary Ann Liebert Inc
@LiebertPub
Join Redox Medicine 2024 - the official partner of our journal Antioxidants & Redox Signaling! The 26th International Conference will be held on June 27-28, at Fondation Biermans-Lapôtre, Paris, France.
Register today: www.redox-medicine.com -
Mary Ann Liebert Inc
@LiebertPub
GEN "The State of CRISPR" virtual summit today!
🕒 Starts 8:00 am PT | 11:00 am ET | 17:00 CET
Hosted by @GENbio
Sponsored by @Aldevron, @seqwell, @MaxCyte_info, & @GenScript
Featured Speaker: @BioBeef (@ucdavis)
Register: summits.sagepub.com/e/the-state-of-crispr-and-gene-editin…
#crispr #geneediting #biotech -
Mary Ann Liebert Inc
@LiebertPub
Examination of return on investments of a publicly-funded hospital-integrated #biobank consortium over the years 2006–2022. This is an important step to show value of these critical infrastructures for personalized medicine and population health. Read now: www.liebertpub.com/doi/10.1089/bio.2024.0014
-
Mary Ann Liebert Inc
@LiebertPub
🌟 Thrilled to be kicking off three days of strategy and comradery with our partners at @Burgundy_Info, @Accucoms, Maruzen, @CWGAuthors, and @EBSCO South Korea! 🚀✨
#globalpartnership #maryannliebertin #chinafootprint #stmpublishing #authorservices #pharma -
Mary Ann Liebert Inc
@LiebertPub
Today is the last day to join us at #asco2024! Visit booth 36107 to explore cutting-edge research and industry insights on the latest advancements in diagnostics and treatments. #cancerresearch #aiinprecisiononcology
-
Mary Ann Liebert Inc
@LiebertPub
🌈 Celebrate #pridemonth with our 2024 Article Collection!🌈
Explore research on the unique healthcare needs of the #lgbtqia+ community, from inclusive care to mental health. Join us in advocating for better SGM health care!
🔗 Explore Here: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#healthcare -
Mary Ann Liebert Inc
@LiebertPub
Register now for our virtual summit: THE STATE OF CRISPR AND GENE EDITING!
🗓️ June 5th
🕒 8 am PT, 11 am ET, 17:00 CET
📍 Hosted by @GENbio
Sponsored by @Aldevron, @seqwell, @MaxCyte, & @GenScript
✨ Register for free: summits.sagepub.com/e/the-state-of-crispr-and-gene-editin…
#crispr #geneediting #biotech -
Mary Ann Liebert Inc
@LiebertPub
🚨 New Release! 🚨
Check out this month's Open Impact Article Series! Featuring highly cited research in women's health. Don't miss out!
Read now: home.liebertpub.com/lpages/open-access-series-womens-heal…
#womenshealth #openaccess #publichealth #research #healthcare -
Mary Ann Liebert Inc
@LiebertPub
Excited for #asco2024?
Visit us at booth #36107 to explore cutting-edge solutions and meet our team. We're looking forward to discussing how we can work together to advance precision oncology.
📅 May 31 - June 4
📍 Chicago, IL & Online
#precisiononcology#PrecisionMedicine -
Mary Ann Liebert Inc
@LiebertPub
📢 New study in @J_Neurotrauma: Early EVD insertion (<24 hrs) improves outcomes for severe TBI patients. Late insertion linked to higher death/disability risks. Dr. Alex Valadka, MD, emphasizes its potential.
Read more: journals.sagepub.com/doi/10.1089/neu.2023.0493?cf-mal-red…
#tbiresearch #neurotrauma -
Mary Ann Liebert Inc
@LiebertPub
🧠 Traumatic intracranial aneurysms (TICAs) in civilian gunshot wounds to the head are often missed on initial scans. A @J_Neurotrauma study shows early CTA reveals TICAs are 10x more frequent and predict surgery.
Learn more: journals.sagepub.com/doi/10.1089/neu.2023.0576?cf-mal-red…
#neurotrauma #tbi #research -
Mary Ann Liebert Inc
@LiebertPub
Register today for THE STATE OF CRISPR AND GENE EDITING!
🗓️June 5th
Hosted by @GENbio
Sponsored by @Aldevron, @seqwell, @MaxCyte_info, & @GenScript
Featured Speaker: @LauraSepplore (@Intellia_Tx)
Register Now: summits.sagepub.com/e/the-state-of-crispr-and-gene-editin…
#statecrispr24 #crispr #geneediting #biotech -
Mary Ann Liebert Inc
@LiebertPub
🔥 Hot off the library cart! 🔥
Librarians, it’s your time to shine! Cast a vote for your favorite tote and help us pick this year’s #totevote design! Open access, journal pride, or a simple heart for books?
👜✅ Vote by May 31: www.surveymonkey.com/r/totevote2024
#librariansunite -
Mary Ann Liebert Inc
@LiebertPub
NEW RICHARD WOLF PODCAST- #67 AVAILABLE NOW! Amongst the many options for treatment of enlarged prostate, aquablation is growing in popularity. Dr. Netsch offers his expertise in discussing this technology. LISTEN: soundcloud.com/mary-ann-liebert-inc/richard-wolf_ep_67_v1
-
Mary Ann Liebert Inc
@LiebertPub
New Research on Gender-Affirming Care in Pediatrics! 🩺
A study in Telemedicine and e-Health shows consultative support boosts PPCPs' comfort in offering gender-affirming care, improving outcomes for gender-diverse adolescents.
Read more: journals.sagepub.com/doi/10.1089/tmj.2023.0537?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Register now for our half-day virtual summit: THE STATE OF CRISPR AND GENE EDITING!
🗓️ June 5th
🕒 4.5-hour FREE event
📍 Hosted by @GENbio
Sponsored by @Aldevron and @seqwell
✨Register for free: webinars.liebertpub.com/e/the-state-of-crispr-and-gene-ed…
#stateofcrispr2024 #crispr #geneediting #biotechnology -
Mary Ann Liebert Inc
@LiebertPub
🎉 Librarians, your expertise is in demand ! 📚
Which slogan speaks to your librarian heart? Vote now for your favorite design in the #totevote2024 campaign.
🗳️ Vote here: www.surveymonkey.com/r/totevote2024
#librarians #totevote2024 -
Mary Ann Liebert Inc
@LiebertPub
Last chance! Today, our expert panelists from across the CGT space will discuss a concept-to-cure program pathway, sharing insights and exploring challenges from a development, manufacturing, and testing perspective. REGISTER: www.workcast.com/register?cpak=4265468031252650&referrer=900 #genetherapy
-
Mary Ann Liebert Inc
@LiebertPub
NEW RICHARD WOLF PODCAST- #67 AVAILABLE NOW! Amongst the many options for treatment of enlarged prostate, aquablation is growing in popularity. Dr. Netsch offers his expertise in discussing this technology. LISTEN: soundcloud.com/mary-ann-liebert-inc/richard-wolf_ep_67_v1
-
Mary Ann Liebert Inc
@LiebertPub
Don't miss out! On 5/13, our expert panelists from across the CGT space will discuss a concept-to-cure program pathway, sharing insights and exploring challenges from a development, manufacturing, and testing perspective. REGISTER: www.workcast.com/register?cpak=4265468031252650&referrer=900 #genetherapy
-
Mary Ann Liebert Inc
@LiebertPub
Exciting healthcare news! 🎉 Explore the Academic Payvider model, bridging payers & providers for better care. Discover its impact on healthcare, reducing admin burdens & improving outcomes! Don't miss out!
Read more: www.liebertpub.com/doi/10.1089/pop.2023.0300 #healthcareinnovation #valuebasedcare -
Mary Ann Liebert Inc
@LiebertPub
We're excited to be exhibiting at #asgct2024! Find us at Booth 714 for an exclusive look at journals driving today's explosion of gene therapy advances 🧬
-
Mary Ann Liebert Inc
@LiebertPub
Don't miss out! On 5/7, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by binding to mRNA and improving translation. REGISTER: www.workcast.com/register?cpak=7767621630157261&referrer=900 @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
🔬Major MS breakthrough! IFN-ß regulates gene expression & splicing, enhancing our understanding of autoimmunity. Study by Anthony Reder & Xuan Feng @UChicagoMed, supported by @Bayer, @mssociety, & @UChicago. #multiplesclerosis
🔗www.liebertpub.com/doi/10.1089/jir.2024.0032 -
Mary Ann Liebert Inc
@LiebertPub
📚✨ Librarians, have your say in #totevote2024! ✨📚 Choose your favorite tote design:
1️⃣ "This Tote is Open Access"
2️⃣ "In My Journals Era"
3️⃣ "I ❤️ Journals"
🗳️ Vote now: www.surveymonkey.com/r/totevote2024 and share with your peers!
#librarians #totevote2024 -
Mary Ann Liebert Inc
@LiebertPub
Don't Miss Out on NNS 2024 Regular Registration Savings! This is your last chance to save on registration fees for #nns2024, so act now before the deadline on April 26, at 11:59 PM (PDT). Register here to join us in San Francisco June 9-12: neurotrauma-symposium.org/registration/ @Neurotrauma
-
Mary Ann Liebert Inc reposted
NeurotraumaSociety
@Neurotrauma
Join us for a Keynote Session with Dr. Monica Perez on June 12, 2024! With over 15 years of dedicated research in neural mechanisms controlling voluntary movement, Dr. Perez is a leading authority in her field. Her journey began with a BS degree in PT from the Catholic University of Chile, followed by a Ph.D. in PT from the University of Miami and The Miami Project To Cure Paralysis.
Check out the #nns2024 Scientific Program for details: www.neurotrauma-symposium.org/5ztg -
Mary Ann Liebert Inc reposted
NeurotraumaSociety
@Neurotrauma
Join us for a Keynote Session with Dr. @DamsOConnor on June 10, 2024! Dr. Dams-O'Connor, Ph.D., is Jack Nash Professor and Vice Chair of Research in the Department of Rehabilitation and Human Performance at Icahn School of Medicine at Mount Sinai (ISMMS) in New York, USA. She is Director of the Brain Injury Research Center (BIRC) and Professor of Neurology at ISMMS.
Check out the #nns2024 Scientific Program for details: www.neurotrauma-symposium.org/5ztg -
Mary Ann Liebert Inc reposted
NeurotraumaSociety
@Neurotrauma
Join us for a Keynote Session with Chris Barr on June 10, 2024! Chris's journey began with a life-altering accident in February 2017, where he broke his neck in eight places while surfing at Ocean Beach San Francisco. Since then, Chris has undertaken extensive rehabilitation and participated in many clinical trials and studies.
Check out the #nns2024 Scientific Program for details: www.neurotrauma-symposium.org/5ztg -
Mary Ann Liebert Inc reposted
NeurotraumaSociety
@Neurotrauma
Join us for a Keynote Session with @JamieMocrazy on June 10, 2024! Expect an engaging, vulnerable, and passionate storytelling session where Jamie will delve into understanding recovery from brain injury, supporting TBI survivors in rebuilding their lives, exploring complementary medicine for full recoveries, and climbing alternative peaks after brain injury.
Check out the #nns2024 Scientific Program for details: www.neurotrauma-symposium.org/5ztg -
Mary Ann Liebert Inc
@LiebertPub
New webinar! On 5/13, our expert panelists from across the CGT space will discuss a concept-to-cure program pathway, sharing insights and exploring challenges from a development, manufacturing, and testing perspective. REGISTER: www.workcast.com/register?cpak=4265468031252650&referrer=900 #genetherapy
-
Mary Ann Liebert Inc
@LiebertPub
🌟 At Mary Ann Liebert, Inc., we advance biotech, life sciences, and public health, supporting UN SDGs like Health, Gender Equality, & Sustainable Cities. What drives you? Let's unite for sustainable progress. #sdgs #globalimpact #earthday
Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Journal of Medical Extended Reality
@JMedXR
New Articles Alert!
Be among the first to read these new articles from @JMedXR.
1. journals.sagepub.com/doi/10.1089/jmxr.2023.0013?cf-mal-re…
2. journals.sagepub.com/doi/10.1089/jmxr.2024.0002?cf-mal-re…
3. journals.sagepub.com/doi/10.1089/jmxr.2024.0005?cf-mal-re… -
Mary Ann Liebert Inc
@LiebertPub
New eBook from Abott!
Read now: multimedia.sagepub.com
For this eBook, interdisciplinary teams from hospital centers leading implementation of Alinity i TBI test came together in a round table discussion to share progress and discuss encountered challenges. @AbbottNews -
Mary Ann Liebert Inc
@LiebertPub
🏙️ Building Sustainable Cities: Our journals highlight key publications on urban development and community resilience. Explore more ➡️ www.sagepub.com/journals/mary-ann-liebert-journals-transi… #sustainablecommunities #communitydevelopment
What innovation will shape our future? Share your ideas! -
Mary Ann Liebert Inc
@LiebertPub
New webinar! On 5/7, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by binding to mRNA and improving translation. REGISTER: www.workcast.com/register?cpak=7767621630157261&referrer=900 @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
New Richard Wolf Podcast- Episode #66! With the increased popularity and success of focal therapy for prostate cancer, we hear from two international experts and what the challenges are of establishing and maintaining programs after training. LISTEN: soundcloud.com/mary-ann-liebert-inc/episode-66-focal-ther…
-
Mary Ann Liebert Inc
@LiebertPub
We are excited to present you with the third installment of our innovative Open Impact Series, showcasing influential open access research.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
The articles included are among our most cited in the area of public health. -
Mary Ann Liebert Inc
@LiebertPub
REGISTER TODAY! The April 26 registration deadline is quickly approaching for the 41st Annual Symposium of the National Neurotrauma Society. Don't miss out - register now to join us in San Francisco June 9-12: neurotrauma-symposium.org/registration/ #nns2024
-
Mary Ann Liebert Inc
@LiebertPub
✨ Advancing #genderequality! @LiebertPub publishes research addressing gender inequities and promotes empowerment, fostering balance in academia. Explore our impactful work ➡️ www.sagepub.com/journals/mary-ann-liebert-journals-transi… #empowerment
What recent gender equality advancements have inspired you? -
Mary Ann Liebert Inc
@LiebertPub
🌟@LiebertPub champions good health & well-being with our clinical medicine publications. Discover new medical research and insights for better global health. ➡️www.sagepub.com/journals/mary-ann-liebert-journals-transi… #wellbeing #goodhealth
Which health & well-being study has inspired you to take action? -
Mary Ann Liebert Inc
@LiebertPub
New eBook from Abott!
Read now: multimedia.sagepub.com
For this eBook, interdisciplinary teams from hospital centers leading implementation of Alinity i TBI test came together in a round table discussion to share progress and discuss encountered challenges. @AbbottNews -
Mary Ann Liebert Inc
@LiebertPub
New Expert Panel Discussion: Getting Started with mRNA-Based Therapeutics! This free expert panel discussion explores mRNA challenges, including usability, stability, and technological limits. DOWNLOAD NOW: multimedia.sagepub.com
-
Mary Ann Liebert Inc
@LiebertPub
New RIchard Wolf Podcast- Episode #66! With the increased popularity and success of focal therapy for prostate cancer, we hear from two international experts and what the challenges are of establishing and maintaining programs after training. LISTEN: soundcloud.com/mary-ann-liebert-inc/episode-66-focal-ther…
-
Mary Ann Liebert Inc
@LiebertPub
Visit us at Stand #19 at UKSG 2024 in Glasgow and learn more about our latest launch, AI in Precision Oncology, and cast your ballot in our #totevote2024 campaign! www.uksg.org/event/conference24 #uksg2024
-
Mary Ann Liebert Inc
@LiebertPub
Visit us at Stand #19 at UKSG 2024 in Glasgow and learn more about our latest launch, AI in Precision Oncology, and cast your ballot in our #totevote2024 campaign! www.uksg.org/event/conference24 #uksg2024
-
Mary Ann Liebert Inc
@LiebertPub
Every April, National Minority Health Month seeks to build "awareness about the disproportionate burden of premature death and illness in people from racial and ethnic minority groups".
Enjoy full access to our National Minority Health Month collection: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Visit us at Stand #19 at UKSG 2024 in Glasgow and learn more about our latest launch, AI in Precision Oncology, and cast your ballot in our #totevote2024 campaign! www.uksg.org/event/conference24 #uksg2024
-
Mary Ann Liebert Inc
@LiebertPub
🌟Don't miss out! Join us for "Monthly Mondays," hosted by @WomenScienceRFS, @GENbio & @LiebertPub.
🤝Spotlighting the incredible achievements of women & minorities in #stem. Inspiring sessions & groundbreaking research.
✨Register now: www.workcast.com/register?cpak=3840743328901613
#scienceforall -
Mary Ann Liebert Inc
@LiebertPub
We are thrilled to bring you the second installment of our Open Impact Series, highlighting open access research defining the landscape of various fields.
The articles included are among our most cited in the area of molecular biology.
Read now: home.liebertpub.com/lpages/open-access-series-molecular-b… -
Mary Ann Liebert Inc
@LiebertPub
Fantastic week at #attd2024! Thanks to everyone who visited us. Don't miss out on the latest DTT issue & learn about opportunities.
Official Journal of ATTD👉 home.liebertpub.com/DTT
#diabetescare #diabetestechnology #medicalpublishing -
Mary Ann Liebert Inc
@LiebertPub
Have you had a chance to read the first articles published with JMXR?
Read them here: journals.sagepub.com/toc/jmxr/1/1?cf-mal-redirected=true&
Included are medical extended reality guidelines from @theAMXRA, a perspective piece on the therapeutic potential of immersive VR, and more.
@BrennanSpiegel -
Mary Ann Liebert Inc
@LiebertPub
Call for papers alert! 🚨
@GENBiotechJrnl is accepting submissions for the upcoming special issue: Diversity, Equity, and Inclusion in Biotechnology led by guest editors @BrianAguado, Karmella Haynes, and @AnaMaPorras.
Deadline: April 15
More info:➡️ home.liebertpub.com/cfp/call-for-papers-diversity-equity-… -
Mary Ann Liebert Inc
@LiebertPub
Visiting #attd2024 in Florence, Italy March 6-9? Stop by the ATTD booth for the latest DTT issue & explore publishing/sponsorship opportunities with the journal!
Official Journal of ATTD
👉home.liebertpub.com/publications/diabetes-technology-and-…
#diabetescare #diabetestechnology #medicalpublishing -
Mary Ann Liebert Inc
@LiebertPub
We are thrilled to introduce our Open Impact Series, highlighting open access research defining the landscape of various fields.
The articles included in this collection are among our most cited in the area of genetics & heredity.
Read now: home.liebertpub.com/lpages/open-access-series-april/372 -
Mary Ann Liebert Inc
@LiebertPub
🌟 Celebrate #blackhistorymonth with our Expert Roundtable!
Explore changing mindsets, promoting antiracism in health delivery systems, and advocating for antiracist health policies.
Presented by @commonwealthfnd. Dive in: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#antiracism #healthequity -
Mary Ann Liebert Inc
@LiebertPub
🌟 Celebrating #blackhistorymonth! 🌟
Former VA Attorney General Mark Herring, Gail Christopher, Brian Smedley, Heather McGhee, & Mike Wenger discuss urgent racial inequities.
Dive into their Roundtable here: www.liebertpub.com/doi/10.1089/heq.2023.29041.nche
#racialequity #justiceforall
@NatlCo -
Mary Ann Liebert Inc
@LiebertPub
🌟 Meet Our Expert Sales Team in Clinical Medicine & Life Sciences! Passionate professionals ready to elevate your brand with custom publications, flexible subs and much more.
Ready to amplify your impact? DM us or email collaborate@liebertpub.com.
#lifesciences #customsolutions -
Mary Ann Liebert Inc
@LiebertPub
The Surgical Infection Society @SurgInfxSoc is pleased to announce that Robert G. Sawyer, MD has been selected as the new Editor-in-Chief of Surgical Infections. Read the full Press Release: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #surgicalinfections
-
Mary Ann Liebert Inc
@LiebertPub
We are pleased to announce that the 1st set of articles published with @theJMXR have just gone live! Included are medical XR guidelines from @theAMXRA, a piece on the therapeutic potential of VR, and more.
Be among the 1st to read them: journals.sagepub.com/toc/jmxr/1/1?cf-mal-redirected=true&
@BrennanSpiegel -
Mary Ann Liebert Inc
@LiebertPub
DON'T MISS OUT on the Richard Wolf Podcast- Episode #63! In this episode, we discuss the advantages and disadvantages of robotic cystectomy with Dr. Guru. www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
Those in the field of social justice and health equity advocacy say, as popularized by Dr. Martin Luther King Jr., “the arc of the moral universe is long, but it bends toward justice.”
Read this new expert roundtable calling for unity today: journals.sagepub.com/doi/10.1089/heq.2023.29041.nche?cf-m…
@NatlCo -
Mary Ann Liebert Inc
@LiebertPub
📅 Save the date: Jan 25-26! Join @WomenScienceRFS FREE virtual event celebrating women & minorities in science. Hear from top scholars & leaders on challenges & achievements in STEM.
🔗 Register now: www.workcast.com/register?cpak=2941543525644859
#scienceforall #diversityinstem #womeninscience -
Mary Ann Liebert Inc
@LiebertPub
New Richard Wolf Podcast- Episode #63! In this episode, we discuss the advantages and disadvantages of robotic cystectomy with Dr. Guru. www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
REGISTER Now! On Jan. 25-26, join us for our virtual event for the Rosalind Franklin Society. It's FREE! We're celebrating the incredible achievements of women and minorities in science and diving deep into the challenges they still face. www.workcast.com/register?cpak=2941543525644859
#womeninscience -
Mary Ann Liebert Inc
@LiebertPub
Time is running out! Free virtual summit on AI in Precision Oncology! Don’t miss Dr. Loaiza-Bonilla, a board-certified oncologist and hematologist at Capital Health, leading the Generative AI in Cancer Research session. webinars.liebertpub.com/e/the-state-of-ai-in-precision-on… #artificialintelligence #oncology
-
Mary Ann Liebert Inc
@LiebertPub
🚨 Hurry! Register for the free AI in Precision Oncology virtual summit. Discover insights from Dr. Sarah McGough is an epidemiologist and principal data scientist at Genentech/Roche.
Join us: webinars.liebertpub.com/e/the-state-of-ai-in-precision-on…
#ai #oncology #medicalinnovation -
Mary Ann Liebert Inc
@LiebertPub
Join this free virtual summit on AI in Precision Oncology! Don't miss Eric Topol, MD, founder and director of the Scripps Research Translational Institute, professor of Molecular Medicine and Executive Vice President of Scripps Research, in La Jolla, CA.. webinars.liebertpub.com/e/the-state-of-ai-in-precision-on…
-
Mary Ann Liebert Inc
@LiebertPub
Join the free virtual summit by AI in Precision Oncology and connect with top physicians, oncologists, and AI experts. Meet Dr. Blythe Adamson, a scientist and economist leading the Regulation of AI 1 session. webinars.liebertpub.com/e/the-state-of-ai-in-precision-on…
-
Mary Ann Liebert Inc
@LiebertPub
Don't miss this! Join the virtual summit by AI in Precision Oncology editors, Mary Ann Liebert Inc. Hear from leading experts on AI in precision oncology, including Dr. Thaker, a pioneering radiation oncologist and health policy expert.
webinars.liebertpub.com/e/the-state-of-ai-in-precision-on… #ai #oncology -
Mary Ann Liebert Inc
@LiebertPub
AI is reshaping lives and revolutionizing science and medicine, particularly in oncology. Explore the future of AI in Precision Oncology at our virtual summit with global experts. Spread the word among your professional network - you won't want to miss it! webinars.liebertpub.com/e/the-state-of-ai-in-precision-on…
-
Mary Ann Liebert Inc
@LiebertPub
New COOK Medical eBook! Be fully equipped for stones and BPH. Your single source for lasers and disposables. DOWNLOAD: multimedia.sagepub.com @cookmedical
-
Mary Ann Liebert Inc
@LiebertPub
Webinar: Explores a fully scalable method to efficiently enrich the percentage of full capsids by anion exchange chromatography. @unchainedlabs #aav #capsid #webinar
www.workcast.com/register?cpak=3711450465715971&referrer=900 -
Mary Ann Liebert Inc
@LiebertPub
New roundtable! Boston Scientific discusses experiences using the first ureteroscope with intrarenal pressure monitoring. READ MORE: engraffo.com/p/uGq5n2OU2h @bostonsci
-
Mary Ann Liebert Inc
@LiebertPub
#digitalhealth Ethics for #precisionmedicine in #palliativecare
New article in OMICS: A Journal of Integrative Biology examines digital health technologies' ethical, equity, and societal/relational implications for precision medicine in end-of-life care: journals.sagepub.com/doi/10.1089/omi.2023.0120?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
The American Thyroid Association® (ATA®) is pleased to announce that Trevor E. Angell, MD has been selected as the new Editor-in-Chief of the ATA monthly journal Clinical Thyroidology®. Dr. Angell’s term as Editor-in-Chief will begin in January 2024. www.liebertpub.com/CT
-
Mary Ann Liebert Inc
@LiebertPub
REGISTER NOW: A virtual summit hosted by the editors of AI in Precision Oncology, the groundbreaking new peer-reviewed journal from Mary Ann Liebert Inc. This free webinar sponsored by @ExactSciences
webinars.liebertpub.com/e/the-state-of-ai-in-precision-on…
#artificialintelligence #oncology -
Mary Ann Liebert Inc
@LiebertPub
Health Security #openaccess Supplement on Reimagining US Public Health Preparedness with Lessons from COVID-19.
Read today: www.liebertpub.com/toc/hs/21/S1
#publichealth #covid19 @NACCHOmeets @NACCHOalerts -
Mary Ann Liebert Inc
@LiebertPub
New COOK Medical eBook! Be fully equipped for stones and BPH. Your single source for lasers and disposables. DOWNLOAD: multimedia.sagepub.com @cookmedical
-
Mary Ann Liebert Inc
@LiebertPub
New roundtable! Boston Scientific discusses experiences using the first ureteroscope with intrarenal pressure monitoring. READ MORE: engraffo.com/p/uGq5n2OU2h @bostonsci
-
Mary Ann Liebert Inc
@LiebertPub
Webinar: Design of Experiment Based Optimization of Full AAV Particle Enrichment Using Stunner® as a High-Throughput Analysis Tool. @unchainedlabs #aav #capsid #webinar www.workcast.com/register?cpak=3711450465715971&referrer=900
-
Mary Ann Liebert Inc
@LiebertPub
CALL FOR COVER ART:
AIDS Research and Human Retroviruses invites our community and audience to submit art to be considered for the AIDS Research and Human Retroviruses covers of 2024 (Volume 40).
Learn more: home.liebertpub.com/lpages/aids-research-call-for-art/364 -
Mary Ann Liebert Inc
@LiebertPub
NEW SPECIAL ISSUE:
This special issue of the Journal of Ocular Pharmacology and Therapeutics (JOPT) represents selected research findings on Restoring Vision Through Regeneration
Read the issue now:journals.sagepub.com/toc/jop/39/8?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Early exposure to group research-based learning can have lasting positive impacts on #youth and their careers. A new article emphasizes the importance of making research-based #education in #lifesciences available to #highschool youth internationally: journals.sagepub.com/doi/10.1089/omi.2023.0079?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Health Security #openaccess Supplement on Reimagining US Public Health Preparedness with Lessons from COVID-19.
Read today: www.liebertpub.com/toc/hs/21/S1
#publichealth #covid19 @NACCHOmeets @NACCHOalerts -
Mary Ann Liebert Inc
@LiebertPub
NEW SPECIAL ISSUE based on an NIH sponsored a four-phase workshop to identify and prioritize key research needs for furthering our understanding of violence affecting #sgm communities. @NIH
Read the issue now: journals.sagepub.com/toc/lgbt/10/S1?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
New eBook! “The Copan Guide to Forensic Sampling” @ForensicGen @CopanUSA
Aiming to help forensic professionals choose the appropriate evidence collection method and ensure the success of their investigation.
Discover more: multimedia.sagepub.com -
Mary Ann Liebert Inc
@LiebertPub
Recently published #openaccess Supplement on Reimagining US Public Health Preparedness with Lessons from COVID-19. Read the supplement: www.liebertpub.com/toc/hs/21/S1
#publichealth #covid19 @NACCHOmeets @NACCHOalerts -
Mary Ann Liebert Inc
@LiebertPub
Last chance to register! On October 6, join the "Getting started with mRNA-based therapeutics" roundtable to explore mRNA challenges, including usability, stability, and technological limits. www.workcast.com/register?cpak=4970807526553236&referrer=900 @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
Treatment of Chronic #spinalcordinjury Restores Function to Forelimb
New study @J_Neurotrauma demonstrates a strategy for treating chronic SCI in rats that led to functional recovery of the paralyzed forelimb and paw and precision movements of the digits: journals.sagepub.com/doi/10.1089/neu.2023.0117?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Participants in a recently published Roundtable discussed how to support the development of ethical principles/standards to guide AI/ML infrastructure development and implementation in health research settings. @NADPH_ORG @NIH @AIM_AHEAD
journals.sagepub.com/doi/10.1089/big.2023.29061.rtd?cf-ma… -
Mary Ann Liebert Inc reposted
William S. Boyd School of Law at UNLV
@BoydLawUNLV
Congratulations to third-year law student Charlie Cahillane (@Charlie12365) for publishing his new paper, Don't Level Up With Loot Boxes: A Reconsideration of Senate Bill 1629, in the Gaming Law Review (@LiebertPub)! Check out Charlie's full paper at www.liebertpub.com/doi/10.1089/glr2.2023.0013.
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Celebrating 26 years of excellence @Cyberpsych_Jn @LiebertPub! We're proud to share some of our top accomplishments this year. In libraries and institutions across 170 countries, free online access in 106 developing nations. Thank you to our amazing team for making this possible!
-
Mary Ann Liebert Inc
@LiebertPub
New eBook! “The Copan Guide to Forensic Sampling” @ForensicGen @CopanUSA
Aiming to help forensic professionals choose the appropriate evidence collection method and ensure the success of their investigation.
Discover more: multimedia.sagepub.com -
Mary Ann Liebert Inc
@LiebertPub
NEW SPECIAL ISSUE covers the following areas: changing mindsets, promoting antiracism in health delivery systems, and promoting antiracism in health policy. @commonwealthfnd
Read the issue now: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
NEW SPECIAL ISSUE based on an NIH sponsored a four-phase workshop to identify and prioritize key research needs for furthering our understanding of violence affecting #sgm communities. @NIH
Read the issue now: journals.sagepub.com/toc/lgbt/10/S1?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
The National Alliance against Disparities in Patient Health presents a Roundtable Discussion on the topic of embedding ethics and equity into artificial intelligence and machine learning infrastructure.
@NADPH_ORG
journals.sagepub.com/doi/10.1089/big.2023.29061.rtd?cf-ma… #artificialintelligence #machinelearning -
Mary Ann Liebert Inc
@LiebertPub
Last chance to register! Tomorrow, Dr. Neff will discuss the existing literature on MOSES™ Holmium Laser Ablation of the Prostate, his surgical technique, clinical outcomes and how HoLAP helped him learn enucleation. www.workcast.com/register?cpak=6370727558634057&referrer=900 @JEndourology @bostonsci #urology
-
Mary Ann Liebert Inc
@LiebertPub
Optimizing Treatment for Acute #spinalcordinjury
A special focus issue @J_Neurotrauma highlights the latest findings of the North American Clinical Trials Network (NACTN), aimed at improving outcomes for individuals with acute spinal cord injury: journals.sagepub.com/toc/neu/40/17-18?cf-mal-redirected=t… -
Mary Ann Liebert Inc reposted
Dr. Kent Key
@DrKentDKey
"Advancing Equity Through Centering Societal Values to Operationalize Racism as a Public Health Crisis" published in Health Equity @LiebertPub liebertpub.com/doi/full/10.10 @, Jennifer Carrera, @DrL_LLapeyrouse @DjMcmaughan! @PCHP @BresciaUC @roulahawa
www.liebertpub.com/doi/full/10.1089/heq.2023.0113 -
Mary Ann Liebert Inc reposted
Roula Kteily-Hawa, PhD
@roulahawa
Thrilled to see our paper "Advancing Equity Through Centering Societal Values to Operationalize Racism as a Public Health Crisis" published in Health Equity @LiebertPub www.liebertpub.com/doi/full/10.1089/heq.2023.0113 🙏🏽team @DrKentDKey, Jennifer Carrera, @DrL_LLapeyrouse @DjMcmaughan! @PCHP @BresciaUC
-
Mary Ann Liebert Inc reposted
Mila ProkuninaOlsson
@prokuninaolsson
IFN Lambda siblings are not teens anymore - turned 20 😊. Check our special issue www.liebertpub.com/toc/jir/43/9 with reports based on our Lambda meeting in Hawaii, @CytokineSociety, Ray Donnelly, @LiebertPub, @drdeannasanter, @PlossLab and many more
Dr. Deanna Santer
@drdeannasanter
Happy 20th birthday to #ifnls! 🎂Check out @Journal_JICR IFNL special issue as open access including our article profiling new antibodies to finally quantify the high affinity IFNLR1 subunit at the protein level 😀 Other great articles to read too 👇
www.liebertpub.com/toc/jir/43/9 -
Mary Ann Liebert Inc reposted
NIH Women's Health
@NIH_ORWH
#icymi: The Journal of Women's Health (@LiebertPub) published a special issue focused on ORWH’s SCORE CEC program. Read the issue here:
NIH Women's Health
@NIH_ORWH
📰Fresh off the Press: The Journal of Women's Health (@LiebertPub) published a special issue focused on ORWH’s Specialized Centers of Research Excellence (SCORE) Career Enhancement Core (CEC) program. Read the latest issue here: orwh.od.nih.gov/in-the-spotlight/all-articles/journal-of-…
-
Mary Ann Liebert Inc
@LiebertPub
Curious about lab animal welfare? Join our expert-led webinar and discover a wealth of insights, including the impact of cage change frequency on mouse behavior, health, and ammonia levels. @Tecniplast3
TODAY 8:00 PT, 11:00 ET, 17:00 CET
Register now: www.workcast.com/register?cpak=4279954677216786&referrer=600 -
Mary Ann Liebert Inc reposted
@BigData_Journal
The ability to estimate the current mood states of web users has considerable potential for realizing user-centric opportune services in pervasive computing.
#openaccess www.liebertpub.com/doi/full/10.1089/big.2022.0211 -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on Citizen & Community Science Changing the Status Quo
Action research, community science, & participatory approaches may deliver on the environmental side of #environmentaljustice, but do they deliver on the justice? SUBMIT www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
We are proud to announce the launch of Journal of Medical Extended Reality (JMXR), the new open access peer-reviewed research journal dedicated to the advancement of extended reality in medicine.
Learn more: journals.sagepub.com/publications/journal-of-medical-exte… -
Mary Ann Liebert Inc
@LiebertPub
NEW SPECIAL ISSUE covers the following areas: changing mindsets, promoting antiracism in health delivery systems, and promoting antiracism in health policy. @commonwealthfnd
Read the issue now: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Astrobiology Journal
@Astrobiology_jn
When sending the #mars 2020 flight system, controlling Earth-sourced biological contamination was paramount to protecting scientific results and complying with Planetary Protection requirements before launch.
Explore an article collection on this subject: journals.sagepub.com/toc/ast/23/8?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! With recent #tech breakthroughs, #healthcare faces improvements that may benefit millions plagued by chronic conditions. Submit your paper on the role of intelligent computation optimization algorithms in #genomics and #precisionmedicine: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc reposted
Brennan Spiegel, MD, MSHS
@BrennanSpiegel
📢 Announcing JMXR: The Journal of Medical Extended Reality! Couldn't be more excited to launch this peer-reviewed journal today w/ @theAMXRA & @LiebertPub. Inaugural cover below! I'll be editor along with amazing board. Already getting submissions! Info: home.liebertpub.com/publications/journal-of-medical-exten…
-
Mary Ann Liebert Inc reposted
American Medical Extended Reality Association
@theAMXRA
We are proud to sponsor JMXR as the official journal of AMXRA! With unparalleled leadership from @BrennanSpiegel, JMXR is positioned to be the journal of record for medical extended reality and set a strong foundation for the field!
@theJMXR @markzhangdo @LiebertPub
Brennan Spiegel, MD, MSHS
@BrennanSpiegel
📢 Announcing JMXR: The Journal of Medical Extended Reality! Couldn't be more excited to launch this peer-reviewed journal today w/ @theAMXRA & @LiebertPub. Inaugural cover below! I'll be editor along with amazing board. Already getting submissions! Info: home.liebertpub.com/publications/journal-of-medical-exten…
-
Mary Ann Liebert Inc reposted
Mark Zhang DO MMSc FMXR
@markzhangdo
So proud to see what we accomplished in a year! AMXRA is breaking new ground in making substantial contributions to the field of Medical Extended Reality with @theJMXR. Thanks to @LiebertPub and @BrennanSpiegel for leading these efforts and getting us to the finish line.
-
Mary Ann Liebert Inc
@LiebertPub
New eBook: “The Copan Guide to Forensic Sampling”. @ForensicGen @CopanUSA
Aiming to help forensic professionals choose the appropriate evidence collection method and ensure the success of their investigation.
Discover more: multimedia.sagepub.com -
Mary Ann Liebert Inc
@LiebertPub
FREE WEBINAR TODAY! This webinar will provide a timely introduction to the world of mRNA-based therapeutics, encompassing their design, synthesis, modifications, and applications. @TriLinkBioTech: www.workcast.com/register?cpak=8375252374608147&referrer=900
-
Mary Ann Liebert Inc reposted
Tripathi Lab at Brown University
@LabTripathi
Congratulations to Dr. Kiara Lee (@PhDKiaraLee) on her new paper in @LiebertPub!
Dr. Lee discusses insights into improving gDNA recovery from dried blood spots, examining various parameters of interest for the first time in the literature!
www.liebertpub.com/doi/abs/10.1089/bio.2022.0181 -
Mary Ann Liebert Inc reposted
Brennan Spiegel, MD, MSHS
@BrennanSpiegel
Stay tuned... very soon we'll be announcing the official launch of JMXR: The Journal of Medical Extended Reality! This will be the official journal of @theAMXRA with an international editorial board of top #mxr experts. Will be published by @LiebertPub. More soon!
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
What distinguishes real-world from online? Social and cognitive neuroscience research on social networks and collective intentionality is used to answer this question. Read online now! @LiebertPub @Cyberpsych_Jn @RivaGiuseppe @FabryCom #vr #metaverse www.liebertpub.com/doi/10.1089/cyber.2023.0040
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
The Virtual Patient and You: How #ai Can Enhance Both Sides of the Therapeutic Relationship...Read the latest from @LiebertPub @Cyberpsych_Jn ...This editorial explores #vr #dtx #ai and the benefits it may have for #mentalhealth treatments. www.liebertpub.com/doi/10.1089/cyber.2023.29292.editorial
-
Mary Ann Liebert Inc
@LiebertPub
Last chance to register! On 9/18, join the free webinar to discuss a timely introduction to the world of mRNA-based therapeutics, encompassing their design, synthesis, modifications, and applications. @TriLinkBioTech: www.workcast.com/register?cpak=8375252374608147&referrer=900
-
Mary Ann Liebert Inc
@LiebertPub
Mark your calendars! On October 6, join the "Getting started with mRNA-based therapeutics" roundtable to explore mRNA challenges, including usability, stability, and technological limits. www.workcast.com/register?cpak=4970807526553236&referrer=900 @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
Mark your calendars! On 9/28, Dr. Donald Neff will discuss the existing literature on MOSES™ Holmium Laser Ablation of the Prostate, his surgical technique, clinical outcomes and how HoLAP helped him learn enucleation. www.workcast.com/register?cpak=6370727558634057&referrer=900 @JEndourology @bostonsci #urology
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Advancing Human-Robot Interaction: Empirical Insights & Innovative Applications
As #robots transition from isolated machines to interactive entities, take part in exploring & understanding the complex dynamics of human-robot interaction: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Curious about lab animal welfare? Join our webinar and discover a wealth of insights, including the impact of cage change frequency on mouse behavior, health, and ammonia levels. @Tecniplast3
September 25th 8:00 PT, 11:00 ET, 17:00 CET
Register: www.workcast.com/register?cpak=4279954677216786&referrer=600 -
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Transformation of Travel in the Mixed Reality Era ..."by offering new ways to feel immersed, mixed reality" can help people feel like they have traveled to far-off locations. Now online at www.liebertpub.com/doi/10.1089/cyber.2023.29288.editorial @Cyberpsych_Jn @LiebertPub #vr #ar #metaverse
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
#haptics: Making the #metaverse a Touching Experience Read my latest thoughts online now at @LiebertPub @Cyberpsych_Jn
#healthandwellness #psychology #virtualreality www.liebertpub.com/doi/10.1089/cyber.2023.29278.editorial -
Mary Ann Liebert Inc reposted
3D Printing
@3DPrintingJrnl
A recent #openaccess article on "3D Printed Lenses for Vertical Beam Collimation of Optical Phased Arrays" presents the design, fabrication, and characterization of edge-coupled 1D optical phased arrays combined with collimating lenses.
www.liebertpub.com/doi/full/10.1089/3dp.2022.0314 -
Mary Ann Liebert Inc
@LiebertPub
History of #thyroidultrasound
From low-resolution images in the 1960s to current high-resolution technology, #ultrasound has proven to be the initial imaging modality of choice for #thyroid application. Learn more in @thyroidjournal: journals.sagepub.com/doi/full/10.1089/THY.2022.0346?cf-ma… -
Mary Ann Liebert Inc reposted
Childhood Obesity
@ChildObesity_jn
Read and share these recently published articles from @ChildObesity_jn. These articles are free to access now through September 6.
www.liebertpub.com/doi/10.1089/chi.2022.0232
www.liebertpub.com/doi/10.1089/chi.2023.0021
www.liebertpub.com/doi/10.1089/chi.2022.0216
www.liebertpub.com/doi/10.1089/chi.2022.0234 -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue: #ai in #tissueengineering and #biology
@TissueEngin will highlight the rapidly growing applications of AI, #machinelearning, and computationally supported methods to the study of tissue engineering & biology. Submit by 10/1:www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
#naturopathicmedicine: Joshua Levitt, ND emphasizes the essential need to share written and spoken content with the public about the benefits and truths of using herbal, nutritional and supplemental medicine. Here's what Dr. Levitt wants to share with you: journals.sagepub.com/doi/10.1089/ict.2023.29081.jle?cf-ma…
-
Mary Ann Liebert Inc
@LiebertPub
New article collection from @Bayer on the future of #populationhealth management, particularly as it is applied in managing complex patient populations (eg, chronic kidney disease [CKD] in #type2diabetes).
Read now: journals.sagepub.com/toc/pop/26/S1?cf-mal-redirected=true& -
Mary Ann Liebert Inc reposted
NIH Women's Health
@NIH_ORWH
📰Fresh off the Press: The Journal of Women's Health (@LiebertPub) published a special issue focused on ORWH’s Specialized Centers of Research Excellence (SCORE) Career Enhancement Core (CEC) program. Read the latest issue here: orwh.od.nih.gov/in-the-spotlight/all-articles/journal-of-…
-
Mary Ann Liebert Inc reposted
Cannabis and Cannabinoid Research Journal
@CannabisJrnl
Driving while high:
This study used a driving simulator to explore the utility of THC cutoff levels in blood & saliva to detect impaired driving.
Read more here: journals.sagepub.com/doi/10.1089/can.2022.0187?cf-mal-red…
#cannabis #marijuana #drivinghigh #thc #distractedriving #research #medicine -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #ai has the potential to revolutionize the science & practice of the field of #urology. As the leading journal in this field for over 30 years, @JEndourology invites you to contribute to two upcoming special issues on this exciting topic: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
#digitalsustainability: Paving the Way Toward a #greeneconomy?
Standing on the cusp of a new era with the marriage of digital tech & sustainability, it is evident that digital sustainability is not merely a good-to-have; it is an imperative for our future.journals.sagepub.com/doi/10.1089/scc.2023.0069?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
#asthma Prediction for Infants with Severe #bronchiolitis
Researchers @MGHMedicine used data from infants with severe bronchiolitis to predict asthma at age 6Y. Their results demonstrate the need for new infancy-based asthma prediction tools. Learn more: journals.sagepub.com/doi/10.1089/ped.2023.0016?cf-mal-red… -
Mary Ann Liebert Inc reposted
Journal of Computational Biology
@JournalCompBio
The first issue in a series from the Intl. Symp. on Bioinformatics Research and Applications (ISBRA) 2022 is out now. ISBRA is a meeting that "provides a forum for the exchange of ideas and results among researchers, developers, and practitioners." www.liebertpub.com/toc/cmb/30/8
-
Mary Ann Liebert Inc
@LiebertPub
Reminder: Call for Papers! #exvivogenetherapy for #geneticdiseases
@HGTJournal special issue will focus on ex vivo gene therapy to highlight recent advancements, present new findings, and discuss the future goals and directions of the field. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Are #microbiometherapeutics Finally Here?
@FDA approvals of microbiome therapeutics are welcome signs of progress in the field. What does it tell us about the long-term potential of the #microbiome as a tool for preventing & curing disease?journals.sagepub.com/doi/10.1089/genbio.2023.29105.mki?cf… @GENBiotechJrnl -
Mary Ann Liebert Inc reposted
Cellular Reprogramming
@CellRepJrnl
We'd like to congratulate @_CristianaPires, our distinguished recipient of the 2022 annual RFS Award in Science. This accolade recognizes exceptional research and published contributions from women and underrepresented minority scientists, physicians, and engineers.
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #immuneresponses to rAAV #genetherapy
#raav vectors are now approved for human use, yet, immune responses limit its ability to live up to full potential for safe and effective gene transfer. Submit your paper on this topic to @HGTJournal: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: #mars 2020 Planetary Protection and Contamination Knowledge Investigations
READ NOW in @Astrobiology_jn: journals.sagepub.com/toc/ast/23/8?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Special Supplement: Population-Based Approaches to Improving Outcomes and Reducing Costs of Chronic #kidneydisease Associated with #t2d
@Bayer partners with health care leaders to advance #healthcare delivery through research, collaboration, & innovation: journals.sagepub.com/toc/pop/26/S1?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: Origins of #medicine
For this special issue, we aim to better understand how ancient medicine shaped the modern allopathic and Chinese medicine that is practiced today by using research tools unavailable to our ancestors. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Twist Bioscience
@TwistBioscience
Looking for a new science podcast? Check out @GrinsteinJ’s "The Leading Strand” featuring candid conversations with pioneers of biotechnology.
With a logo like that 🧬, we couldn’t help but share!
@LiebertPub
The Leading Strand | Podcast on Spotify spoti.fi/3OO2Whx -
Mary Ann Liebert Inc reposted
Dhanesh D. Binda, MD, MMSc
@DhaneshBinda
Our systematic review and meta-analysis on the utility of targeted temperature management in #covid19 patients who suffer cardiac arrest is available now ahead of print @LiebertPub. Normothermia (∼37°C) would most likely be optimal for these patients.
www.liebertpub.com/doi/full/10.1089/ther.2023.0033 -
Mary Ann Liebert Inc reposted
Brennan Spiegel, MD, MSHS
@BrennanSpiegel
Can't wait! The Journal of Medical Extended Reality (JMXR) will launch very soon! On behalf of @theAMXRA and @LiebertPub, I'll be the inaugural editor-in-chief along with an amazing, 13-member, international editorial board and 32-member advisory board. Formal announcements soon!
-
Mary Ann Liebert Inc reposted
Ezra Cohen
@DrEzraCohen
It is my honor to join the Editorial Board of AI in Precision Oncology and looking forward to the first issue in October. @LiebertPub
home.liebertpub.com/publications/ai-in-precision-oncology… -
Mary Ann Liebert Inc
@LiebertPub
Curious about lab animal welfare? Join our webinar and discover a wealth of insights, including the impact of cage change frequency on mouse behavior, health, and ammonia levels. @Tecniplast3
September 25th 8:00 PT, 11:00 ET, 17:00 CET
Register: www.workcast.com/register?cpak=4279954677216786&referrer=600 -
Mary Ann Liebert Inc
@LiebertPub
#genetherapy Targeting the #brainvasculature
Researchers have developed an engineered #aav vector than yields high transduction of brain vascular pericytes and smooth muscle cells. The characterization of this novel AAV capside described in @HGTJournal: journals.sagepub.com/doi/10.1089/hum.2022.211?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
How #technoference May Be Affecting Parent–Child Relationships
What are the impacts of parental technoference on parent–child relationships and children's health and development? A new article in @Cyberpsych_Jn takes a critical, closer look: journals.sagepub.com/doi/10.1089/cyber.2022.0278?cf-mal-r… -
Mary Ann Liebert Inc
@LiebertPub
New article collection from @Bayer on the future of #populationhealth management, particularly as it is applied in managing complex patient populations (eg, chronic kidney disease [CKD] in #type2diabetes).
Read now: journals.sagepub.com/toc/pop/26/S1?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #softrobots in the Real World
The grand challenge of autonomous mobile soft robots sits within reach. Take part in identifying opportunities and challenges of field deployed soft robots and chart a roadmap towards real world deployments: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Videogames for Depression
Games for Health Journal shines light on one of the most urgent issues of our time and for #mentalhealth researchers looking into person-centered, fresh developments with #videogames as aiding tools in treatments for #depression. journals.sagepub.com/doi/10.1089/g4h.2022.0094?cf-mal-red… -
Mary Ann Liebert Inc reposted
GEN Biotechnology
@GENBiotechJrnl
In a new study in @GENBiotechJrnl, @Omar_Akbari_ and colleagues demonstrate the first method for genetic modification in D. citri for vector control to combat citrus greening disease. #crispr
www.liebertpub.com/doi/10.1089/genbio.2023.0022 -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #indigenouspeoples and #environmentaljustice
In order to push against existing divides between Indigenous Peoples and environmental justice policies, join us to center Indigenous Peoples’ voices, perspectives, and knowledge systems: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
#cellreprogramming Techniques: Contributions to #cancertherapy
Researchers discuss recent advances in iPSC cancer models for cancer research, the effects of cancer cell reprogramming on cancer cells,& its potential use in immune cell therapy: journals.sagepub.com/doi/10.1089/cell.2023.0011?cf-mal-re… @CellRepJrnl -
Mary Ann Liebert Inc
@LiebertPub
Traumatic Brain Injury (TBI) is a major medical challenge globally, causing frequent ER consultations. Explore @AbbottGlobal's eBook featuring an expert discussion and two research articles on #biomarkers for TBI evaluation.
Discover more: multimedia.sagepub.com #brainhealth -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #nature and #health
Envisioning "a world in which everybody has access to nature and can sustain the benefits of nature": Take part in the growing body of research connecting improved health through increased time in nature: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in #glioma
New article published in Journal of Interferon & Cytokine Research reviews the pathophysiological roles and the therapeutic values of IL-7/IL-7R in tumors, focusing on gliomas: journals.sagepub.com/doi/10.1089/jir.2023.0050?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #autism and #aging: A Lifespan Approach
This special issue of @AutismAdulthood will address the dearth of published research on older Autistic adults by focusing on autism and aging. Submit your manuscript today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Connections Between Present-Day #wateraccess and Historical #redlining
The demonstration of the present-day impacts of redlining after nearly 90 years emphasizes the need to intentionally mitigate past injustices to ensure modern-day equity. journals.sagepub.com/doi/10.1089/env.2022.0115?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #artificialintelligence & #additivefabrication
Convergence of #ai and #3dp to revolutionize design & manufacturing: @3DPrintingJrnl calls researchers & practitioners from academia & industry to lay the foundations for this exciting field: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Inside Precision Medicine
@Inside_PM
Long-Term Exposure to #airpollution Increases #dementia Risk. Find out more: www.insideprecisionmedicine.com/topics/patient-care/neuro…
-
Mary Ann Liebert Inc reposted
AnnemiekeAartsma-Rus
@oligogirl
AND the paper I wrote with @roon_mom and Chantal Ferguson on the tofersen approval for ALS is out in @OTSociety journal NAT www.liebertpub.com/doi/epub/10.1089/nat.2023.0027 Open access courtesy of @LiebertPub and @OTSociety who picked this for special open access so you can all read it. Enjoy!
-
Mary Ann Liebert Inc reposted
Brennan Spiegel, MD, MSHS
@BrennanSpiegel
I'm honored to serve as inaugural editor-in-chief for #jmxr, the Journal of Medical Extended Reality! We'll launch soon as official journal of @theAMXRA in partnership with @LiebertPub. Board kickoff today (pic)! Not shown are 50+ international advisory board members. More soon!
American Medical Extended Reality Association
@theAMXRA
We made history.
#jmxr
💯💯💯
@BrennanSpiegel @IAmSusanPersky @koraksarkar_M3D @MinLangMD @mikejsz @SkipRizzoVR @markzhangdo @SueWoods @micuparamedic @sunjooahn @_The_Kate_D @rohan_jotwani @henryxiangmd @MargotPaul8 @LiebertPub @VirtualBrenda -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #biosafety and #biosecurity for #syntheticgenomics
The availability of synthetically produced, rapidly advancing technologies is raising concerns among biosecurity experts and policymakers. Submit your manuscript on this topic today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Genetic Engineering & Biotechnology News
@GENbio
Congratulations to senior editor @GrinsteinJ on the launch of this fabulous new scitech podcast:
THE LEADING STRAND
A fascinating span of guests and topics, many aligning with sister journals in the @LiebertPub portfolio.
Check it out on your favorite platform!
Jonathan D. Grinstein
@GrinsteinJ
My podcast "The Leading Strand" with @LiebertPub is available!
E1 w/ @geochurch
E2 w/ @MarthaClokie
E3 w/ Nessan Bermingham from @khoslaventures
E4 w/ @NicoleNovroski
Spotify: open.spotify.com/show/6U5s0gnEyCuqqhbqbn5H9Q
Amazon: music.amazon.in/podcasts/51d573d3-0860-4490-86f8-a6c9d56e… -
Mary Ann Liebert Inc
@LiebertPub
Is #lumbopelvicpain in #pregnancy Under-Reported?
A new study shows that pregnancy-related lumbopelvic pain is under-reported to healthcare providers, and under-treated, even though treatment is usually effective. Full study in Journal of Women’s Health: journals.sagepub.com/doi/10.1089/jwh.2022.0459?cf-mal-red… -
Mary Ann Liebert Inc reposted
Jonathan D. Grinstein
@GrinsteinJ
My podcast "The Leading Strand" with @LiebertPub is available!
E1 w/ @geochurch
E2 w/ @MarthaClokie
E3 w/ Nessan Bermingham from @khoslaventures
E4 w/ @NicoleNovroski
Spotify: open.spotify.com/show/6U5s0gnEyCuqqhbqbn5H9Q
Amazon: music.amazon.in/podcasts/51d573d3-0860-4490-86f8-a6c9d56e… -
Mary Ann Liebert Inc reposted
Del Rio’s Lab @Unipr
@phisquarelab
Our systematic review on the bioavailability of hydroxycinnamic acids is now free online in its final version here: www.liebertpub.com/doi/10.1089/ars.2023.0254. Long and boring, but terribly useful for everyone working in the field. @PMenaParreno @FoodPhyt_JPI @JPI_HDHL @HNUnipr @unipr @LiebertPub
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #newspace: Opportunities in and to #brazil
For this Special Issue, @NewSpace_JRNL invites you to submit abstracts which address policy gaps and relevant areas to improve the space sector in Brazil. Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Menstrual Equity in the Criminal Legal System
Among incarcerated women, many have to trade or barter to access menstrual hygiene products, according to a new study. Access the study that examines menstrual equity in the criminal legal system:journals.sagepub.com/doi/10.1089/jwh.2023.0085?cf-mal-red… #healthequity -
Mary Ann Liebert Inc reposted
Kaiser Permanente Research NorCal
@KPDOR
More evidence that the #a1c blood test, which is widely used to diagnose #diabetes and monitor its control, more often incorrectly estimates average blood sugar levels in Black patients from @KPDOR @kpnorcal @PermanenteDocs now in @LiebertPub
Story: ibit.ly/4UqaA -
Mary Ann Liebert Inc reposted
Children's National Hospital 🏥
@ChildrensNatl
Congratulations to @dreleanormackey who received the 2022 Rosalind Franklin Society Special Award in Science by @WomenScienceRFS for her @LiebertPub paper on structural racism and childhood #obesity. ➡️ www.rosalindfranklinsociety.org/index.php?option=com_cont…
-
Mary Ann Liebert Inc reposted
Kaiser Permanente Research NorCal
@KPDOR
Now in @LiebertPub by @KPDOR @kpnorcal @PermanenteDocs: More evidence that the #a1c blood test — widely used to diagnose #diabetes and monitor its control — more often incorrectly estimates average blood sugar levels in Black patients. #t2d
Story: ibit.ly/4UqaA -
Mary Ann Liebert Inc reposted
ASCO
@ASCO
Dr. Douglas Flora of @StElizabethNKY and @ShaalanBeg of @Science37x discuss the potential opportunities and challenges of emerging #ai applications in oncology on the #ascodailynews Podcast. 👉 dailynews.ascopubs.org/do/podcast-ai-allow-doctors-reclai… #onctwitter
-
Mary Ann Liebert Inc
@LiebertPub
Traumatic Brain Injury (TBI) is a major medical challenge globally, causing frequent ER consultations. Explore @AbbottGlobal's eBook featuring an expert discussion and two research articles on #biomarkers for TBI evaluation.
Discover more: multimedia.sagepub.com #brainhealth -
Mary Ann Liebert Inc reposted
VideoEndocrinology
@VEndocrinology
Just released an insightful video on #thyroidfunctiontests! Explore intricacies of diagnostic & monitoring techniques for thyroid disorders. From TSH to T3 & T4, uncover the clinical significance & interpretive considerations. Expand your expertise now!
journals.sagepub.com/doi/10.1089/ve.2023.0009?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Application of #machinelearning and Novel #genomesequencing Technology in #genetherapy
Special Issue @HGTJournal will focus on innovative deep learning models as an emerging approach in genome sequencing for use in gene therapy. SUBMIT: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Enzymes from Extremophiles & Their Industrial Applications
This special issue will present latest developments and recent scientific advances in the microbial enzymes derived from the extremophiles & their industrial applications. SUBMIT: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Top Ten Tips #palliativecare Clinicians Should Know About #integrativepalliativecare
Here's an evidence-based guide to incorporating integrative palliative care practices into the care of seriously ill individuals: journals.sagepub.com/doi/10.1089/jpm.2023.0219?cf-mal-red… @PalliativeMed_j -
Mary Ann Liebert Inc reposted
Asgard Therapeutics
@AsgardThx
Exciting news! Our CEO, @_CristianaPires, has been honored with the prestigious 2022 @WomenScienceRFS, in partnership with @LiebertPub publisher, Award in Science for her publication in Cellular Reprogramming journal, co-authored with @CellReproLab. More: journals.sagepub.com/doi/10.1089/cell.2023.29097.rfs2022?…
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
What's next for #telehealth #teletherapy #mentalhealth Read the latest @Cyberpsych_Jn @LiebertPub #virtualreality #mentalhealth www.liebertpub.com/doi/10.1089/cyber.2023.29277.editorial
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #ai and #machinelearning have the potential to revolutionize the field of #urologicsurgery. Special Issue @JEndourology will address how #ai serves as a powerful tool in robotic #endourology and minimally invasive #oncology. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
Mark your calendars! On 8/24, join experts to learn about the importance of monitoring intrarenal pressure and to hear about their initial clinical experiences using the first ureteroscope with IRP monitoring. REGISTER: www.workcast.com/register?cpak=4598312122043815&referrer=900 @JEndourology @bostonsci #urology
-
Mary Ann Liebert Inc reposted
Genetic Engineering & Biotechnology News
@GENbio
Join us on September 12 at 1 pm ET for our free webinar sponsored by @AnimaBiotech
Our experts will discuss the latest advancements in #mrna biology high-content technologies and their impact on drug discovery and research. Register now: www.workcast.com/register?cpak=4041324383393643&referrer=400 -
Mary Ann Liebert Inc
@LiebertPub
Special Issue @Cyberpsych_Jn yields powerful insights into the formulation of policies & strategies for intervention intending to reduce exposure to the contemporary challenges concerning #hatespeech & #fakenews throughout various stages of life. Read now: journals.sagepub.com/toc/cyber/26/7?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
Special Issue @TissueEngin highlights recent progress of biomaterial and cell-based strategies for #regenerativedentistry, providing valuable perspective for accelerating the design of new #tissueengineering strategies and clinical translation. Read Pt 3: journals.sagepub.com/toc/tec/29/7?cf-mal-redirected=true&
-
Mary Ann Liebert Inc reposted
Thyroid Journal
@thyroidjournal
Epub Ahead of Print - Systematic review & network meta-analysis comparing efficacy & adverse effects of #ablation techniques & surgery for benign #thyroidnodules.
journals.sagepub.com/doi/10.1089/thy.2022.0671?cf-mal-red…
#rfa #laserablation #microwaveablation #medtwitter #endotwitter #lobectomy #thyroidjournal -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! @TissueEngin aims to comprise research that investigates the interaction between the #immunesystem and #tissueregeneration, and to inhibit, promote, alter, or monitor that interaction to enhance remodeling and tissue growth. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
#ferroptosis: Ultimate Target of #cancertherapy
The significance of ferroptosis in #cancer therapeutics is unveiled. Recent research efforts suggest ferroptosis, a novel mode of regulated necrosis, as an ultimate candidate for therapeutic target of cancer.journals.sagepub.com/doi/10.1089/ars.2022.0048?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #biobased Design
Biobased materials exhibit numerous benefits over synthetic materials for our environment and health. @3DPrintingJrnl will focus on latest developments in biobased #3dp and #additivemanufacturing processes. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Clinical Thyroidology
@clinicalthyroid
The latest study tackling the prognosis of #pediatric #thyroid cancers, from @thyroidjournal by @BeninatoToni and others. @PedsEndoSociety @AmThyroidAssn @PESTOLAORG
journals.sagepub.com/doi/10.1089/ct.2023%3B35.279-281?cf-…
#medtwitter #endotwitter -
Mary Ann Liebert Inc reposted
Afra ÇALIK
@calikafra
I'm very proud to be worthy of Rosalind Franklin Society Awards in Science Award 2022 😎
Thank you @WomenScienceRFS
@LiebertPub and @GamesforHealthJ -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: @AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology highlight current understanding & content related to the diagnosis & management of #gravesdisease which also span related topics of #thyroid eye disease & #hyperthyroidism: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
Data-Driven Leadership: Clinical Registries Drive Higher Value Health Care
Does the American #healthcare system reward questionable decisions based on questionable data or evidence-based decisions based on valid data? journals.sagepub.com/doi/10.1089/pop.2023.0066?cf-mal-red… -
Mary Ann Liebert Inc reposted
Telemedicine Journal
@Telemedicine_Jn
Please join us in congratulating Dr. Carolyn Turvey - this year's recipient of the RFS Award in Science for @Telemedicine_Jn!
@WomenScienceRFS -
Mary Ann Liebert Inc
@LiebertPub
Aerosol Particle Size May Be An Important Factor Influencing Risk of COVID-19 Transmission
Study assesses the influence of aerodynamic diameter on the infectivity and virulence of #aerosols containing #sarscov2 in a hamster model of inhalational #covid19: journals.sagepub.com/doi/10.1089/jamp.2022.0072?cf-mal-re… -
Mary Ann Liebert Inc
@LiebertPub
A Deep Condition in Popular Hair Care Practices and Ingredients
Researchers review ingredients in #haircare products that can cause allergic contact #dermatitis and practical tips for allergen identification. Here's what you should know: journals.sagepub.com/doi/10.1089/derm.2023.0045?cf-mal-re… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! The Role of Intelligent Computation Optimization Algorithms in #genomics and #precisionmedicine
This special issue examines unique algorithms for data analytics approaches that use #ai and #machinelearning models. Submit your manuscript: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
HSS Anesthesiology
@HSSAnesthesia
Congrats @StephChengMD, who won the 2023 Rosalind Franklin Society Special Award in Science for "Intraoperative Acupuncture as Part of a Multimodal Analgesic Regimen to Reduce Opioid Usage After Total Knee Arthroplasty" published in @LiebertPub! Read here: rb.gy/0p5xj
-
Mary Ann Liebert Inc reposted
Stephanie Cheng, MD, DABMA, FAAMA
@StephChengMD
HBD Rosalind Franklin!! I am HONORED to win your award for Best Paper of 2022 in Medical Acupuncture ❤️#womeninstem #medicalacupuncture @LiebertPub @WomenScienceRFS @HSSAnesthesia @HSpecialSurgery @AAMAcupuncture
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: The Impact of High Potency #cannabis
@CannabisJrnl aims to provide insight into our current understanding of the short- and long-term impact of high-potency cannabis on health and society. Submit your manuscript for consideration today: journals.sagepub.com/publications/cannabis-and-cannabinoi… -
Mary Ann Liebert Inc
@LiebertPub
The robotic platform is well known for its use in surgery for malignant conditions. In Ep 60 of Endourology Sound Bites, we have a panel discussion on operating for benign conditions of the genitourinary system. Listen now: soundcloud.com/mary-ann-liebert-inc/episode-60-robotic-su… @JEndourology #roboticsurgery
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue: #ai in #tissueengineering and #biology
@TissueEngin will highlight the rapidly growing applications of AI, #machinelearning, and computationally supported methods to the study of tissue engineering & biology. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Health Equity
@HealthEquityJrl
Our first impact factor is only the beginning . @HealthEquityJrl is here as a definitive and transformative voice for research on, with, and by populations made vulnerable by systems of power and oppression. Under the visionary leadership of @mclemoremr
Mary Ann Liebert Inc
@LiebertPub
Health Equity Announces Impact Factor: 2.7*!
This upholds @HealthEquityJrl position as leading peer-reviewed journal in its field, delivering authoritative information about #healthdisparities #healthequity among vulnerable populations. Join our community:journals.sagepub.com/publications/health-equity/641/for-a… -
Mary Ann Liebert Inc
@LiebertPub
This exciting series of @Telemedicine_Jn looks at clinical appropriateness in #virtualcare, the role of payment systems, and the critical importance of virtual care in the broader context of the patient experience and digital #healthequity: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #telemedicine
-
Mary Ann Liebert Inc
@LiebertPub
The Long-Awaited #rsv Vaccine
Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. Here's the latest update on RSV #vaccine research: journals.sagepub.com/doi/10.1089/jir.2023.0076?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Promoting #healthequity in #digitalhealth Technologies and Communication
Take part in @Cyberpsych_Jn special issue dedicated to health equity promotion in the context of digital health communication and intervention -- Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
LizzyMcAninchMD
@LizzyMcAninchMD
I’m overwhelmed with honor and gratitude to receive a 2022 Rosalind Franklin Society (RFS) Award in Science for my contributions to @clinicalthyroid . Thank you @WomenScienceRFS , @LiebertPub and @clinicalthyroid for this generous recognition and for highlighting #hypothyroidism
-
Mary Ann Liebert Inc
@LiebertPub
RFS Awards in Science Announced, Recognize Outstanding Contributions from Women and Minorities
The 2022 RFS Awards in Science, recognizing outstanding peer-reviewed research by #women and #minorities in #stem, released by @LiebertPub @WomenScienceRFS: rfs.memberclicks.net/rfs-awards-in-science-2022 -
Mary Ann Liebert Inc reposted
Telemedicine Journal
@Telemedicine_Jn
This exciting series of #openaccess articles looks at clinical appropriateness in #virtualcare, the role of payment systems, and the critical importance of virtual care in the broader context of the patient experience and digital #healthequity.
Read now: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
PHAGE: Therapy, Applications, and Research
@PHAGEJournal
Calling all phage researchers! Register for the 25th @Evergreen_Phage Meeting Aug 6-11! This year we are celebrating Betty's legacy and her life’s accomplishments. Register Today: evergreen.phage.directory
#phage #bacteriophage -
Mary Ann Liebert Inc reposted
Cyberpsychology Journal
@Cyberpsych_Jn
Are you researching virtual reality in medical education?
Just ONE MONTH left to submit your manuscript to our upcoming special collection on this important topic: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
When influencers go beyond self-help tidbits, instead offering #mentalhealth content that borders on #medicaladvice: Is it legal? Is it ethical? @VirtualBrenda @Cyberpsych_Jn shares her thoughts on the line between friendly guidance and official counsel: journals.sagepub.com/doi/10.1089/cyber.2023.29270.editori…
-
Mary Ann Liebert Inc
@LiebertPub
High-Performance Catalysis of Cold-Rolling Sludge for the Recovery of Combustible Gas and Tar from Waste Demulsification Oil Scum
A promising strategy of “treating wastes with wastes” for converting oil scum to valuable gas, base oil, and magnetic char: journals.sagepub.com/doi/10.1089/ees.2022.0288?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Application of #machinelearning and Novel #genomesequencing Technology in #genetherapy
Special Issue @HGTJournal will focus on innovative deep learning models as an emerging approach in genome sequencing for use in gene therapy. SUBMIT: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
UCSF Surgery
@UCSFSurgery
1/3‼️A paper on abortion ethics that @DrLauraEsserman and a number of other doctors wrote was published in the Journal of Women's Health @LiebertPub. In it, they said that it is far too complicated to legislate, and that the patient should make decisions with her doctor's help.
-
Mary Ann Liebert Inc reposted
Journal of Palliative Medicine
@PalliativeMed_j
@PalliativeMed_j July Notes from the Editor: Spotlighting Death Anxiety in Palliative Care @alijohnzarrabi @dioisdio www.liebertpub.com/doi/10.1089/jpm.2023.0301 #palliativecare #anxiety
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #ai has the potential to revolutionize the science & practice of the field of #urology. As the leading journal in this field for over 30 years, @JEndourology invites you to contribute to two upcoming special issues on this exciting topic: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
.@thyroidjournal publishes jointly with @JASCJOURNAL a Special Article: The 2023 Bethesda System for Reporting Thyroid Cytopathology. This latest report summarizes the 3rd edition of The Bethesda System for Reporting Thyroid Cytopathology. Read it here: journals.sagepub.com/doi/10.1089/thy.2023.0141?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Journal of Endourology
@JEndourology
How to optimize PCNL care in transgender female patients? @RutulPatel_DO @alexcsmall and colleagues highlight the unique aspects of patient interaction, surgical approach, postoperative care associated with PCNL in this patient population #videourology
www.liebertpub.com/doi/10.1089/vid.2023.0036 -
Mary Ann Liebert Inc
@LiebertPub
We Have a Mission to Complete: #mpox is Not Over
Great progress has been made, with few cases currently being reported every week. Our work, however, is not done. Read the new virtual issue on Mpox in the journal LGBT Health: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Researchers highlight recent progress of bone marrow mesenchymal stem cell mitochondrial transfer, including its routes and effects on #organinjury repair, to point out the direction for further study and lay a foundation for future clinical applications: journals.sagepub.com/doi/10.1089/scd.2023.0019?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Genetically Modified #mscs in #cartilageregeneration
New review in the journal Stem Cells and Development summarizes recent research findings and developments in #geneticengineering strategies to enhance stem cell-based therapy for cartilage regeneration: journals.sagepub.com/doi/10.1089/scd.2022.0242?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
2023 Education Issue of #zebrafish: Call for Submissions!
Take part in a special issue that will focus on how zebrafish and other aquarium fish species can be used to promote innovation in science education. Submit your manuscript for consideration today: journals.sagepub.com/doi/10.1089/zeb.2022.29009.cfp?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
#misinformation Continues to Harm #lgbtq People
@TransgenderHlth Editor-in-Chief @DrRobGarofalo states “#lgbtqyouth need love, support, and acceptance, not misinformation and hate thinly veiled as compassion." Click here to read the full statement: journals.sagepub.com/doi/10.1089/trgh.2023.29001.editoria… -
Mary Ann Liebert Inc reposted
Tissue Engineering
@TissueEngin
Check out this new review titled "Human Mesenchymal Stem Cells and Innovative Scaffolds for Bone Tissue Engineering Applications" in Tissue Engineering Part B!
Read now: doi.org/10.1089/ten.teb.2022.0217 -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on #electroacupuncture
Take part in fostering a better understanding of the underlying mechanisms and the clinical effectiveness of electroacupuncture -- Submit your manuscript to the journal Medical Acupuncture today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Now We're Cooking With #electromagnetism: Making #inductionstoves Cool
The culture wars are heating up once again, this time over gas stoves. Perhaps, “Now we're cooking with electromagnetism!” can become the 21st century's new maxim for doing it better: journals.sagepub.com/doi/10.1089/scc.2023.0044?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Genome Sequencing Using Convolution Neural Networks
This special issue will focus on innovative #deeplearning models as an emerging approach in #genomesequencing. Submit your manuscript today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Episode #59 Education session: How does one learn prostate enucleation and what is needed to sustain a successful program? These experts offer insight as to how to accomplish a successful enucleation program. Listen now: soundcloud.com/mary-ann-liebert-inc/episode-59-education-… @JEndourology #urology #prostate
-
Mary Ann Liebert Inc reposted
Human Gene Therapy
@HGTJournal
Complement component binding and activation following AAV9 vector exposure to human neutralizing serum: www.liebertpub.com/doi/10.1089/hum.2023.018
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #softrobots in the Real World
The grand challenge of autonomous mobile soft robots sits within reach. Take part in identifying opportunities and challenges of field deployed soft robots and chart a roadmap towards real world deployments: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: Advances in #alzheimers Disease
Read Part I of this special issue published in the journal Brain Connectivity: journals.sagepub.com/toc/brain/13/5?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
New study @J_Neurotrauma shows positron emission tomography with radiotracer (18F)-FTP to detect p-tau may not be appropriate for diagnosing chronic traumatic encephalopathy neuropathologic changes in former professional American-style #football players: journals.sagepub.com/doi/10.1089/neu.2022.0454?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Burgundy
@Burgundy_Info
Fantastic to have recently visited our friends @LiebertPub and participated in their global sales meeting. It’s the perfect way to prepare for the coming subscription year, discuss market trends, build relationships and to learn about exciting new products home.liebertpub.com/publications/ai-in-precision-oncology…
-
Mary Ann Liebert Inc
@LiebertPub
Bioelectricity Announces First Impact Factor of 2.3*!
This achievement upholds the Journal's position as the leading peer-reviewed journal in its field, dedicated to the field of #bioelectricity. Take this opportunity to join our scholarly community: journals.sagepub.com/publications/bioelectricity/647/for-… -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: #inflammation Networks in #genetherapy
Special Issue @HGTJournal covers the genetic and non-genetic determinants in pathological inflammation and identifies new genetic variants linked to the cause and consequences of inflammatory diseases: journals.sagepub.com/toc/hum/34/11-12?cf-mal-redirected=t… -
Mary Ann Liebert Inc reposted
The CRISPR Journal
@CRISPRjournal
Fanzor: First CRISPR-Like System Found in Eukaryotes
-- our colleagues @genbio cover the latest advance from @zhangf and colleagues.
www.genengnews.com/topics/genome-editing/fanzor-first-cri… via @GENbio -
Mary Ann Liebert Inc
@LiebertPub
PHAGE: Therapy Applications, and Research Announces Impact Factor of 2.7*!
This achievement upholds @PHAGEJournal position as the leading peer-reviewed journal in its field, dedicated to #bacteriophage research. Take this opportunity to join our community:journals.sagepub.com/publications/phage/652/for-authors?c… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #environmentaldermatitis
The role of exposomal factors (indoors or outdoors) in inducing or modifying the course of such #dermatitis is of interest. Submit your research on this topic for publication consideration: journals.sagepub.com/publications/dermatitis/672/for-auth… -
Mary Ann Liebert Inc
@LiebertPub
Neurotrauma Reports Announces Impact Factor: 2.4*!
This upholds the Journal's position as the leading OA peer-reviewed journal in its field, delivering authoritative research on a range of topics related to #tbi and #spinalcordinjury. Join our community: journals.sagepub.com/publications/neurotrauma-reports/657… -
Mary Ann Liebert Inc reposted
Soft Robotics
@SoftRobotics_JN
Yunce Zhang, Tao Wang, Weidong He, and Shiqiang Zhu have developed portable human-powered master controllers to provide an alternative solution for the master-slave control of the fluidic soft robots.
www.liebertpub.com/doi/10.1089/soro.2022.0077 -
Mary Ann Liebert Inc
@LiebertPub
Industrial Biotechnology is coming to the rescue to enhance #skinhealth. We are at the beginning of a journey leading to more effective, naturally derived microbial surfactants for numerous applications, including #cosmetic ingredients: journals.sagepub.com/doi/10.1089/ind.2023.29315.rgr?cf-ma… #biotechnology
-
Mary Ann Liebert Inc
@LiebertPub
Palliative Medicine Reports Announces Impact Factor: 2.5*!
This achievement upholds @PallmedR position as the leading peer-reviewed OA journal in its field! Join our community covering medical, psychosocial, policy, and legal issues in #endoflife care: journals.sagepub.com/publications/palliative-medicine-rep… -
Mary Ann Liebert Inc
@LiebertPub
How #nature & #horticultural, #culinary, & #botanicalmedicine Can Improve #clinicianshealth
In this clinician wellness column, experts offer practical advice for optimizing health & provide suggestions for incorporating more wellness in day-to-day living: journals.sagepub.com/doi/10.1089/ict.2023.29076.mlo?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Journal of Women's Health Announces New Impact Factor of 3.5*!
This achievement upholds the Journal's position as a leading peer-reviewed journal. Ensure your manuscript has the impact and receives the attention it deserves -- Submit today: journals.sagepub.com/publications/journal-of-womens-healt… #womenshealth -
Mary Ann Liebert Inc reposted
LGBT Health
@LGBTHealthJrnl
Last Chance to Read the Special Issue on Mpox in the #pride2023 Special Collection and get 25% off a new Personal Journal Subscription www.sagepub.com/journals/mary-ann-liebert-journals-transi…
-
Mary Ann Liebert Inc
@LiebertPub
Treatment for #highbloodpressure in #africanamericans
African Americans have the highest prevalence of HBP in the US. A new study suggests that home remedies may be an effective complementary/integrative treatment option for HBP in this population: journals.sagepub.com/doi/10.1089/ict.2023.29078.eed?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Health Equity Announces Impact Factor: 2.7*!
This upholds @HealthEquityJrl position as leading peer-reviewed journal in its field, delivering authoritative information about #healthdisparities #healthequity among vulnerable populations. Join our community:journals.sagepub.com/publications/health-equity/641/for-a… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on Citizen & Community Science Changing the Status Quo
Action research, community science, & participatory approaches may deliver on the environmental side of #environmentaljustice, but do they deliver on the justice? SUBMIT:www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
New Space
@NewSpace_JRNL
Authors recently addressed the need for a standardized software architecture of #newspace companies in "Software Reference Architecture for CubeSats: A Direct Approach". #cubesats
www.liebertpub.com/doi/10.1089/space.2021.0069 -
Mary Ann Liebert Inc
@LiebertPub
Astrobiology Announces New Impact Factor: 4.2*!
This upholds @Astrobiology_jn position as the leading peer-reviewed journal in its field, delivering research on understanding of life's origin, evolution, & distribution in the universe. Join our community: journals.sagepub.com/publications/astrobiology/99/for-aut… -
Mary Ann Liebert Inc
@LiebertPub
Status of Biobased Production of #succinicacid and Derivatives
The current status & future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the journal Industrial Biotechnology: journals.sagepub.com/doi/10.1089/ind.2023.0001?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Efficacy and Safety of Novel MDXX Analogues in Treating #autismspectrumdisorder
A new review in the journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogues, or MDXX drugs, and how they may help treat #asd: journals.sagepub.com/doi/10.1089/psymed.2023.0023?cf-mal-… -
Mary Ann Liebert Inc
@LiebertPub
Brain Connectivity Announces New Impact Factor: 3.4*!
This achievement upholds the Journal's position as the leading peer-reviewed journal in its field, delivering groundbreaking research on #brainconnectivity & #brainmapping research. Join our community: journals.sagepub.com/publications/brain-connectivity/389/… -
Mary Ann Liebert Inc
@LiebertPub
Acupuncture in Addiction Medicine
Considering the mounting #opioid use concerns & deficiencies in substance-use disorder treatment availability in the United States, #acupuncture can be a safe, feasible treatment option and adjunct in #addictionmedicine: journals.sagepub.com/doi/10.1089/acu.2023.0021?cf-mal-red… -
Mary Ann Liebert Inc reposted
Astrobiology Journal
@Astrobiology_jn
Aquatic Ferrous Solutions of Prebiotic Mineral Salts as Strong UV Protectants and Possible Loci of Life Origin
Read now: journals.sagepub.com/doi/full/10.1089/ast.2023.0011?cf-ma…
#originoflife #openaccess -
Mary Ann Liebert Inc reposted
Cornell Bowers Computing and Information Science
@Cornell_Bowers
“How fast a researcher can process genomic data poses an implicit limit to the insights they can gain from it.” - Guilia Guidi, Assistant Professor @cs_cornell
Read more from @LiebertPub: journals.sagepub.com/doi/10.1089/genbio.2023.29100.sra?cf… -
Mary Ann Liebert Inc
@LiebertPub
Autism in Adulthood Announces First Impact Factor: 6.8*!
This achievement upholds @AutismAdulthood's position as a leading peer-reviewed journal in its field, delivering the most pressing issues affecting adults on the #autism spectrum. Join our community:journals.sagepub.com/publications/autism-in-adulthood/646… -
Mary Ann Liebert Inc
@LiebertPub
Election administration faced a turning point in 2020. Special Issue @ElectionLawJrnl presents articles from 2022 Conference in Election Sciences, Reform, and Administration that reflect on the elections & discuss how to improve #elections into the future: journals.sagepub.com/doi/10.1089/elj.2023.29004.mkr?cf-ma…
-
Mary Ann Liebert Inc
@LiebertPub
Soft Robotics Announces New Impact Factor of 7.9*!
This achievement upholds @SoftRobotics_JN's position as the leading #robotics journal in its field, publishing world-class peer-reviewed research. Take this opportunity to join our research community: journals.sagepub.com/publications/soft-robotics/616/for-a… -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: @AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology recent publications regarding #differentiatedthyroidcancer highlights current understanding and most recently published information on this topic. Read the full collection: www.sagepub.com/journals/liebert-info
-
Mary Ann Liebert Inc reposted
3D Printing
@3DPrintingJrnl
Recent #openaccess study on "The Inner Complexities of Multimodal Medical Data: Bitmap-Based 3D Printing for Surgical Planning Using Dynamic Physiology"
www.liebertpub.com/doi/full/10.1089/3dp.2022.0265
#3dprinting #medical #biomedical #medicalimaging -
Mary Ann Liebert Inc
@LiebertPub
.@Cyberpsych_Jn Announces New Impact Factor: 6.6*!
This upholds the Journal's position as the leading peer-reviewed journal in its field, delivering the latest research on understanding the impact of today's #socialnetworking practices. Join our community:journals.sagepub.com/publications/cyberpsychology-behavio… -
Mary Ann Liebert Inc
@LiebertPub
Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies
These antibodies are promising candidates for biological therapeutics that target the #thyroid in mice to model treatments for #hashimotosthyroiditis or #gravesdisease: journals.sagepub.com/doi/10.1089/mab.2022.0037?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Big Data Announces New Impact Factor: 4.6*!
This upholds @BigData_Journal's position as the leading peer-reviewed journal covering challenges and opportunities in collecting, analyzing, and disseminating vast amounts of #data. Join our research community: journals.sagepub.com/publications/big-data/611/for-author… -
Mary Ann Liebert Inc
@LiebertPub
Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice
In a new study, researchers employed APP/PS1 mice to explore the neuroprotective mechanism of Kai-Xin-San. Discover the findings: journals.sagepub.com/doi/10.1089/rej.2022.0063?cf-mal-red… -
Mary Ann Liebert Inc reposted
Childhood Obesity
@ChildObesity_jn
Behavior Change Techniques that Prevent or Decrease Obesity in Youth with a Low Socioeconomic Status: A Systematic Review and Meta-Analysis, published in @ChildObesity_jn
Link to pub: www.liebertpub.com/doi/full/10.1089/chi.2022.0172 -
Mary Ann Liebert Inc
@LiebertPub
Epigenetic Modifiers as Game Changers for Healthy #aging
New review covers key findings in epigenetics related to aging, age-related diseases, and how epigenetic modification have an impact on lifespan and health span extension: journals.sagepub.com/doi/10.1089/rej.2022.0059?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Dermatitis® Announces First Impact Factor with @LiebertPub: 5.2*!
This upholds the Journal’s position as leading peer-reviewed journal publishing research in atopic, contact, occupational, environmental, & drug dermatitis. Recommend to your library now: journals.sagepub.com/publications/dermatitis/672/recommen… -
Mary Ann Liebert Inc
@LiebertPub
Thyroid® Announces New Impact Factor of 6.6*!
This achievement upholds @thyroidjournal's position as the leading peer-reviewed journal in its field. Submit your research to this influential and field-defining Journal today: journals.sagepub.com/publications/thyroid/55/for-authors?… -
Mary Ann Liebert Inc reposted
Cannabis and Cannabinoid Research Journal
@CannabisJrnl
Is cannabis use associated with violence?
This longitudinal study explored this question in a sample of 98 outpatients with severe mental disorders: journals.sagepub.com/doi/10.1089/can.2022.0038?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #biosafety and #biosecurity for #syntheticgenomics
The availability of synthetically produced, rapidly advancing technologies is raising concerns among biosecurity experts and policymakers. Submit your manuscript on this topic today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Special Issue of @TissueEngin highlights recent progress of biomaterial and cell-based strategies for regenerative dentistry, aiming to provide valuable perspective for accelerating the design of new #tissueengineering strategies and clinical translation: journals.sagepub.com/toc/tec/29/6?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
Digitally Connected Diagnostics Data in the Future of #publichealth
How public–private partnerships between digitally connected diagnostic companies and public health agencies could enable building the public heath monitoring systems of the future: journals.sagepub.com/doi/10.1089/genbio.2023.0016?cf-mal-… -
Mary Ann Liebert Inc reposted
Journal of Computational Biology
@JournalCompBio
Just in time for your summer travel the June issue is out! 5 new research articles and one software publication (EnsMOD, a tool for -omics outlier detection from authors at @NIH).
www.liebertpub.com/toc/cmb/30/6 -
Mary Ann Liebert Inc
@LiebertPub
Bioorthogonal Stimulated Raman Scattering Imaging Uncovers Lipid Metabolic Dynamics in Drosophila #brain During #aging
New study @GENBiotechJrnl illuminates interconnection of aging, dietary, and genetic manipulations on brain lipid metabolic regulation: journals.sagepub.com/doi/10.1089/genbio.2023.0017?cf-mal-… -
Mary Ann Liebert Inc
@LiebertPub
The development of foods with enhanced nutritional profiles can greatly impact #globalhealth & improve access to essential nutrients. Researchers @SeoulNatlUni have applied #crispr to produce #tomatoes with enhanced levels of provitamin D3: journals.sagepub.com/doi/10.1089/genbio.2023.0015?cf-mal-… @GENBiotechJrnl
-
Mary Ann Liebert Inc
@LiebertPub
Special Issue: LGBTQIA+ Autistic Adults
This special issue of @AutismAdulthood, dedicated to the common intersection of autism and LGBTQ+ identities, presents 10 new contributions to the field. Read the full issue here: journals.sagepub.com/toc/aut/5/2?cf-mal-redirected=true&
#autism #autistic #lgtbqia -
Mary Ann Liebert Inc reposted
Michael F. Chiang, MD
@NEIDirector
Limiting ocular inflammation is a challenge in gene therapy delivery. This #neifunded research finds AAV serotype and delivery routes mediate the degree of inflammation.
@3Y3MD @ChoroidLab @StemCellsEh @IowaMed @uiowaeye
@LiebertPub paper: pubmed.ncbi.nlm.nih.gov/36793189/ -
Mary Ann Liebert Inc reposted
Cornell Bowers Computing and Information Science
@Cornell_Bowers
“How fast a researcher can process genomic data poses an implicit limit to the insights they can gain from it.” - Guilia Guidi, Assistant Professor @cs_cornell
Read more from @LiebertPub: journals.sagepub.com/doi/10.1089/genbio.2023.29100.sra?cf… -
Mary Ann Liebert Inc reposted
Cellular Reprogramming
@CellRepJrnl
A Safer Path to Cellular Rejuvenation: Endogenous Oct4 Activation via CRISPR/dCas9 in Progeria Mouse Models! News and Views from
@RetroBio_ commenting on the Aging Cell article: onlinelibrary.wiley.com/doi/10.1111/acel.13825 -
Mary Ann Liebert Inc
@LiebertPub
Development of an Eczema Area and Severity Index (EASI) Atlas for Diverse Skin Types
Researchers created a photographic atlas and updated guidance language for implementing EASI in diverse populations, including those with higher skin phototypes: journals.sagepub.com/doi/10.1089/derm.2023.0051?cf-mal-re… #eczema -
Mary Ann Liebert Inc
@LiebertPub
#gastriccancer Biomarker Candidates Identified by #machinelearning and Integrative #bioinformatics: Toward #personalizedmedicine
Study reveals novel potential diagnostic biomarker candidates for gastric cancer through integrated bioinformatics approaches: journals.sagepub.com/doi/10.1089/omi.2023.0015?cf-mal-red… -
Mary Ann Liebert Inc reposted
GEN Biotechnology
@GENBiotechJrnl
Researchers search for less toxic alternatives to busulfan as a bone conditioning regimen, a crucial component of cell and gene therapy protocols.
Read accounts from sickle cell patient, Victoria Gray.
News by @GrinsteinJ & @AlexWestchester:
liebertpub.com/doi/10.1089/genbio.2023.29103.jdg -
Mary Ann Liebert Inc
@LiebertPub
New study in Journal of Interferon & Cytokine Research performs high-throughput #cytokine analysis spanning the whole #covid19 severity spectrum and shows apparent proinflammatory cytokine surge among severe and critically ill COVID-19 patients from Egypt: www.liebertpub.com/doi/10.1089/jir.2023.0029
-
Mary Ann Liebert Inc reposted
CABBI
@CABBIbio
CABBI researchers have proved in principal a new method of spectroscopy to decide the ideal growth stage for harvesting bioenergy crops. Full study in @liebertpub Industrial Biotechnology: www.liebertpub.com/doi/abs/10.1089/ind.2022.0039?journalC…
-
Mary Ann Liebert Inc
@LiebertPub
Mini Special Issue of @BigData_Journal: Evaluation and Experimental Design in #datamining and #machinelearning
Read Now: journals.sagepub.com/toc/big/11/3?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: #genetherapy for #muscledisorders
In this special issue of @HGTJournal, experts in the field present reviews on some of the most pressing issues and recent advances in the field. Read the full issue: journals.sagepub.com/toc/hum/34/9-10?cf-mal-redirected=true& -
Mary Ann Liebert Inc reposted
Human Gene Therapy
@HGTJournal
Join our community! Sign up to receive email alerts on published research. @HGTJournal provides all-inclusive coverage of the research, methods, and clinical developments in gene therapy.
home.liebertpub.com/publications/human-gene-therapy/19/si… -
Mary Ann Liebert Inc
@LiebertPub
.@LiebertPub Announces the Launch of AI in Precision Oncology
AI in Precision Oncology, the only academic, bimonthly peer-reviewed research journal dedicated to the advancement of #artificialintelligence applications in clinical and precision #oncology: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
#earthsystem at Risk: Challenging Environmental (In)Justice
This Special Issue has opened the scholarly debate to the richness of reflections coming from the ground, across geographies, political contexts, and a diversity of perspectives. Read now: www.liebertpub.com/toc/env/16/3 -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: Mycobacterial Cell‐Envelope as a Target for Drug Development
Read the full issue: journals.sagepub.com/toc/mdr/29/5?cf-mal-redirected=true&
#drugdevelopment #drugdiscovery -
Mary Ann Liebert Inc reposted
Soft Robotics
@SoftRobotics_JN
No submission fees!
Latest Impact Factor: 7.784
Free 30-day access to share your published research with your colleagues
We look forward to your submission: home.liebertpub.com/cfp/submit-today-with-zero-submission… -
Mary Ann Liebert Inc
@LiebertPub
New Episode of Endourology Sound Bites Podcast — Listen Now!
In Episode 58, @noahcanvasser @UCDavisUrology summarizes the take-home messages from the #endourology sessions at #aua23 in Chicago. Listen here: soundcloud.com/mary-ann-liebert-inc/episode-58-endourolog… @JEndourology #richardwolf -
Mary Ann Liebert Inc
@LiebertPub
Special Issue "Adverse Childhood Experiences" in the journal Violence and Gender sheds light on findings from recent research on the effect of direct or indirect exposure to #violence during #childhood and the long-range consequences of that exposure: journals.sagepub.com/toc/vio/10/2?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #biotechnological Routes to #cosmetic & #foodbioactives & Ingredients
As the cosmetic and food industries are investing more & more in biotechnological processes for safer products for the environment, submit your research on this topic: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Paradoxical Neurocognitive Effects of Cannabis Use in Patients with Psychotic Disorders
The association between #cannabis and #cognitive functions has been studied in #psychoticdisorders, but conflictual/paradoxical results have emerged. journals.sagepub.com/doi/10.1089/can.2021.0163?cf-mal-red… @CannabisJrnl -
Mary Ann Liebert Inc
@LiebertPub
#mrna vaccines and therapeutics are expanding rapidly. TOMORROW, Dr. Chunping @TriLinkBioTech will discuss the latest progress in next-generation mRNA design in a new webinar hosted by @CRISPRjournal Don't miss out -- REGISTER NOW: www.workcast.com/register?cpak=5827477065713913&referrer=600
-
Mary Ann Liebert Inc reposted
Inside Precision Medicine
@Inside_PM
Could a Keto Diet Be the Game Changer for Cancer Patients?
Scientists have discovered that a keto-diet can stunt tumor growth in mice models but also has a potentially lethal side effect. Learn more: www.insideprecisionmedicine.com/topics/oncology/could-a-k… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #immuneresponses to rAAV #genetherapy
#raav vectors are now approved for human use, yet, immune responses limit its ability to live up to full potential for safe and effective gene transfer. Submit your paper on this topic to @HGTJournal: www.sagepub.com/journals/liebert-info -
Mary Ann Liebert Inc
@LiebertPub
Biosentinel: NASA'S First Deep Space Bioscience Mission
Read this new Special Collection published in the peer-reviewed @Astrobiology_jn: journals.sagepub.com/toc/ast/23/6?cf-mal-redirected=true&
#biosentinel #nasa #deepspace #bioscience #astrobiology -
Mary Ann Liebert Inc
@LiebertPub
#biomaterials and #cellstrategies for #regenerativedentistry
Special Issue @TissueEngin, published in 3 parts, presents a collection of articles that highlight recent progress of biomaterial & cell-based strategies for regenerative dentistry. Read Part 1: journals.sagepub.com/toc/tec/29/5?cf-mal-redirected=true& -
Mary Ann Liebert Inc reposted
SWHR
@SWHR
What role do academic journals play in advancing our understanding of #sexdifferences and #sager guidelines? Check out this expert panel for more: swhr.org/event/a-conversation-on-the-elevation-of-sex-and…
@BiologySexDiff @SpringerNature @SowmyaSwaminat1 @JAMANetwork @DrMelissaSimon @women_neurosci @LiebertPub -
Mary Ann Liebert Inc
@LiebertPub
Special issue @JICM_Journal on Global Public Health, a response to the Declaration of Astana @WHO @UNICEF: Traditional, complementary, & integrative medicine offer #globalhealth to governments & health providers seeking to fulfill the declaration’s promise:journals.sagepub.com/toc/jicm/29/6-7?cf-mal-redirected=true&
-
Mary Ann Liebert Inc reposted
TERMIS-EU 2022 Krakow
@TermisEU2022
#termiseu2022 Chapter
Conference Book and Book of Abstracts
Kraków, 28 June – 1 July, 2022
Tissue Engineering Part A @TissueEngin (@liebertpub)
Now Available at doi.org/10.1089/ten.tea.2023.29046.abstracts -
Mary Ann Liebert Inc
@LiebertPub
As adoption of #continuousglucosemonitoring continues to increase, there is a growing body of evidence supporting the use of this technology in improving #diabetes outcomes. Here's an excellent perspective of the past, present, and future of #cgm: www.liebertpub.com/toc/dia/25/S3
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
citylife.capetown/uncategorized/the-social-impact-of-mmog… A study published in @Cyberpsych_Jn @LiebertPub found that playing #mmogs can help to reduce feelings of #loneliness and #socialanxiety, particularly for individuals who struggle with these issues in their offline lives
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Application of #machinelearning and Novel #genomesequencing Technology in #genetherapy
Special Issue @HGTJournal will focus on innovative deep learning models as an emerging approach in genome sequencing for use in gene therapy. SUBMIT: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Oncolytic Reoviruses: Can Emerging Zoonotic Reoviruses Be Tamed & Utilized?
The risk of #reovirus as #zoonosis or #zooanthroponosis is debated, and concerns are raised, which warrant continued surveillance of reovirus in animals, humans, & the environment.journals.sagepub.com/doi/10.1089/dna.2022.0561?cf-mal-red… -
Mary Ann Liebert Inc reposted
SWHR
@SWHR
The recording of the SWHR & @OSSDtweets event "A Conversation on the Elevation of Sex and Gender in Publishing Academic Research" is now available! swhr.org/event/a-conversation-on-the-elevation-of-sex-and… @BiologySexDiff @SpringerNature @SowmyaSwaminat1 @JAMANetwork @DrMelissaSimon @women_neurosci @LiebertPub
-
Mary Ann Liebert Inc
@LiebertPub
Inside the June Issue of Planned Giving Today: American Awareness and Attitudes Toward Philanthropy and the Nonprofit Sector, and more -- Read the full issue: journals.sagepub.com/doi/epdf/10.1089/pgt.2023.34.6-1?cf-…
#plannedgiving #giftplanning #nonprofit #philanthropy -
Mary Ann Liebert Inc
@LiebertPub
#mrna vaccines and therapeutics are expanding rapidly. On June 15, Dr. Chunping @TriLinkBioTech will discuss the latest progress in next-generation mRNA design in a new webinar hosted by @CRISPRjournal. Don't miss out -- REGISTER NOW: www.workcast.com/register?cpak=5827477065713913&referrer=600
-
Mary Ann Liebert Inc
@LiebertPub
#reproductivehealth Counseling Among Women with #congenitalheartdefects
A new study shows that among women with #chd, reproductive counseling, concerns, & experiences differ by #disability status. Read the full study published in Journal of Women’s Health:journals.sagepub.com/doi/10.1089/jwh.2022.0395?cf-mal-red… -
Mary Ann Liebert Inc reposted
UPMC Heart and Vascular Institute
@HviUpmc
Feasibility of Utilizing Telehealth in a Multidisciplinary Postpartum Hypertension Clinic @malamo512 @valenjaramillo7 Shruti Bidani @LiebertPub @PittCardiology #pubmed #cardiotwitter #womenshealth #cardiology #meded
pubmed.ncbi.nlm.nih.gov/36479373/ -
Mary Ann Liebert Inc reposted
Genetic Engineering & Biotechnology News
@GENbio
The nation’s life science research workforce is expected to remain stable this year rather than shrink like the broader tech sector and overall U.S. employment after outgrowing the overall U.S. economy last year as it has for the past 20 years. Learn more: www.genengnews.com/news/industry-news/research-workforce-…
-
Mary Ann Liebert Inc
@LiebertPub
Therapeutics and #mrna vaccines have recently gained immense attention, particularly with the advent of #covid19.
TOMORROW, @GENBiotechJrnl webinar sponsored by @thermofisher will share best practices for navigating the mRNA journey. REGISTER NOW: www.workcast.com/register?cpak=8349121918763757&referrer=600 -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #virtualreality in #medicaleducation
Take part in how #vr is transforming #healthcare, delivering altogether new types of treatments and diagnostics, and changing how and where care is delivered. Submit your manuscript to @Cyberpsych_Jn: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
What Drives Children's Seasonal BMI Gain?
Interventions during breaks from school may be warranted no matter the season–A new study @ChildObesity_jn explores seasonal changes in #childrenshealth behaviors and its connection to seasonal #bmi gain: www.liebertpub.com/doi/10.1089/chi.2023.0029 -
Mary Ann Liebert Inc reposted
SWHR
@SWHR
"As you can see, we have a powerhouse panel joining us today," says host Dr. Irene O. Aninye, with SWHR. @BiologySexDiff @women_neurosci @LiebertPub @SpringerNature @SowmyaSwaminat1 @JAMANetwork @DrMelissaSimon
Join the #sabv webinar happening now: swhr.org/event/a-conversation-on-the-elevation-of-sex-and… -
Mary Ann Liebert Inc reposted
Thyroid Journal
@thyroidjournal
#thyroidcancer #disparities: Lopez et al @umiamimedicine @BIDMCSurgery @MassEyeAndEar find Non-White Medicare/Medicaid/uninsured patients, or distance, associated w/ care delays & advanced disease.
journals.sagepub.com/doi/10.1089/thy.2022.0723?cf-mal-red…
#thyroidjournal #medtwitter #endotwitter -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue will explore the role of #gapjunctions as intercellular channels alongside growing evidence of channel-independent signal regulation with consideration for gap junctions as novel targets for therapeutic interventions.
SUBMIT: home.liebertpub.com//cfp/special-issue-gap-junctions/456/ -
Mary Ann Liebert Inc
@LiebertPub
#mentalhealth Pandemic During the #covid19 Outbreak: #socialmedia As a Window to Public Mental Health
A new study in @Cyberpsych_Jn shows how social media analysis could be utilized for public mental health surveillance during a global health crisis: journals.sagepub.com/doi/10.1089/cyber.2022.0116?cf-mal-r… -
Mary Ann Liebert Inc reposted
Clinical Thyroidology
@clinicalthyroid
A recent @thyroidjournal study shows promising results of neoadjuvant therapy for patients with BRAF-mutated anaplastic #thyroid cancers. @ASCO @ITOGinfo
journals.sagepub.com/doi/10.1089/ct.2023%3B35.208-211?cf-…
#endotwitter #onctwitter -
Mary Ann Liebert Inc
@LiebertPub
The Demand for Timely #mentalhealth Counseling
The growing demand for mental health services and artificial intelligence #chatbots to replace human agents have led to increased attention to chatbot anthropomorphizing: journals.sagepub.com/doi/10.1089/cyber.2022.0157?cf-mal-r… @Cyberpsych_Jn -
Mary Ann Liebert Inc
@LiebertPub
The Unbearable Cost of #drugdevelopment
A pair of recently released studies shine new light on the staggering cost of developing new drugs—an expense that now exceeds $2 billion per therapy on average. journals.sagepub.com/doi/10.1089/genbio.2023.29089.aph?cf… @GENBiotechJrnl -
Mary Ann Liebert Inc reposted
PHAGE: Therapy, Applications, and Research
@PHAGEJournal
@MarthaClokie, Editor-in-Chief of @PHAGEJournal will be speaking on the challenges and opportunities for bacteriophage therapy at the upcoming 6th World Conference on Targeting Phage Therapy in Paris, France. There is still time to register: phagetherapy-site.com
-
Mary Ann Liebert Inc
@LiebertPub
#nature Experiences in #childhood
Combining empirical studies on the interplay between experiences in nature during childhood, connectedness with nature, and action for nature uncover a new way of structuring understandings of connectedness with nature: journals.sagepub.com/doi/10.1089/eco.2022.0080?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: International Thyroid Awareness Month
Recent publications from @AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology highlight current understanding in #thyroidology from across the globe. Access the full collection here: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Centering Equity in the Nation's #weather, #water, and #climate Services
Water, weather, and climate affect everyone. The necessary work of moving from good intentions to sustained action lies ahead. journals.sagepub.com/doi/10.1089/env.2022.0048?cf-mal-red… #environmentaljustice -
Mary Ann Liebert Inc
@LiebertPub
Therapeutics and #mrna vaccines have recently gained immense attention, particularly with the advent of #covid19.
This @GENBiotechJrnl webinar sponsored by @thermofisher will share best practices for navigating the mRNA journey. REGISTER NOW: www.workcast.com/register?cpak=8349121918763757&referrer=600 -
Mary Ann Liebert Inc
@LiebertPub
Improving Care for #veterans Through #healthequity Research
Special issue @HealthEquityJrl discusses issues vital to Veterans, ranging from highlighting the importance of expanding the scientific workforce to promoting health equity within @VeteransHealth:www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
A new study published in OMICS: A Journal of Integrative Biology identifies #genes for virulence and #antimicrobialresistance in two bacteria that co-occur with #cdifficile, suggesting these pathogens as emerging potential threats in #planetaryhealth: journals.sagepub.com/doi/10.1089/omi.2023.0034?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Stéphanie Eid, PhD
@EidSteph
Time for a paradigm shift for the treatment of #diabetic #neuropathy? Very interesting review by @jon_enders @DEW_Neuropathy about the importance of lifestyle interventions, specifically #exercise and #ketodiet in improving nerve function. @LiebertPub
pubmed.ncbi.nlm.nih.gov/36503268/ -
Mary Ann Liebert Inc reposted
National Health and Aging Trends Study (NHATS)
@NHATS_NSOC
New work using #nhats @b4lynn27 et al. @LiebertPub
Rural–Urban Differences in Telehealth Utilization & Delayed Care During the COVID-19 Pandemic
"rurality is associated with lower rates & lower odds of telehealth use compared with urban older adults"
doi.org/10.1089/tmj.2022.0497 -
Mary Ann Liebert Inc
@LiebertPub
How #syntheticbiology Can Make a Materials Difference
Among the advanced technologies racing to solve big problems, synthetic biology stands out. #synbio offers new ways of producing almost everything we consume, from flavors & fabrics to foods & fuels: journals.sagepub.com/doi/10.1089/ind.2023.29306.aro?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #biobased Design
Biobased materials exhibit numerous benefits over synthetic materials for our environment and health. @3DPrintingJrnl will focus on latest developments in biobased #3dp and #additivemanufacturing processes. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Funded by @RWJF a special publication "Charting an Equity-Centered Public Health Data System" is now available. This collection dives into the role of the #data and #tech industries in contributing to a transformed #publichealth data system: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#healthequity -
Mary Ann Liebert Inc reposted
IU Simon Comprehensive Cancer Center
@IUCancerCenter
Our own Terry Vik, MD, and Sandeep Batra, MD, were among the researchers to publish a new article in the Journal of Adolescent and Young Adult Oncology. Learn more: journals.sagepub.com/doi/10.1089/jayao.2022.0028?cf-mal-r…. #researchcurescancer #ncicomprehensive @LiebertPub
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! The Impact of High Potency #cannabis
Take part in providing insight into our current understanding of the short- and long-term impact of high-potency cannabis on health and society. Submit your manuscript to @CannabisJrnl today: journals.sagepub.com/publications/cannabis-and-cannabinoi… -
Mary Ann Liebert Inc reposted
Telemedicine Journal
@Telemedicine_Jn
Family Use of Remote Infant Viewing in the Neonatal Intensive Care Unit: Impact of the COVID-19 Pandemic and Patient Room Type
Read now: journals.sagepub.com/doi/10.1089/tmj.2022.0195?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Racial Disparities for #pregnant and #postpartum #veterans and Their #infants
Despite no significant racial disparities in access or use of care during the perinatal period among veterans, study shows access is not sufficient for ensuring #healthequity: journals.sagepub.com/doi/10.1089/jwh.2022.0507?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Assessing Gene Supplementation in a Mouse Model of #retinitispigmentosa
Study @HGTJournal shows total RPE65 protein levels in mice with autosomal dominant retinitis pigmentosa were doubled following subretinal delivery of #aav-RPE65 gene supplementation: journals.sagepub.com/doi/10.1089/hum.2022.240?cf-mal-redi… -
Mary Ann Liebert Inc reposted
Cyberpsychology Journal
@Cyberpsych_Jn
Read wide-ranging perspectives and research exploring affective experiences in the #metaverse now: journals.sagepub.com/toc/cyber/26/4?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
New Ways to Protect the Host from #sarscov2?
New observations on the importance of #lung microbiome metabolites that regulate the host #immunesystem in patients with #covid19 may open up new avenues for preventive medicine and therapeutics innovation: journals.sagepub.com/doi/10.1089/omi.2023.0002?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Global Governance in International Esports Society?
How the international esports society has been governed by esports publishers and international #esports governing bodies and how it should be understood under international law, explained: journals.sagepub.com/doi/10.1089/glr2.2023.0004?cf-mal-re… #gaminglaw -
Mary Ann Liebert Inc
@LiebertPub
#photosyntheticfuelcells: An Interesting Concept or a Promise for Future Technology?
The potential of photosynthetic-based #bioelectricity production to become a real applicative solution that will be able to compete with existing technologies, discussed: journals.sagepub.com/doi/10.1089/bioe.2022.0043?cf-mal-re… -
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
A study published in @Cyberpsych_Jn @LiebertPub found that a break from #socialmedia for 1 week led to significant improvements in #mentalhealth #wellbeing www.wfla.com/bloom-tampa-bay/unplugging-to-recharge-the-p…
-
Mary Ann Liebert Inc
@LiebertPub
The first report to demonstrate the production of MSTN gene-edited cloned embryos of the Murrah #buffalo, this approach presented in @CellRepJrnl allows the use of the #crispr/#cas9 system and #scnt for future production of genome-edited buffaloes: journals.sagepub.com/doi/10.1089/cell.2023.0003?cf-mal-re…
-
Mary Ann Liebert Inc
@LiebertPub
Recent years have seen a resurgence in clinical interest in, and increased public acceptance of, #psychedelicdrugs in #canada. Researchers develop the Canadian Psychedelic Survey (CPS) to gather real-world evidence about psychedelic drug use in Canada: journals.sagepub.com/doi/10.1089/psymed.2023.0002?cf-mal-…
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Treading Carefully in the #metaverse: The Evolution of #ai #avatars
Read my latest thoughts @LiebertPub @Cyberpsych_Jn doi.org/10.1089/cyber.2023.29280.editorial #mentalhealth #virtualreality #cyberpsychology #socialnetworking -
Mary Ann Liebert Inc
@LiebertPub
#uv may be harmful to life, but it can trigger reactions of prebiotic importance on the surface of a potentially habitable planet. Scientists assess the potential of UV radiation as a driver of prebiotic chemistry on #planets in habitable zone of #mdwarfs: journals.sagepub.com/doi/10.1089/ast.2022.0050?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Single-use technology of urologic endoscopes has exploded in recent years. @kvnkoo shares his experience & opinion on use, misuse, & new policies regarding the billing in the latest episode of Endourology Sound Bites:soundcloud.com/mary-ann-liebert-inc/episode-57-single-use… @JEndourology @RichardWolfGmbH #urology
-
Mary Ann Liebert Inc reposted
Journal of Palliative Medicine
@PalliativeMed_j
@PalliativeMed_j Study explored the perspectives of #caregivers of adults with Alzheimer's and related dementias around #hospice re-enrollment following a live discharge from hospice www.liebertpub.com/doi/10.1089/jpm.2023.0059 @spwladkowski @SusanEnguidanos
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #newspace: Opportunities in and to #brazil
For this Special Issue, @NewSpace_JRNL invites you to submit abstracts which address policy gaps and relevant areas to improve the space sector in Brazil. Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
#biologicalrobots: Emerging Interdisciplinary Field
The emerging consilience of techniques & concepts at the intersection of #materialsscience #computing #bioengineering is an exciting new field with potential to create technological machines in new ways. journals.sagepub.com/doi/full/10.1089/soro.2022.0142?cf-m… -
Mary Ann Liebert Inc
@LiebertPub
"I'm inviting you to celebrate what I'm celebrating and that is this experience of the miracle of where we find ourselves." Dr. Roland Griffiths, world-renowned scientist and healer and editorial board member of Psychedelic Medicine chats with @NPR: www.npr.org/2023/05/14/1175762261/cancer-patients-psyched…
-
Mary Ann Liebert Inc
@LiebertPub
Funded by @RWJF a special publication "Charting an Equity-Centered Public Health Data System" is now available. This collection dives into the role of the #data and tech industries in contributing to a transformed public health data system: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#healthequity -
Mary Ann Liebert Inc reposted
Journal of Endourology
@JEndourology
In this systematic review, machine learning helped with outcome prediction, diagnostics, and therapeutics for urolithiasis and BPH. It is important to adhere to the STREAM-URO framework to ensure high-quality studies @BouhadanaD @NaeemBhojani7
www.liebertpub.com/doi/10.1089/end.2022.0311 -
Mary Ann Liebert Inc reposted
Billy Rosa, PhD, MBE, APRN
@BillyRosaPhD
🚨Thrilled to work with this powerhouse interprofessional group to talk about how we can inform #psychedelic-assisted therapy with what we know from #hospice & #palliativecare➡️new @LiebertPub journal, Psychedelic Medicine. Check out paper & journal: www.liebertpub.com/doi/10.1089/psymed.2022.0009
-
Mary Ann Liebert Inc
@LiebertPub
Deciphering Adult #neuralstemcells with #singlecellsequencing
Understanding of NSCs in physiological & pathological settings provide insights for the rejuvenation of the aged brain & restoration of normal brain function in multiple neurological disorders. journals.sagepub.com/doi/10.1089/scd.2022.0234?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on Modulation of the #immunesystem to Improve #tissueregeneration Strategies
Submit your manuscript to @TissueEngin for publication consideration today! Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
When to Withdraw Care in Severe #traumaticbraininjury
More than 40 traumatic brain injury experts were surveyed on the use of prognostication & withdrawal of care decisions in severe #tbi. The survey results published in the peer-reviewed @J_Neurotrauma: journals.sagepub.com/doi/10.1089/neu.2022.0414?cf-mal-red… -
Mary Ann Liebert Inc reposted
Annovis Bio
@AnnovisBio
As more companies step away from #amyloid theory in pursuit of novel therapeutics for #alzheimers, what are some alternative strategies according to specialists?
Read the @LiebertPub article featuring our CEO, Maria Maccecchini: www.liebertpub.com/doi/10.1089/genbio.2023.29090.aas -
Mary Ann Liebert Inc
@LiebertPub
#gynecologicsurgery Increases Risk of #cardiovasculardisease
A new study showed that #hysterectomy alone, hysterectomy with oophorectomy, & tubal ligation were all associated with an increased risk of CVD. Read more from the findings & their implications: journals.sagepub.com/doi/10.1089/jwh.2022.0207?cf-mal-red… -
Mary Ann Liebert Inc reposted
Marie E McVeigh
@JopieNet
@AutismAdulthood (@LiebertPub) is committed to their community, and to ensuring all of their authors are accommodated.
It's really impressive.
Christina Nicolaidis, MD, MPH
@cnicolaidis
Fantastic article in Nature re autistic peoples' (well-founded) demands for inclusion in research. Quotes from @KristenBott, @DrMBotha, @drstevenkapp, @AutisticDoctor, @liz_pellicano, and me with discussion of @aaspireproject and @AutismAdulthood papers. www.nature.com/articles/d41586-023-01549-1
-
Mary Ann Liebert Inc
@LiebertPub
Mortality Prediction in Severe #tbi
A new article published in @J_Neurotrauma represents an important step forward in accuracy of mortality predictions after severe traumatic brain injury: journals.sagepub.com/doi/10.1089/neu.2022.0221?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
An Equitable Future Through Data Disaggregation
"We are in the midst of an exciting time, where there is a major opportunity to actually impact how race & ethnicity data are collected, analyzed, reported, & disseminated to promote greater #healthequity." journals.sagepub.com/doi/10.1089/heq.2023.29036.rtd?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Analytical Methods for Preclinical Stage #genetherapy Programs
Read the full study "Application of Size Exclusion Chromatography with Multiangle Light Scattering in the Analytical Development of a Preclinical Stage Gene Therapy Program" in @HGTJournal: journals.sagepub.com/doi/10.1089/hum.2022.218?cf-mal-redi… -
Mary Ann Liebert Inc reposted
ICFO
@ICFOnians
📝#newpaper:@ICFOnians & @vallhebron-@VHIR_ developed an advanced statistical method using noninvasive hybrid #diffuseoptics to detect #miseryperfusion to prevent ischemia in traumatic brain injury patients during hyperventilation.
Paper in @LiebertPub
🔗journals.sagepub.com/doi/abs/10.1089/neu.2022.0419?cf-mal… -
Mary Ann Liebert Inc reposted
WashU Medicine Division of Urology
@WashU_Uro
R. Sherburne Figenshau, MD, served as the corresponding author for a new article published ahead of print in the Journal of Endourology (@liebertpub). Read the abstract: www.liebertpub.com/doi/10.1089/end.2023.0103
-
Mary Ann Liebert Inc
@LiebertPub
Women are Underrepresented in Cardiovascular Clinical Trials
A new study has shown that women are underrepresented in late-breaking cardiovascular clinical trials #lbct presented at national meetings. Full article published in Journal of Women’s Health: journals.sagepub.com/doi/10.1089/jwh.2022.0536?cf-mal-red… -
Mary Ann Liebert Inc reposted
PHAGE: Therapy, Applications, and Research
@PHAGEJournal
The 6th World Conference on Targeting Phage Therapy covers all aspects related to phages and phage therapy and highlights the recent innovations and clinical applications of phages, validation and limitations.
To Register: phagetherapy-site.com -
Mary Ann Liebert Inc reposted
Tissue Engineering
@TissueEngin
NEW UPCOMING WEBINAR
Learn about the latest research in developing Advanced Therapy Medicinal Products (ATMPs) and delivering a scalable and sustainable future of medicine in cell and gene therapies.
Register Now: www.workcast.com/register?cpak=9714695884087374 -
Mary Ann Liebert Inc
@LiebertPub
Helping to Pave the Way For A Healthy & More Equitable Future For All
In a new roundtable @BigData_Journal, experts highlight their efforts to build data capacity in underserved communities & enhance community involvement in shaping equitable data systems:journals.sagepub.com/doi/10.1089/big.2023.29057.rtd?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
#cellulartherapies: Yesterday, Today, & Tomorrow
Once seen as a promising discipline within the vast medical scenario, cellular therapy represents one of the pillars of medicine in the 21st century. Exciting times of challenges & opportunities are ahead: journals.sagepub.com/doi/10.1089/scd.2022.0294?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Disparities in #telehealth Utilization Among #medicare Beneficiaries
A new study of telehealth utilization among Medicare beneficiaries in Arkansas showed race/ethnicity and rural/urban disparities. More from the study reported in @Telemedicine_Jn: journals.sagepub.com/doi/10.1089/tmj.2023.0012?cf-mal-red… -
Mary Ann Liebert Inc reposted
Human Gene Therapy
@HGTJournal
PASTE, Don’t Cut: #genome Editing Tool Looks Beyond #crispr and Prime. Details in @HGTJournal #genetherapy Briefs: www.liebertpub.com/doi/10.1089/hum.2023.29238.bfs
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #artificialintelligence & #additivefabrication
Convergence of #ai and #3dp to revolutionize design & manufacturing: @3DPrintingJrnl calls researchers & practitioners from academia & industry to lay the foundations for this exciting field: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
New Review in @CellRepJrnl researchers demonstrate the characteristics of #exosomes and emphasize their biological functions and clinical capacity from #dtmscs on the recent new findings to achieve and gather contemporary precious knowledge in this field: journals.sagepub.com/doi/10.1089/cell.2022.0147?cf-mal-re…
-
Mary Ann Liebert Inc
@LiebertPub
Impact of Limited #healthliteracy
New study shows that lower health literacy was significantly associated with lower adherence to medication among Black #medicaid beneficiaries with #hypertension in Delaware. Read the full study with additional findings: www.liebertpub.com/doi/10.1089/pop.2022.0270 -
Mary Ann Liebert Inc reposted
The CRISPR Journal
@CRISPRjournal
Announcing our next Special Issue:
Manipulating the Microbiome with CRISPR
Guest editor: @bradyfcress
(ms submissions by Sept 30, 2023) -
Mary Ann Liebert Inc
@LiebertPub
Study @HGTJournal reports findings of 6 #aav vectors in 12 preclinical models of the human #liver, aiming to uncover which combination is most relevant for identification of AAV capsid variant for safe & efficient #genetherapy to primary human hepatocytes: journals.sagepub.com/doi/10.1089/hum.2022.188?cf-mal-redi…
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! The advent of CRISPR-based technologies has revolutionized our ability to edit genomes of organisms across the tree of life. @CRISPRjournal announces new special issue—Manipulating the #microbiome with #crispr—to publish early 2024.
SUBMIT:www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Guttmacher Institute
@Guttmacher
NEW: Across surveys in 3 US states, 73% of women report that they prefer multiple options for where and how to get #contraception, according to our latest analysis published in @LiebertPub Journal of Women’s Health. Read more: www.guttmacher.org/news-release/2023/nearly-three-quarter…
-
Mary Ann Liebert Inc
@LiebertPub
The Anti-Viral Gut: The Gut-Immune Connection—What Clinicians Need to Know
In this column, @DrChutkan explains the gut-immune connection and the importance of lifestyle behaviors and how they affect #guthealth. Here's what you & your clinician should know:journals.sagepub.com/doi/10.1089/ict.2023.29063.rch?cf-ma… -
Mary Ann Liebert Inc reposted
Soft Robotics
@SoftRobotics_JN
Recent work experimentally investigates a model-predictive motion planning strategy to impose oscillatory and undulation movements in a macro fiber composite-actuated robotic fish. #aquatic #softrobot
www.liebertpub.com/doi/10.1089/soro.2022.006 -
Mary Ann Liebert Inc
@LiebertPub
Join us on 5/4 for this exciting @GENBiotechJrnl webinar! Hear experts from industry & academia share their insights & experiences as they lay out the potential of stirred-tank bioreactors for #celltherapy #genetherapy development & manufacturing.
REGISTER:www.workcast.com/register?cpak=5007519913355022&referrer=920 -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: Virtual Emotions
Join us in understanding affective experiences in the metaverse -- Access the full issue in @Cyberpsych_Jn: journals.sagepub.com/toc/cyber/26/4?cf-mal-redirected=true&
#virtualreality #vr #virtualemotions #virtualenvironment #metaverse -
Mary Ann Liebert Inc
@LiebertPub
#bioengineering a Better #adenoassociatedvirus Vector for #genetherapy
#aav3b-V04 provides advantages such as improved human hepatocyte tropism & immune evasion & propose its utility as a superior candidate for liver gene therapy, reported in @HGTJournal: journals.sagepub.com/doi/10.1089/hum.2022.176?cf-mal-redi… -
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
www.liebertpub.com/toc/cyber/26/4
Thank you to #guesteditors @gag4all @alicechirico on a fantastic @Cyberpsych_Jn Issue just out #virtual #emotions: UNDERSTANDING AFFECTIVE EXPERIENCES IN THE #metaverse Free to read through May 15th @LiebertPub -
Mary Ann Liebert Inc
@LiebertPub
Although the path to the clinic of #crispr-based technologies has focused primarily on therapeutics, the road to most consumers is much more likely to be in the realm of diagnostics. @CRISPRjournal presents a special issue dedicated to CRISPR Diagnostics: journals.sagepub.com/toc/crispr/6/2?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
#lymedisease in #europe
A new Special Issue in Vector-borne and Zoonotic Diseases, prepared by researchers from different countries, presents data & resources to elevate awareness & inform our international readership on the importance of Lyme in Europe: journals.sagepub.com/toc/vbz/23/4?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
Impact of #sdoh on #childhoodobesity
@ChildObesity_jn sheds light on a child's probability of overweight & obesity based on exposure to risk factors in 4 SDOH domains, suggesting a complex & multilayered relationship between the SDOH & childhood obesity: journals.sagepub.com/doi/10.1089/chi.2022.0222?cf-mal-red… -
Mary Ann Liebert Inc reposted
New Space
@NewSpace_JRNL
Publish your work in a special, curated issue on Opportunities in and to Brazil. @NewSpace_JRNL is now accepting research that addresses policy gaps and relevant areas to improve the #space sector in #brazil. #alcantara #satellite
home.liebertpub.com/cfp/new-space-opportunities-in-and-to… -
Mary Ann Liebert Inc reposted
Clarivate for Academia & Government
@ClarivateAG
We analyzed 21k journals in the Web of Science. 45% of all papers map to an SDG, 38% are gold or hybrid #oa. @LiebertPub with the highest % of SDG related content at 75%.
-
Mary Ann Liebert Inc
@LiebertPub
#systemsbiomarkers #ai & #onehealth Can Help Fight #antimicrobialresistance
Integrated approaches grounded in One Health, systems science, & digital technologies stand to improve #publichealth outcomes & address the current antimicrobial resistance crisis:journals.sagepub.com/doi/10.1089/omi.2023.0021?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: #hashimotosthyroiditis
@AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology highlights current understanding and new information related to Hashimoto’s Thyroiditis from across the globe. Read the full collection: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Dr. Rob Sweet, one of the foremost experts & success stories on developing & maintaining simulation labs for advancement & education of learners across the world joins @JEndourology @RichardWolfGmbH to speak on the establishment & maintenance of a sim lab: soundcloud.com/mary-ann-liebert-inc/episode-56-establishm…
-
Mary Ann Liebert Inc
@LiebertPub
Acthar Gel Inhibits the Activation of CD4+ and CD8+ T Cells
New research shows that #acthar may be beneficial for the treatment of inflammatory diseases characterized by active #cd4+ and #cd8+ #tcells: journals.sagepub.com/doi/full/10.1089/jir.2022.0257?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Severe inequities in maternal & infant health in the US are caused by the many forms of #systemicracism. An article @HealthEquityJrl that sheds critical light on racial/ethnic inequities in paid #parentalleave access journals.sagepub.com/doi/10.1089/heq.2021.0001?cf-mal-red… cited in @TIME: time.com/6270034/back-to-work-after-baby-kristin-gallant/
-
Mary Ann Liebert Inc reposted
@BigData_Journal
A recent roundtable discussed the importance of community voice in developing 21st century public health systems and the need to ensure that historically excluded populations are represented in the data collection process. www.liebertpub.com/doi/10.1089/big.2023.29057.rtd @RWJF
-
Mary Ann Liebert Inc
@LiebertPub
#psychedelicassistedpsychotherapy for Treatment of #caregiver Distress
Researchers examine the rationale for why psychedelic-assisted psychotherapy may be useful for treating caregiver distress & how it can be effectively studied in future clinical trials:journals.sagepub.com/doi/10.1089/psymed.2022.0011?cf-mal-… -
Mary Ann Liebert Inc
@LiebertPub
To #mars and Beyond: Engineering Life as a Moral Duty
"These are not just tools of a biotechnological revolution—they are the tools of a moral duty to Life itself, past, present, and future." journals.sagepub.com/doi/10.1089/genbio.2023.29094.cma?cf… @GENBiotechJrnl -
Mary Ann Liebert Inc reposted
Health Equity
@HealthEquityJrl
Join us at this Fireside chat with @AudreTaughtMe2 @TiffanyYounger4 hosted by @mclemoremr and @ElleLettMDPhD. Set reminder at twitter.com/i/spaces/1jMJgLqNMlWxL/peek!
-
Mary Ann Liebert Inc reposted
Astrobiology Journal
@Astrobiology_jn
The April issue of @Astrobiology_jn has just published online. Check it out now: journals.sagepub.com/toc/ast/23/4?cf-mal-redirected=true&
-
Mary Ann Liebert Inc
@LiebertPub
Recent research shows that #sexualminority status may be linked to #sleep disturbance in early #adolescence. The findings from the adolescent brain cognitive development study published in @LGBTHealthJrnl www.liebertpub.com/doi/10.1089/lgbt.2022.0268 has been cited in @usnews: www.usnews.com/news/health-news/articles/2023-03-28/stres…
-
Mary Ann Liebert Inc
@LiebertPub
Phage Cocktail to Control #salmonellosis in Chickens, Pigs, & Humans
Study @PHAGEJournal provides insights into therapeutic potential of #phages to clear representative chicken & swine #salmonella strains in presence of avian, porcine, & human cell lines: www.liebertpub.com/doi/10.1089/phage.2023.0001 -
Mary Ann Liebert Inc
@LiebertPub
#osteoporosis is a Major Comorbidity for Aging Women, and May Be Higher in Women Living with #hiv
With the aging of the HIV-infected population, we need to continue to optimize health and decrease the risk and consequences of comorbidities. journals.sagepub.com/doi/10.1089/aid.2022.0106?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #virtualreality in #medicaleducation
Take part in how #vr is transforming #healthcare, delivering altogether new types of treatments and diagnostics, and changing how and where care is delivered. Submit your manuscript to @Cyberpsych_Jn: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
The Benefits of #breastfeeding on #childintelligence, Behavior, and Executive Function
Recent evidence published in the journal Breastfeeding Medicine demonstrates that breastfeeding is likely to have a positive effect on #iq in later childhood: journals.sagepub.com/doi/10.1089/bfm.2022.0192?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
New study in Journal of Correctional Health Care documents disproportionate #mentalhealth burden among incarcerated #transgender #genderdiverse people, revealing a striking challenge within #prisons that policy makers & correctional officials must confront.journals.sagepub.com/doi/10.1089/jchc.21.10.0109?cf-mal-r…
-
Mary Ann Liebert Inc
@LiebertPub
New research @TransgenderHlth shows #transgender & #nonbinary adolescents and young adults of different gender identities are vulnerable to disordered eating behaviors, used as a way to mediate & control a negative relationship with sex assigned at birth. journals.sagepub.com/doi/10.1089/trgh.2021.0112?cf-mal-re…
-
Mary Ann Liebert Inc reposted
UAB School of Public Health
@uabsoph
Peter Hendricks, PhD, assoc. prof. in the Dept. of Health Behavior, has been named co-editor-in-chief of the new Psychedelic Medicine journal from @LiebertPub. Hendricks is known for his research in psilocybin and addiction treatment. Read more at go.uab.edu/41jLt5F
-
Mary Ann Liebert Inc reposted
3D Printing
@3DPrintingJrnl
Metal #3dprinting technology brings several benefits to the field of high-pressure die casting of aluminum, which enhances its development. Read more about it in this recent article: www.liebertpub.com/doi/full/10.1089/3dp.2022.0225
#additivemanufacturing #diecast #openaccess -
Mary Ann Liebert Inc
@LiebertPub
Meta-Analysis of Hybrid-Closed Loop Control-IQ Technology
A new study evaluated the effect of hybrid-closed loop Control-IQ in the pooled data from three randomized controlled trials, comparing Control-IQ to a control group using #cgm in people with #t1d: journals.sagepub.com/doi/10.1089/dia.2022.0558?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
On 3/21, Health Security @JHSPH_CHS published a commentary on @ONDCP approach to evolving & emerging #drugthreats. On 4/12, @WhiteHouse designated #fentanyl #xylazine as an emerging drug threat, putting into action the approach outlined in the commentary: journals.sagepub.com/doi/full/10.1089/hs.2022.0150?cf-mal…
-
Mary Ann Liebert Inc
@LiebertPub
Obstetric Interventions are Changing the Gestational Age Distribution of U.S. Births
Obstetric interventions such as increases in the use of #inductionoflabor and use of #cesareandelivery is shifting #gestationalage distributions of births in the U.S.: journals.sagepub.com/doi/10.1089/jwh.2022.0167?cf-mal-red… -
Mary Ann Liebert Inc reposted
Malaika Simmons
@MalaikaSimmons
During a recent @LiebertPub roundtable, I highlighted the importance of meeting communities where they are when it comes to data collection and the importance of trust-building in communities when collecting data. journals.sagepub.com/doi/10.1089/BIG.2023.29057.rtd?cf-ma…
-
Mary Ann Liebert Inc
@LiebertPub
A recent roundtable discussed the importance of community voice in developing 21st century #publichealthsystems & the need to ensure historically excluded populations are represented in data collection process. Read the transcript in @BigData_Journal:journals.sagepub.com/doi/10.1089/big.2023.29057.rtd?cf-ma… @RWJF
-
Mary Ann Liebert Inc reposted
Elizabeth Garner
@egarnermd
According to a paper published in @LiebertPub, research on conditions that primarily affect women has been and still is underfunded. @JessGrose explains the consequences this has on #womenshealth and what we must do to reverse this trend. #healthequity www.nytimes.com/2023/03/18/opinion/womens-health-care.html
-
Mary Ann Liebert Inc
@LiebertPub
Explore the Latest Research on #cannabidiol
@CannabisJrnl publishes a new Special Issue on Cannabidiol -- Access the full issue: journals.sagepub.com/toc/can/8/2?cf-mal-redirected=true& -
Mary Ann Liebert Inc reposted
Childhood Obesity
@ChildObesity_jn
Maternal Risk of Cardiovascular Disease Is Associated with Higher BMI Among Preschool-Aged Children: A Cross-Sectional Study, published in @ChildObesity_jn
Link to pub: doi.org/10.1089/chi.2022.0207 -
Mary Ann Liebert Inc
@LiebertPub
#globalhealthequity Requires #globalequity
If we are to improve global health equity, there is a need to focus more on foundational—rather than proximal—causes of ill health and propose ways in which this can be achieved. www.liebertpub.com/doi/10.1089/heq.2022.0169 @HealthEquityJrl #healthequity -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #biotechnological Routes to #cosmetic & #foodbioactives & Ingredients
As the cosmetic and food industries are investing more & more in biotechnological processes for safer products for the environment, submit your research on this topic: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Special Issue: The #microbiome & #surgicalinfections
The broad influence of the #microbiota in #surgicaldiseases is of particular importance to surgeons. This important special issue reviews our current knowledge in this field -- here's why it's important:journals.sagepub.com/toc/sur/24/3?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
An article published in the journal Advances in Wound Care that discusses the pathophysiology of complex #chronicwounds and the means and modalities available to achieve healing in patients (journals.sagepub.com/doi/10.1089/wound.2015.0635?cf-mal-r…) has been cited in @nypost. Read it here: nypost.com/2023/03/24/cheap-smart-bandage-heals-infected-…
-
Mary Ann Liebert Inc reposted
Cannabis and Cannabinoid Research Journal
@CannabisJrnl
The Endocannabinoid System as a Potential Therapeutic Target for HIV-1-Associated Neurocognitive Disorder
Read now: journals.sagepub.com/doi/10.1089/can.2022.0267?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Transforming Data Collection to Advance Health Equity
A critical new article highlights the need for a transformational change in our #healthcare systems to advance #healthequity and address #structuralracism and #healthdisparities affecting #wellbeing: journals.sagepub.com/doi/10.1089/pop.2023.0005?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! #exvivogenetherapy for #geneticdiseases
@HGTJournal is organizing a special issue focused on ex vivo gene therapy to highlight recent advancements, present new findings, and discuss the future goals & directions of the field. Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
Journal of Computational Biology
@JournalCompBio
Did you know you can find all of our papers online before the issue they will be in is published? New work is being added all the time!
www.liebertpub.com/toc/cmb/0/0 -
Mary Ann Liebert Inc
@LiebertPub
#coronaviruses Outsmart the Host
Given the extensive involvement of #lysosomes in the viral life cycle, they serve as an important target to limit viral replication and potential therapies in #covid19 and other infections mediated by β-coronaviruses: journals.sagepub.com/doi/10.1089/dna.2023.0002?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on #spatialomics
Take part in @GENBiotechJrnl's inaugural special issue on one of the fastest-paced growth areas in the #biotech industry, poised to drive the next wave of #biology revolution -- Submit your manuscript today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
The 21st century has been marked by significant advancements in technology, yet, hundreds of thousands of #nativeamericans live without access to safe, clean, reliable #drinkingwater.
Critically covered in:
Health Security: journals.sagepub.com/doi/10.1089/hs.2021.0034?cf-mal-redi…
@PopSci: www.popsci.com/environment/drinking-water-plastic-bottle-… -
Mary Ann Liebert Inc reposted
Cellular Reprogramming
@CellRepJrnl
A Fundamental Research in In Vitro Spermatogonial Stem Cell Culturing: What Are Clump Cells? www.liebertpub.com/doi/10.1089/cell.2022.0123
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue: Innovations in Science Education
This special issue of the journal Zebrafish will focus on how #zebrafish and other #aquariumfish species can be used to promote innovation in #scienceeducation. Submit your manuscript today: journals.sagepub.com/doi/10.1089/zeb.2022.29009.cfp?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Interaction Between #humanendogenousretroviruses and #tolllikereceptors
Studies of the interaction between HERV elements and Toll-like receptors reveal their role in the immunopathological mechanisms of inflammatory and autoimmune diseases: journals.sagepub.com/doi/10.1089/vim.2022.0090?cf-mal-red… @viral_im_jrnl -
Mary Ann Liebert Inc reposted
GEN Biotechnology
@GENBiotechJrnl
Lightspeed Ventures and the Laws of Biotech Relativity -- story by @GrinsteinJ
www.genengnews.com/gen-edge/lightspeeds-jonathan-macquitt… -
Mary Ann Liebert Inc
@LiebertPub
Understanding the Protein Structure of SARS-CoV-2 for Effective Therapies
New research reports mapping the accessory proteins of #sarscov2 that may aid in designing novel therapies, antiviral, and vaccines to protect against #covid19: journals.sagepub.com/doi/10.1089/regen.2022.0056?cf-mal-r… -
Mary Ann Liebert Inc
@LiebertPub
A new study in Journal of Women's Health shows that among healthy #pregnant women at term, more than half do not achieve optimal weight gain and such abnormal #gestational weight gain associated with higher odds of adverse #childbirth & #perinatal outcomes:journals.sagepub.com/doi/10.1089/jwh.2022.0278?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Orphan Drug & Rare Pediatric Disease Designations for #genetherapy
Providing an overview of @US_FDA applications for #orphandrugdesignation #rarepediatricdiseasedesignation, @HGTJournal article helps developers of gene therapies for rare genetic diseases: journals.sagepub.com/doi/10.1089/hum.2022.232?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
#naturopathic Management of #pediatricrespiratoryinfections
Study @JICM_Journal identifies strategies used by naturopathic practitioners to treat #respiratoryinfection in children, safely filling the gap between watchful waiting & antibiotic prescription: journals.sagepub.com/doi/10.1089/jicm.2022.0669?cf-mal-re… -
Mary Ann Liebert Inc reposted
alonzo plough
@alonzoplough
Health systems, hospitals, and the public health sector must work together to set comprehensive and unifying standards for data collection that incorporate social determinants of health. More of my words in @LiebertPub: www.liebertpub.com/doi/10.1089/pop.2023.0005
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue will explore the role of #gapjunctions as intercellular channels alongside growing evidence of channel-independent signal regulation with consideration for gap junctions as novel targets for therapeutic interventions.
SUBMIT: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Cardiovascular diseases are a major global health burden. #multiomics research offers a new lens for precision/personalized medicine for existing and emerging drugs used in the #cardiovascular clinic: journals.sagepub.com/doi/10.1089/omi.2023.0003?cf-mal-red… #precisionmedicine
-
Mary Ann Liebert Inc
@LiebertPub
#epsteinbarrvirus Associated #tumors & #drugrepurposing
A new study identified differentially expressed host and viral #mirnas in six Epstein-Barr virus associated tumors and reports several drug candidates for repurposing & targeting EBV latent infection:journals.sagepub.com/doi/10.1089/omi.2023.0005?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Is Service-Related #tbi in #veterans a Prelude to #alzheimersdisease?
TBI is common among #military veterans and has been associated with an increased risk of #dementia. Whether this is due to an increased risk for #alzheimers is the focus of a new study: journals.sagepub.com/doi/10.1089/neu.2022.0172?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
New findings in the journal Psychedelic Medicine are the first to support the theory that #psychedelicdrugs could have a role clinically in combination with #brainstimulation to achieve enhanced effects on #brainactivity and relevant clinical outcomes: www.liebertpub.com/doi/10.1089/psymed.2022.0014
-
Mary Ann Liebert Inc
@LiebertPub
Researchers report the latest findings that identify #glucosemetabolism as the crucial parameter in mesenchymal stromal cell survival and the subsequent functions pertinent to new tissue formation of importance in #tissueregeneration: journals.sagepub.com/doi/10.1089/ten.teb.2022.0063?cf-mal… #mscs @TissueEngin
-
Mary Ann Liebert Inc reposted
Palliative Medicine Reports
@PallmedR
@PallmedR Brief Report: Recognizing Pandemic Grief and adjusting bereavement services for individuals www.liebertpub.com/doi/10.1089/pmr.2022.0060 Melanie Vachon @debi_u Alexandra Guité-Verret et al #covid19 #bereavement #griefawareness
-
Mary Ann Liebert Inc
@LiebertPub
Stem cells from various sources have become options for range of cell-based therapies for smooth muscle #tissueregeneration. @TissueEngin review covers various approaches involved in regeneration of vascular #smoothmuscles by conditioning human #stemcells: journals.sagepub.com/doi/10.1089/ten.teb.2022.0039?cf-mal…
-
Mary Ann Liebert Inc
@LiebertPub
Comparison of Epifluorescence & Immunostaining for Assessing Viral Mediated Gene Expression in Primate Brain
New research reinforces an emerging viewpoint that #viralvectors tailored for the #primatebrain are necessary for basic research & #genetherapy: journals.sagepub.com/doi/10.1089/hum.2022.194?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
#augmentedreality may reduce the perceived risk of buying a product online, according to new study @Cyberpsych_Jn. As #ar integrates virtual elements into the real world and impacts decision-making, researchers shed light on this corner of the #metaverse: journals.sagepub.com/doi/10.1089/cyber.2022.0087?cf-mal-r…
-
Mary Ann Liebert Inc
@LiebertPub
New study @HGTJournal shows the use of a #monoclonalantibody led to a decrease in preexisting neutralizing antibodies to #aav and that this strategy enabled #genedelivery to the liver & heart via systemic AAV-based #genetherapy in mice & non-human primates:journals.sagepub.com/doi/10.1089/hum.2022.216?cf-mal-redi…
-
Mary Ann Liebert Inc reposted
Inside Precision Medicine
@Inside_PM
#obesity may spur #dna damage in the breast tissue of women who carry BRCA1 or BRCA2 mutations, possibly contributing to #breastcancer development in this already high-risk group, according to new research led by @WeillCornell scientists. Learn more: www.insideprecisionmedicine.com/topics/oncology/breast-ca…
-
Mary Ann Liebert Inc
@LiebertPub
Prolonged Interferon-Stimulated Gene and Protein Signatures in #multiplesclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a journals.sagepub.com/doi/10.1089/jir.2022.0238?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
mRNA Technology to Reduce #acuterespiratorydistresssyndrome Severity
Study findings indicate nebulized #mrna therapeutics are a promising approach to #ards therapy, with rapid expression of protein and observable amelioration of #pneumonia symptoms: journals.sagepub.com/doi/full/10.1089/nat.2022.0049?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Managing Infant #nightfeedings
By following normal mother infant physiology, parents can get more #sleep. @BFMedicine released new guidelines to help parents manage night-time #breastfeeding in young infants. Read the new clinical protocol: journals.sagepub.com/doi/10.1089/bfm.2023.29236.abm?cf-ma… #postpartum -
Mary Ann Liebert Inc
@LiebertPub
Diagnosis of #subclinicalthyroiddysfunction
New study results @thyroidjournal led to conclusion that age- & sex-specific reference ranges of thyroid hormone measurements should be used to avoid over- & under-diagnosis of subclinical thyroid dysfunction: journals.sagepub.com/doi/10.1089/thy.2022.0567?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue: The Role of Acupuncture in Sports Injuries and Best Practices
We invite you to contribute your clinical experience and research on the use of #acupuncture and #electroacupuncture in treating #sportsinjuries. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc reposted
VideoEndocrinology
@VEndocrinology
View 2022 Year in Surgical Thyroidology by Dr. Kepal Patel, features research in parathyroid autofluorescence, advanced radiofrequency ablation, extent of #thyroid surgery, prophylactic central neck dissection, & intraoperative laryngeal nerve monitoring.
journals.sagepub.com/doi/full/10.1089/ve.2022.0046?cf-mal… -
Mary Ann Liebert Inc
@LiebertPub
#dupilumab as the First Target-Specific Biological Treatment for #atopicdermatitis
Dupilumab treatment of moderate-to-severe atopic dermatitis in adults, adolescents, and children is a promising, effective, and tailored treatment of atopic dermatitis: journals.sagepub.com/doi/10.1089/DERM.0000000000000905?cf… -
Mary Ann Liebert Inc
@LiebertPub
In recent years, continuous glucose monitor use is increasing in people without diabetes to promote healthy lifestyle; But are the metrics accurate for this population? journals.sagepub.com/doi/10.1089/dia.2022.0544?cf-mal-red…
#continuousglucosemonitor #cgm #diabetes #nondiabetics #glucose #hba1c -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: #medullarythyroidcancer
@AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology highlights current understanding and the most recently published information and content on medullary thyroid cancer. Read the full collection: www.sagepub.com/journals/liebert-info -
Mary Ann Liebert Inc
@LiebertPub
Is #artificialintelligence customer service satisfactory? An article published in @Cyberpsych_Jn takes a closer look at the growing number of sectors delivering #customerservice powered by #ai instead of humans: journals.sagepub.com/doi/10.1089/cyber.2021.0155?cf-mal-r…
More in @Forbes: www.forbes.com/sites/forbesbusinesscouncil/2023/03/01/und… -
Mary Ann Liebert Inc
@LiebertPub
#infection or #inflammation: Are Uncomplicated Acute Appendicitis, Acute Cholecystitis, and Acute Diverticulitis Infectious Diseases? journals.sagepub.com/doi/10.1089/sur.2022.363?cf-mal-redi…
#infectiousdiseases #abdominalinfection #surgicalinfection #appendicitis #cholecystitis #diverticulitis #dysbiosis -
Mary Ann Liebert Inc
@LiebertPub
Role of #homehealth for Community-Dwelling Older Adults Near the #endoflife: A Resource Beyond #hospice?
Home health has the potential to serve a population not reached by hospice & improve the quality of end-of-life care: journals.sagepub.com/doi/10.1089/jpm.2022.0272?cf-mal-red… @PalliativeMed_j #palliativecare -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: To further advance the understanding of the impact of #violence on #health within sexual and gender #minority communities, @LGBTHealthJrnl @NIH will be publishing a Special Issue devoted to this critical topic. Submit by 3/31: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #lgbtqhealth
-
Mary Ann Liebert Inc
@LiebertPub
Diverse Functions of MiR-425 in Cancer
While many investigations discovered that #mirnas have a role in development of #cancer, this review may broaden our horizon for better understanding the role of #mir425 as biomarkers & therapeutic targets in cancer: journals.sagepub.com/doi/10.1089/dna.2022.0557?cf-mal-red… -
Mary Ann Liebert Inc reposted
Wyatt Bensken, PhD
@Wyatt_Bensken
In our ahead-of-print paper in @LiebertPub @PM_Alberti, @bakematt02, and @SKoroukian and I highlight how Z-codes for #socialrisks #socialneeds have been increasing in use over time - yet their use is variable across states and care settings. More here:
doi.org/10.1089/pop.2022.0248 -
Mary Ann Liebert Inc
@LiebertPub
A study in Pediatric Allergy, Immunology, and Pulmonology sheds light on how the surge in #covid19 cases led to a nationwide shortage of #albuterol inhalers, making it difficult for patients to obtain refills. @washingtonpost covers this critical shortage: www.washingtonpost.com/business/2023/03/01/drug-shortages…
-
Mary Ann Liebert Inc
@LiebertPub
Mind- and Body-Based Interventions Improve #glycemiccontrol in Patients with #type2diabetes
A new study @JICM_Journal suggests that mind and body practices may be an effective, complementary nonpharmacological intervention for #t2d: journals.sagepub.com/doi/10.1089/jicm.2022.0586?cf-mal-re… #complementarymedicine -
Mary Ann Liebert Inc reposted
Genetic Engineering & Biotechnology News
@GENbio
PASTE, Don’t Cut: Genome Editing Tool Looks Beyond #crispr and Prime
A recently patented #genomeediting tool called PASTE holds genuine promise for expanding the universe of treatable genetic diseases. Learn more: www.genengnews.com/topics/genome-editing/paste-dont-cut-g… -
Mary Ann Liebert Inc
@LiebertPub
Robust Billing & Coding System For #psychedelictherapy
When psychedelic therapies begin to gain regulatory approval, a robust medical billing & coding strategy is needed to ensure equitable patient access. The future of #psychedelicmedicine depends on it. journals.sagepub.com/doi/10.1089/psymed.2022.0005?cf-mal-… -
Mary Ann Liebert Inc
@LiebertPub
The #pandemic was fertile ground for #conspiracies and #misinformation on #twitter. @ASU @Cyberpsych_Jn take a closer look into #conspiracytheories about the role of @BillGates during the pandemic and how conspiracy theories spread & interact during crises:journals.sagepub.com/doi/10.1089/cyber.2022.0218?cf-mal-r…
-
Mary Ann Liebert Inc
@LiebertPub
Improvement of #precisiongrasping for #softrobots
Engineers @uectokyo develop artificial anthropomimetic fingertips that show how mimicking the human fingertip precisely can significantly improve grasping performance of soft robotic hands:journals.sagepub.com/doi/10.1089/soro.2021.0231?cf-mal-re… @SoftRobotics_JN -
Mary Ann Liebert Inc
@LiebertPub
An article published in @AutismAdulthood journals.sagepub.com/doi/10.1089/aut.2020.0083?cf-mal-red… that describes experiences of #masking—the process of intentionally, or unintentionally, hiding aspects of yourself to avoid harm—in #autistic & #nonautistic adults has been cited in @Forbes: www.forbes.com/sites/drnancydoyle/2023/02/28/black-future…
-
Mary Ann Liebert Inc reposted
Thyroid Journal
@thyroidjournal
Read in #thyroidjournal, infertility rates & time to first pregnancy are compared for female patients w/ #thyroidcancer vs controls, & for #radioactiveiodine therapy vs no RIA use.
journals.sagepub.com/doi/10.1089/thy.2022.0501?cf-mal-red…
#americanthyroidassociation #atathyroid2023 #medtwitter #endotwitter -
Mary Ann Liebert Inc
@LiebertPub
Treating #idiopathicpulmonaryfibrosis with #nebulizer Technologies
The development of new inhalation treatments for idiopathic pulmonary fibrosis is indispensable to offer alternatives to patients with this condition: journals.sagepub.com/doi/10.1089/jamp.2022.0020?cf-mal-re… -
Mary Ann Liebert Inc
@LiebertPub
Telemedicine facilitated continued access to #genderaffirmingcare services for #transgender #genderdiverse youth during the COVID-19 #pandemic, highlighting the importance of #telemedicine in the ongoing provision of gender-affirming care: journals.sagepub.com/doi/10.1089/tmj.2022.0382?cf-mal-red… @Telemedicine_Jn
-
Mary Ann Liebert Inc
@LiebertPub
#dnaanalysis helped lead to the arrest of accused murderer in the #homicide of Idaho students. While the investigation continues to unfold, #forensicgenetics, #familialsearching, & #forensicgeneticgenealogy are being discussed by the public more than ever. journals.sagepub.com/doi/10.1089/forensic.2023.0004?cf-ma…
-
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Take a look at my Feb #editorial in @Cyberpsych_Jn @LiebertPub discussing how we can help our #healthcare workers. "Recent studies are beginning to paint a picture of exactly how #covid has impacted providers' #mentalhealth." #burnout #virtualreality www.liebertpub.com/doi/10.1089/cyber.2023.29266.editorial
-
Mary Ann Liebert Inc reposted
Johns Hopkins Center for Health Security
@BSPH_CHS
New paper published in Applied Biosafety (@LiebertPub):
“Improving U.S. #biosafety + #biosecurity: Revisiting #recommendations from the FESAP and the FTAC-SAR” by Analyst @haines_clint + Senior Scholar @ggronvall.
www.liebertpub.com/doi/10.1089/apb.2022.0025 -
Mary Ann Liebert Inc
@LiebertPub
Mark your calendars for March 24! Don't miss Emily Anderson @HZDiscovery describe the development of the Dharmacon™ Edit-R™ #crispr algorithm and the selection of predesigned guide #rnas for functional and highly specific knockouts with @CRISPRjournal: www.workcast.com/register?cpak=2886197989434086&referrer=901
-
Mary Ann Liebert Inc
@LiebertPub
On, With, By—Advancing #transgenderhealthresearch
These necessary steps @HealthEquityJrl to recruit, collaborate, and elevate trans experts can advance the fields of #transgender health research & clinical care & center trans-led scholarship:journals.sagepub.com/doi/10.1089/heq.2022.0146?cf-mal-red… #healthequity -
Mary Ann Liebert Inc reposted
Clinical Thyroidology
@clinicalthyroid
This survey study of clinicians who manage #thyroid #eye disease provides an interesting look at how TED is uniquely approached worldwide.
journals.sagepub.com/doi/10.1089/ct.2023%3B35.61-63?cf-ma…
#americanthyroidassociation #clinicalthyroidology #ophthotwitter @aao_ophth @CANeyeMDs @APAOphth @ETA_Thyroid -
Mary Ann Liebert Inc
@LiebertPub
Explore emerging #inflammasome #inflammation research with field leaders @KeystoneSymp #innateimmunity: From Innate Sensing to Adaptive Responses, this April in Snowbird! www.keystonesymposia.org/conferences/conference-listing/m… @viral_im_jrnl
-
Mary Ann Liebert Inc
@LiebertPub
Ecological and Human Health Risks of Soil Heavy Metals
A comprehensive study of soil #heavymetalpollution, #ecologicalrisks, and #healthrisks could provide a scientific picture for the ecological management of #coastalsoils: journals.sagepub.com/doi/10.1089/ees.2022.0247?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Molecular Mechanisms of #mmpl3 Function and Inhibition
Researchers @michiganstateu summarize new findings in the field and seek to assess future areas of research in our rapidly expanding understanding of MmpL3 as a drug target: journals.sagepub.com/doi/full/10.1089/mdr.2021.0424?cf-ma… #drugdiscovery -
Mary Ann Liebert Inc reposted
PHAGE: Therapy, Applications, and Research
@PHAGEJournal
Gene transfer agents (GTAs) are fascinating phage-like particles that have potential for therapeutic applications. But obtaining pure and functional cultures? Notoriously tricky. Check out this novel method using monolithic chromatography: www.liebertpub.com/doi/10.1089/phage.2022.0035
-
Mary Ann Liebert Inc
@LiebertPub
A New Approach Method to Study #thyroidhormonedisruption: Optimization and Standardization of an Assay to Assess the Inhibition of DIO1 Enzyme in Human #livermicrosomes: journals.sagepub.com/doi/full/10.1089/aivt.2022.0010?cf-m…
-
Mary Ann Liebert Inc
@LiebertPub
#antiinflammatories in the Treatment of #dryeyedisease
Understanding the pathogenesis of inflammatory DED has enabled identification of biomarkers as potential therapeutic targets, resulting in development of effective anti-inflammatory treatment options: journals.sagepub.com/doi/10.1089/jop.2022.0133?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
#monoclonalantibodies Targeted Against #sarscov2
Newly approved products active against the currently circulating #variants and #antibodies in #clinicaltrials may prove in the continuous fight against the #pandemic to be valuable assets: journals.sagepub.com/doi/10.1089/mab.2022.0033?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Gene and Cell Therapies to Combat #pancreaticcancer
#genetherapy is currently in clinical testing to treat this incurable form of #cancer. A comprehensive review of the gene and cell biotherapies in development to combat pancreatic cancer in @HGTJournal: journals.sagepub.com/doi/10.1089/hum.2022.210?cf-mal-redi… -
Mary Ann Liebert Inc reposted
Telemedicine Journal
@Telemedicine_Jn
Postpartum Care in the Time of COVID-19: The Use of Telemedicine for Postpartum Care
Read now: journals.sagepub.com/doi/10.1089/tmj.2022.0065?cf-mal-red… -
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Beginning the year with a @Cyberpsych_Jn @LiebertPub editorial on our future generation's #mentalhealth in a Pandemic-Altered World: Technology's Evolving Role
doi.org/10.1089/cyber.2022.29264.editorial #childrensmentalhealth #cyberpsychology #virtualreality #socialnetworking #digitaltherapeutics -
Mary Ann Liebert Inc
@LiebertPub
#transglutaminase2 May Serve as a Promising Biomarker of #cancer Prognosis
A new meta-analysis is the first of its kind study to demonstrate that elevated TG2 is a promising prognostic factor in patients with cancer: journals.sagepub.com/doi/10.1089/gtmb.2022.0088?cf-mal-re… #solidtumor #cancerbiomarker -
Mary Ann Liebert Inc
@LiebertPub
Local #climateaction Planning toward Larger Impact
Regional park systems hold a vital role in the health and well-being of the social-ecological systems within and surrounding them, and inherently offer an ideal space to advance climate planning. journals.sagepub.com/doi/10.1089/scc.2022.0109?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
A Path Forward for COVID-19 Vaccine Equity
@HopkinsMedicine researchers document key lessons as we continue to confront #covid19 variants & work to adapt #vaccine outreach strategies to best serve our community with hope to end the #pandemic: journals.sagepub.com/doi/10.1089/hs.2022.0096?cf-mal-redi… #healthequity -
Mary Ann Liebert Inc reposted
Brenda K Wiederhold
@VirtualBrenda
Honoured to be involved with this @DigitalEU report on #xr for #health #education #training #vr #behavioralhealth @Cyberpsych_Jn @LiebertPub
Patrick Grady
@patrickgrady_
Wow. Mammoth study on European XR ecosystem.
Kudos @fien_depaepe, @boel_carl, @luisqtr0, @kimthousiast, @TomVanDaele, @VirtualBrenda
digital-strategy.ec.europa.eu/en/library/extended-reality… -
Mary Ann Liebert Inc
@LiebertPub
Codesign of biobased cellulose-filled filaments and mesostructures @Uni_Stuttgart @3DPrintingJrnl opens new opportunities for the utilization of #4dp and natural resources for the development of functional humidity-responsive smart structures: journals.sagepub.com/doi/full/10.1089/3dp.2022.0061?cf-ma…
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue: How Stakeholders Are Working to Advance #healthequity
Submit your manuscript to @HealthEquityJrl focused on the topic of Health Equity in the US -- Learn more: www.sagepub.com/journals/mary-ann-liebert-journals-transi… @commonwealthfnd -
Mary Ann Liebert Inc
@LiebertPub
Fabricating Wood-Like Textures on Multicurved #3dp Architectural Elements
@Eng_IT_Sydney @3DPrintingJrnl reveals novel methods of creating timber-like surface from fused filament fabrication 3DP that can be customized to suit a variety of applications: journals.sagepub.com/doi/10.1089/3dp.2021.0139?cf-mal-red… -
Mary Ann Liebert Inc reposted
Transgender Health
@TransgenderHlth
Just Published: Support Saves Lives: Exploring the Relationship Between Age of Transition, Family Support, and Retrospective K-12 Educational Experiences in Transgender Suicidality journals.sagepub.com/doi/full/10.1089/trgh.2022.0073
-
Mary Ann Liebert Inc
@LiebertPub
New Episode of @JEndourology @CookMedical Open Channels!
How Do Stents Made of Different Materials Help Mitigate Post-URS Problems? LISTEN NOW: www.sagepub.com/journals/mary-ann-liebert-journals-transi…
#uretericstents #stents #endourology #urology -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #indigenouspeoples & #environmentaljustice
In order to push against existing divides between Indigenous Peoples and environmental justice policies, join us to center Indigenous Peoples’ voices, perspectives, and knowledge systems: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Inside the March Issue of Planned Giving Today: The art and science of fundraising, prospect research for planned gift programs, and more -- Read the full issue: journals.sagepub.com/doi/epdf/10.1089/pgt.2023.34.3-1?cf-…
#plannedgiving #plannedgiftprograms #fundraising #prospectresearch #endowments #ira -
Mary Ann Liebert Inc
@LiebertPub
Online Videos on #facialfeminizationsurgery: What Are Patients Watching on #tiktok and #youtube?
Social media videos may present an underutilized opportunity for physicians to provide accessible evidence-based information on facial feminization surgery: journals.sagepub.com/doi/10.1089/fpsam.2022.0329?cf-mal-r… -
Mary Ann Liebert Inc reposted
Health Equity
@HealthEquityJrl
The journal has recently launched a book reviews section, edited by @NursePatMacRN ! This new section is currently not associated with OA fees. Please consider submitting reviews on books that inform your approach to health equity . Reviews on new books or classic texts
-
Mary Ann Liebert Inc
@LiebertPub
Reminder: Call for Papers! #genetic and Non-Genetic #inflammation Networks in Major #humandiseases
In this research topic, @HGTJournal welcomes submissions regarding the genetic and non-genetic determinants in pathological inflammation. Submit today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
#homecooking as a Means to Improve #dietaryquality
More frequent household cooking can improve dietary quality and reduce ultraprocessed food consumption among children and adolescents, according to a new study in @ChildObesity_jn: journals.sagepub.com/doi/10.1089/chi.2022.0200?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Is Public Engagement in #bioengineering and #syntheticbiology Improving #researchoutcomes?
Potentially challenging questions are emerging for the bioengineering and synthetic biology communities in their quest for responsible science development: journals.sagepub.com/doi/10.1089/omi.2022.0181?cf-mal-red… -
Mary Ann Liebert Inc reposted
Journal of Palliative Medicine
@PalliativeMed_j
On behalf of the Publisher of @PalliativeMed_j , we are happy inform you that we will be suspending the submission fee for the journal, effective March 1, 2023, to allow every researcher in the field who wants to submit to JPM to have the opportunity to do so.
-
Mary Ann Liebert Inc
@LiebertPub
Pediatricians’ Interactions with Infant Formula Companies
#pediatrician and #infantformula company interactions in the US are ubiquitous. Could these visits influence the advice pediatricians give to mothers who had planned to #breastfeed exclusively? journals.sagepub.com/doi/10.1089/bfm.2022.0217?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Today is @LiebertPub's 43rd Anniversary!
As we celebrate our dedication to the field, we look ahead to continue to inform, inspire, and advance global innovation to support a healthy, sustainable future. Thank you for 43 fantastic years! -
Mary Ann Liebert Inc
@LiebertPub
#sexting Found to Be Associated with Negative #mentalheath
Given the popularity of sexting, concerns have been raised. A new study @Cyberpsych_Jn shows that sexting was associated with #depression, #anxiety, #sleepproblems, and #compulsivesexualbehaviors. journals.sagepub.com/doi/10.1089/cyber.2022.0312?cf-mal-r… -
Mary Ann Liebert Inc
@LiebertPub
#microgravity & #lymphatics: Health in #space & on #earth
The resurgence of #spacetravel in recent years beckons the need to understand the role of the lymphatic system and of endothelial glycocalyx when subjected to gravitational alterations. Here's why: journals.sagepub.com/doi/10.1089/lrb.2022.0070?cf-mal-red… -
Mary Ann Liebert Inc reposted
Journal of Endourology
@JEndourology
Although SIRS offers higher sensitivity, qSOFA score may offer advantages over SIRS criteria in evaluation of risk for septic shock for patients who present with obstructing ureteral stone and urinary tract infection @BEkidneystone
www.liebertpub.com/doi/10.1089/end.2022.0200 -
Mary Ann Liebert Inc
@LiebertPub
Novel Therapeutics in #nonalcoholicfattyliver Disease: A Focus on Adult #stemcells
Although no specific therapy has been approved for #nafld, researchers review the latest medical therapeutics with emphasis on stem cell-based possibilities: journals.sagepub.com/doi/10.1089/met.2022.0069?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
China Masters Key Technology of #mrnavaccines
The role of the novel #coronavirusvaccine has become more and more critical. Biotechnology Law Report covers the technical route of China's novel #coronavirus research & development as it begins to diversify: journals.sagepub.com/doi/10.1089/blr.2023.29294.hw?cf-mal… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: Special Issue on #spatialomics
Take part in @GENBiotechJrnl's inaugural special issue on one of the fastest-paced growth areas in the #biotech industry, poised to drive the next wave of #biology revolution -- Submit your manuscript today: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Targeting #glucosemetabolism to Help Slow the #aging Process
#acarbose may be considered an #antiaging agent that may provide an innovative strategy for developing an effective treatment for optimal management of oxidative damage to promote healthy aging. journals.sagepub.com/doi/10.1089/rej.2022.0032?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
The Wisdom in Teeth: #neuronaldifferentiation of #dentalpulpcells
Discover the key properties of dental pulp stem cells with a particular focus on their neurogenic potential in @CellRepJrnl: journals.sagepub.com/doi/10.1089/cell.2022.0102?cf-mal-re…
#dentalpulpstemcells #dpscs #mesenchymalstemcells #mscs -
Mary Ann Liebert Inc
@LiebertPub
#pulsecapacitivecouplingelectricfield to Accelerate #woundhealing
A safe and effective pulse capacitive coupling electrical field has been developed to promote wound healing and help alleviate patient suffering, while reducing side effects: journals.sagepub.com/doi/10.1089/wound.2021.0194?cf-mal-r… -
Mary Ann Liebert Inc reposted
Tissue Engineering
@TissueEngin
In case you missed it!
Read our latest special issue on machine learning: www.liebertpub.com/toc/tea/29/1-2 -
Mary Ann Liebert Inc
@LiebertPub
How #nature Can Serve as a Co-Therapist for #adversechildhoodexperiences
Nature therapy is a relational embodied bottom-up approach to trauma-informed treatment that can provide preventative & restorative benefits, according to a study in Ecopsychology: journals.sagepub.com/doi/10.1089/eco.2022.0064?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Where Does #genetherapy Go After #cerebrospinalfluiddelivery?
A new report in @HGTJournal presents a literature review of preclinical studies of adeno-associated virus (#aav)-based gene therapy biodistribution following cerebrospinal fluid delivery: journals.sagepub.com/doi/10.1089/hum.2022.163?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
Global Thiol Proteome Analysis Provides Novel Insights into #macrophage Inflammatory Response & Regulation by #thioredoxin System
New study provides a rich resource for characterization of redox mechanisms that regulate macrophage inflammatory activities: journals.sagepub.com/doi/10.1089/ars.2022.0026?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Growing evidence of #oxidativestress as a pivotal determinant of #cancer- and #chemotherapy-induced #musclewasting in #cachexia paves the way for targeting the redox homeostasis in the attempt to counteract muscle atrophy and dysfunction: journals.sagepub.com/doi/10.1089/ars.2022.0149?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Human Gene Therapy
@HGTJournal
Steven Gray, PhD of @utswnews and co-authors present a literature review of preclinical studies of AAV-based #genetherapy biodistribution following cerebrospinal fluid delivery: www.liebertpub.com/doi/10.1089/hum.2022.163
-
Mary Ann Liebert Inc
@LiebertPub
Personal #psychedelicuse Among #psychedelictherapists
Whether personal use of #psychedelics is appropriate among psychedelic therapists, a new study finds that it may be common. journals.sagepub.com/doi/10.1089/psymed.2022.0004?cf-mal-… -
Mary Ann Liebert Inc
@LiebertPub
Stromal Vascular Fraction Restores Vasodilatory Function by Reducing Oxidative Stress in Aging-Induced Coronary Microvascular Disease journals.sagepub.com/doi/10.1089/ars.2021.0249?cf-mal-red…
#aging #oxidativestress #stromalvascularfraction #coronarymicrovasculardisease #endothelialdysfunction #stemcells -
Mary Ann Liebert Inc
@LiebertPub
Beauty Inside Out: The Fight Against Racialized Beauty Norms
The fight for #environmentalequity includes the right to clean air, land, water, and food as well as safe and healthy cosmetics and personal care products. journals.sagepub.com/doi/10.1089/env.2022.0053?cf-mal-red… #beautyproducts #beautyjustice -
Mary Ann Liebert Inc
@LiebertPub
Wild Urban Injustice: Advancing #environmentaljustice for Humans and Species Alike
A Critical POET Model shows us that addressing environmental injustices is essential for promoting coexistence with wildlife. journals.sagepub.com/doi/10.1089/env.2022.0022?cf-mal-red…
#humanecology #wildlife #multispeciesjustice -
Mary Ann Liebert Inc
@LiebertPub
wnt11f2 Zebrafish, an Animal Model for Development and New Insights in Bone Formation
Discover the characterization of the wnt11f2 zebrafish mutant and new insights concerning its role in skeletal development: journals.sagepub.com/doi/full/10.1089/zeb.2022.0042?cf-ma…
#wnt11f2 #zebrafish #boneformation -
Mary Ann Liebert Inc
@LiebertPub
The Living Archives of #biodiversity: Spotlight on #biodiversitybiobanks
Giving biodiversity biobanks special attention for their significant role in biodiversity research, conservation science, public health, and other basic & translational research: journals.sagepub.com/doi/10.1089/bio.2021.0127?cf-mal-red… -
Mary Ann Liebert Inc reposted
The CRISPR Journal
@CRISPRjournal
We've hit 20,000 followers!
Thank you to everyone for making @CRISPRjournal the largest (and hopefully one of the most informative) communities for #crispr and genome editing.
Special thanks to all our authors, reviewers, and contributors.
home.liebertpub.com/publications/the-crispr-journal/642 -
Mary Ann Liebert Inc
@LiebertPub
In the era of combination #antiretroviraltherapy, people living with #hiv still face an increased risk of #cardiovasculardisease. Research points toward the importance of an individualized approach when selecting an antiretroviral therapy regimen: journals.sagepub.com/doi/10.1089/aid.2022.0086?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Next Generation #biobanking with #robotics
This automatic robotic system can become a tool for biobanking in the field of #immunology & #hematology that may advance research & novel approaches that are pertinent to disease prevention, diagnosis, & therapy:journals.sagepub.com/doi/10.1089/bio.2021.0181?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Efficient Neural Differentiation of Mouse #embryonicstemcells by #masticgum
The results of a new investigation may have an impact on future #stemcelltherapy of neurodegenerative disorders: journals.sagepub.com/doi/10.1089/bio.2021.0130?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Hypoxia Attenuates Colonic Innate Immune Response and Inhibits TLR4/NF-κB Signaling Pathway in Lipopolysaccharide-Induced Colonic Epithelial Injury Mice journals.sagepub.com/doi/10.1089/jir.2022.0194?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Soft Robotics
@SoftRobotics_JN
Recently published article "Bio-Inspired Transparent Soft Jellyfish Robot" developed a fully transparent soft #jellyfish #robot to possess both transparency and bio-inspired omni motions in water.
www.liebertpub.com/doi/10.1089/soro.2022.0027 -
Mary Ann Liebert Inc
@LiebertPub
How a #healthylifestyle Can Help Prevent #cognitivedecline
Let's talk #brainhealth. Sit down for a conversation with Sandra Darling, DO, MPH as she shares her passion in the field and #integrativeapproaches she follows for people with brain health issues: journals.sagepub.com/doi/10.1089/ict.2022.29053.sda?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
#terminalsterilization of #oligonucleotidedrugproducts
A new report, coauthored by several major #pharmaceutical companies, reviews the current state and provides recommendations to aid in the evaluation of sterile #oligonucleotide drug product processing:journals.sagepub.com/doi/10.1089/nat.2022.0073?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Brands Accelerate Push for #biosurfactants
Biosurfactants are already being used in products on sale today and brands continue to push for capacity. Indeed, the market outlook for novel biosurfactants looks bright. journals.sagepub.com/doi/10.1089/ind.2023.29302.editorial… -
Mary Ann Liebert Inc
@LiebertPub
Preconception Blood Glucose Levels and the Risk of Preterm Birth
New study findings replicate prior research showing strong associations between #preconception #diabetes and #pretermbirth, adding that #prediabetes is also associated with higher risk. journals.sagepub.com/doi/10.1089/jwh.2022.0256?cf-mal-red… -
Mary Ann Liebert Inc reposted
LGBT Health
@LGBTHealthJrnl
Call for Special Issue Papers: Violence and Related Health Outcomes in Sexual & Gender Minority Communities
Deadline for Manuscript Submission: March 31, 2023
Learn More Here: journals.sagepub.com/doi/10.1089/lgbt.2022.29008.cfp?cf-m… -
Mary Ann Liebert Inc
@LiebertPub
Call for Papers! Special Issue on #electroacupuncture
Submit your manuscript to join us in fostering a better understanding of the underlying mechanisms and the clinical effectiveness of electroacupuncture: www.sagepub.com/journals/mary-ann-liebert-journals-transi… #medicalacupuncture -
Mary Ann Liebert Inc
@LiebertPub
Second Generation #genetherapy for Alpha 1-Antitrypsin Deficiency
Researchers report on the safety of a gene therapy to treat the common autosomal recessive hereditary disorder alpha 1-antitrypsin (AAT) deficiency: journals.sagepub.com/doi/10.1089/hum.2022.192?cf-mal-redi… #aat #aatdeficiency @HGTJournal -
Mary Ann Liebert Inc
@LiebertPub
Salad Days: @PairwisePL Gene Edits Food to Topple Nutrition Barriers
Under the brand “Conscious Foods,” food tech #geneediting company plans to broaden nutritious options by making fruit & vegetables fresher, tastier, and easier to access: journals.sagepub.com/doi/10.1089/genbio.2023.29078.jdg?cf… @GENBiotechJrnl -
Mary Ann Liebert Inc
@LiebertPub
What Is a Drug? Enabling the #bioeconomy Through Updated @US_FDA Policy
The current U.S. regulatory approaches for #biotechnology & #biomanufacturing innovations place U.S. #animalagriculture at a disadvantage globally. The scientific community weighs in: journals.sagepub.com/doi/10.1089/genbio.2023.0003?cf-mal-… -
Mary Ann Liebert Inc reposted
New Space
@NewSpace_JRNL
"Peace Thought and Socioeconomy for the Space Age Using Satellites" explores new ideas for the peaceful use of the planet, focusing on the sustainable development goals and other economic systems.
www.liebertpub.com/doi/10.1089/space.2021.0017 -
Mary Ann Liebert Inc
@LiebertPub
New Algorithm to Assess #insulinsensitivity in Patients with #t1d
Researchers propose a new index of insulin sensitivity, from glucose sensor & insulin pump data, and thus valuable to quantify insulin sensitivity in real-life conditions in youth with T1D: journals.sagepub.com/doi/10.1089/dia.2022.0397?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Is There a Genetic Link Between #thyroiddysfunction and Common #psychiatricdisorders?
In a new study published in @thyroidjournal, researchers seek new insights into the potentially shared mechanisms underlying thyroid dysfunction & psychiatric disorders: journals.sagepub.com/doi/10.1089/thy.2022.0304?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Potential Therapeutic Target for HIV-1-Associated #neurocognitivedisorder
Targeting the #endocannabinoidsystem may be a promising strategy to alleviate the inflammation and #neurodegeneration caused by #hiv1 infection, according to study in @CannabisJrnl: journals.sagepub.com/doi/10.1089/can.2022.0267?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Building Lunar Landing Pads
A new study in @NewSpace_JRNL digs into the cost of building many more landing pads for commercial & governmental demand as the lunar economy develops: journals.sagepub.com/doi/10.1089/space.2022.0015?cf-mal-r…
#lunarconstruction #lunarlandingpads #newspace #space #moon #lunareconomy -
Mary Ann Liebert Inc reposted
@BigData_Journal
Recently published article "Applications of Bayesian Neural Networks in Outlier Detection" by @tao_chen_ideas aims to propose a widely applicable method of outlier detection using Bayesian Neural Networks based on uncertainty measurement.
www.liebertpub.com/doi/10.1089/big.2021.0343 -
Mary Ann Liebert Inc
@LiebertPub
So much more to #crispr than just the clinic: With less fanfare but huge potential for impact, #genomeediting technologies are poised to revolutionize #agriculture at a time when #sustainability is a global priority.
journals.sagepub.com/doi/10.1089/crispr.2023.0002.editori…
journals.sagepub.com/doi/10.1089/crispr.2022.0072?cf-mal-…
@CRISPRjournal -
Mary Ann Liebert Inc
@LiebertPub
A Call to Action: As #telemedicine use increases, research is urgently needed to document the impact of such services on #transgender and #gendernonconforming youths' access to #genderaffirmingcare. journals.sagepub.com/doi/10.1089/trgh.2021.0063?cf-mal-re… #transgenderhealth #transgenderyouth @TransgenderHlth
-
Mary Ann Liebert Inc reposted
AMWA Doctors
@AMWADoctors
Congrats AMWA Leaders & Students on this article, The Evolution of the National Centers of Excellence in Women's Health - led by AMWA's @SexGenderHealth & @iGIANT4ALL! Special thx to Dr. Deb Kwolek, @SaralynMark & @LiebertPub
#medtwitter #womenshealth
www.liebertpub.com/doi/full/10.1089/jwh.2022.0503?casa_to… -
Mary Ann Liebert Inc
@LiebertPub
A Word on the Recent Changes to Animal Protection Measures in @US_FDA Policy
The removal of federal mandates was promised to “reboot a broken #drugdevelopment paradigm…” but at what cost? journals.sagepub.com/doi/10.1089/adt.2023.29103.bjm?cf-ma…
#fda #drugsafety #animaltesting #clinicaltrials #invivotesting -
Mary Ann Liebert Inc
@LiebertPub
#transgenderhealth in #correctionalsystems
Understanding the experiences of #transgender and #genderdiverse people ultimately serves as the foundation for quality, #genderaffirmingcare, and respectful correctional treatment. Read the Special Issue: journals.sagepub.com/toc/jchc/29/1?cf-mal-redirected=true& -
Mary Ann Liebert Inc reposted
Astrobiology Journal
@Astrobiology_jn
Microbial Motility at the Bottom of North America: Digital Holographic Microscopy and Genomic Motility Signatures in Badwater Spring, Death Valley National Park
Read now: journals.sagepub.com/doi/full/10.1089/ast.2022.0090?cf-ma… -
Mary Ann Liebert Inc
@LiebertPub
Photobiomodulation Reduces Periocular Wrinkle Volume by 30%
Study shows #photobiomodulation, both at red and amber wavelengths, is an effective tool for #rejuvenation, producing a 30% #wrinkle volume reduction. journals.sagepub.com/doi/10.1089/photob.2022.0114?cf-mal-… -
Mary Ann Liebert Inc reposted
Barbara T. Murphy Mount Sinai Div. of Nephrology
@ISMMSKidney
"A Retrospective Cohort Study That Examined the Impact of #cannabis Consumption on Long-Term #kidney Outcomes"
www.liebertpub.com/doi/10.1089/can.2022.0141
@ThepHunClub @scoca1 @DOMSinaiNYC @LiebertPub
#nephrology #ckd -
Mary Ann Liebert Inc
@LiebertPub
Scientists present novel method to construct larger flexible cellular robots for marine applications journals.sagepub.com/doi/10.1089/soro.2022.0117?cf-mal-re…. @PopSci covers the fascinating new advances in developing affordable & adaptable #underwaterrobots showcased in @SoftRobotics_JN: www.popsci.com/technology/mit-voxel-eel-robot/
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: #covid19 #systemsbiology & #digitaltechnologies in #ecology #health & #society
Submit today to rise to the challenges & raise the bar on systems biology to boost discovery & development of new diagnostics & interventions against COVID-19: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Researchers Propose Programmable #antivirals and Just-in-Time #vaccines
There is a novel approach to antiviral drugs that has great promise as a countermeasure against #rna viruses, many of which have #pandemic potential. journals.sagepub.com/doi/10.1089/hs.2022.0098?cf-mal-redi… -
Mary Ann Liebert Inc
@LiebertPub
Biodegradable Chitosan-Based Membranes for Highly Effective Separation of Emulsified Oil/Water
To maintain water and energy sustainability, it is critical to have efficient technologies of purifying oily water in industrial & domestic wastewater streams. journals.sagepub.com/doi/full/10.1089/ees.2022.0254?cf-ma… -
Mary Ann Liebert Inc reposted
3D Printing
@3DPrintingJrnl
A current study demonstrates an alternative model of beam distribution based on a heavy-tailed Lorentzian model, which is able to more accurately predict small build areas for both positive and negative features.
www.liebertpub.com/doi/10.1089/3dp.2022.0193 -
Mary Ann Liebert Inc
@LiebertPub
What We Know About #ticks in #alabama
New study results serve to provide some insights into #tickbornedisease pathogens associated with ticks in Alabama to help to fully understand the tick-borne disease threat to #humanhealth in this population: journals.sagepub.com/doi/10.1089/vbz.2022.0038?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Significant gains have been achieved in the past decade; however, there is still great deal of work to do as it pertains to protecting, promoting & supporting #breastfeeding in Black communities: Breastfeeding Medicine journals.sagepub.com/doi/10.1089/bfm.2020.0314?cf-mal-red… @BostonGlobe www.bostonglobe.com/2023/02/02/magazine/breast-feeding-bl…
-
Mary Ann Liebert Inc
@LiebertPub
Does Regular #cannabisuse Have a Negative Impact on #publichealth?
In a first-time study published in @CannabisJrnl, regular #cannabis consumers were assessed using health indicators, comparing the data with the general population. Discover the findings: journals.sagepub.com/doi/10.1089/can.2022.0231?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
Call for Video Submissions!
Introducing FPSAM Video Journal, the new peer-reviewed video journal and complement to Facial Plastic Surgery & Aesthetic Medicine. Submit today and be a part of our inaugural year: journals.sagepub.com/publications/fpsam-video-journal/671… #plasticsurgery #aestheticmedicine -
Mary Ann Liebert Inc
@LiebertPub
Register Today to Participate Live TOMORROW!
Join us tomorrow, 2/14 to talk new tools for analysis of #crispr editing events with Shondra Pruett-Miller, PhD! Click here to register for this special free webinar hosted by @CRISPRjournal: www.workcast.com/register?cpak=9702616813213987&referrer=… @ersgenomics -
Mary Ann Liebert Inc reposted
Childhood Obesity
@ChildObesity_jn
Parental Perspectives Regarding the Impact of the COVID-19 Pandemic on Their Children, published in @ChildObesity_jn
Link to pub: www.liebertpub.com/doi/10.1089/chi.2021.0216 -
Mary Ann Liebert Inc
@LiebertPub
#phageannotation Guide: This article @PHAGEJournal defines 14 questions for those new to #phagegenomics that should be addressed before submitting a #genomesequence to the International Nucleotide Sequence Database Collaboration or writing a publication: journals.sagepub.com/doi/10.1089/phage.2021.0013?cf-mal-r…
-
Mary Ann Liebert Inc
@LiebertPub
The presence of cross-reactive Abs against two conserved antigens in sera from #sarscov2, particularly in the context of #hybridimmunity, could pave the way for future boosted #vaccines carrying these conserved regions, according to a study @viral_im_jrnl: journals.sagepub.com/doi/10.1089/vim.2022.0186?cf-mal-red…
-
Mary Ann Liebert Inc reposted
Shaowei Wan, PhD, MS, MA, BPharm
@ShaoweiWanPhD
Our paper highlighted by @LiebertPub (email.liebertpub.com/q/13XE89AljSsmLfyPYNJkD/wv) as a high impact article suggests that hospice workforce shortage in rural and frontier communities requiring long commute may contribute to less hospice use among rural older adults with cancer. #ruralpalliativecare
-
Mary Ann Liebert Inc
@LiebertPub
A new study in @J_Neurotrauma finds long-term #cognitive deficits begin to be seen after only three lifetime #mtbis. @guardian covers these findings: www.theguardian.com/sport/2023/jan/31/three-or-more-concu…
-
Mary Ann Liebert Inc
@LiebertPub
Underwater #continuumrobots
A novel method presented in @SoftRobotics_JN demonstrates rapidly manufacturing flexible #robotic platforms for #aquatic applications for more efficient and effective future #oceanexploration and exploitation: journals.sagepub.com/doi/10.1089/soro.2022.0117?cf-mal-re… #softrobots -
Mary Ann Liebert Inc
@LiebertPub
Recent decades have witnessed positive sociocultural shifts for #sexualminority groups, yet growing evidence shows that sexual minority individuals have substantially poorer #mentalhealth & adverse health-related behaviors compared with heterosexual peers. journals.sagepub.com/doi/10.1089/lgbt.2021.0473?cf-mal-re…
-
Mary Ann Liebert Inc reposted
Cannabis and Cannabinoid Research Journal
@CannabisJrnl
The February issue has just published online!
Check it out now: journals.sagepub.com/toc/can/8/1?cf-mal-redirected=true& -
Mary Ann Liebert Inc
@LiebertPub
#acetylcholinereceptors in #mesenchymalstemcells
New evidence suggests that acetylcholine receptors may present as a promising therapeutic target to control the regenerative potential of mesenchymal stem cells: journals.sagepub.com/doi/10.1089/scd.2022.0201?cf-mal-red… -
Mary Ann Liebert Inc
@LiebertPub
As the #additivemanufacturing market continues to grow, the workforce must be equipped with skills & knowledge to meet this growing demand & drive future innovation in industrial product development. @3DPrintingJrnl covers additive manufacturing education: journals.sagepub.com/doi/10.1089/3dp.2022.0180?cf-mal-red…
-
Mary Ann Liebert Inc
@LiebertPub
Register Today for a New, Exciting Webinar hosted by @CRISPRjournal!
Join us on Tuesday, February 14 to talk new tools for analysis of #crispr editing events with Shondra Pruett-Miller, PhD! Click here for event details and to register free: www.workcast.com/register?cpak=9702616813213987&referrer=… @ersgenomics -
Mary Ann Liebert Inc
@LiebertPub
A Special Collection for #internationalthyroidawareness
@AmThyroidAssn @thyroidjournal @clinicalthyroid @VEndocrinology #worldthyroidday Special Collection highlights current understanding and new information in #thyroidology from across the globe: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Special Collection: #thyroidawarenessmonth
This Special Collection from @thyroidjournal @clinicalthyroid @VEndocrinology @AmThyroidAssn highlights current understanding and the most recently published information in the field. Explore the full collection: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
TOMORROW at 11AM ET: Don't miss your chance to participate live with Professor Dan Peer of Precision NanoMedicine @peer_lab as he discusses the state of RNA-based therapeutics & more! It's not too late to register: www.workcast.com/register?cpak=6472982886309388&referrer=200 @GENbio @CRISPRjournal @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
We are just one week away! Join in with your colleagues to hear Professor Dan Peer of Precision NanoMedicine @peer_lab discuss the state of RNA-based therapeutics & more -- Register today to participate live on 8/31: www.workcast.com/register?cpak=6472982886309388&referrer=200 @GENbio @CRISPRjournal @TriLinkBioTech
-
Mary Ann Liebert Inc
@LiebertPub
Have you registered? Don't miss Professor Dan Peer of Precision NanoMedicine @peer_lab discuss the state of RNA-based therapeutics and more in an exciting webinar by @GENbio @CRISPRjournal and @TriLinkBioTech! Register today for free: www.workcast.com/register?cpak=6472982886309388&referrer=200
-
Mary Ann Liebert Inc
@LiebertPub
Call for Papers: The Use of Telehealth in Addressing the Needs of Underserved Populations*
@Telemedicine_Jn with support from @CHCFNews is prioritizing the need for impactful research in the field to support underserved populations during times of crisis: www.sagepub.com/journals/mary-ann-liebert-journals-transi… -
Mary Ann Liebert Inc
@LiebertPub
Coronavirus Highlights Urgent Need for Science-Backed Research: A collection of articles are available free to serve as open resources for the community as it works to ensure that the #covid19 outbreak is fully understood & contained. Stay informed today: www.sagepub.com/journals/liebert-info
-
Mary Ann Liebert Inc
@LiebertPub
Join our team at Booth 83 #vala2020 next week. Swing by to find out how our journals can enrich your library!
@VALAlib @Burgundy_Info -
Mary Ann Liebert Inc
@LiebertPub
Our team will be at Booth 83 at #vala2020. Visit us and find out how our journals can enrich your library!
@VALAlib @Burgundy_Info #academicpublishing #academicresearch #academiclibraries #genetherapy #womenshealth #biotechnology #regenerativemedicine -
Mary Ann Liebert Inc
@LiebertPub
Interested in #acupuncture and #alternativehealth? Catch up on the @SAR_acuresearch June 2019 conference with this special report by John Weeks, EIC, The Journal of Alternative and Complementary Medicine: journals.sagepub.com/doi/10.1089/acm.2019.29073.jjw?cf-ma…
@IntegMedColl












































































































































































































































































































































































































































































































































































































































































































































